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Abstract
The translocation of a facilitative glucose transporter, GLUT4, from an intracellular 
site to the cell surface accounts for the large insulin-dependent increase in glucose 
transport observed in muscle and adipose tissue. Recent studies have indicated that a 
large proportion of intracellular GLUT4 is segregated from the recycling endosomal 
system in a post-endocytic storage compartment in 3T3-L1 adipocytes. However, the 
nature of this GLUT4 storage compartment, and the mechanism by which GLUT4 
reaches the cell surface upon insulin stimulation are poorly understood.
Here, I have used Tf-HRP-mediated endosomal ablation analysis to examine the 
protein composition of the post-endocytic compartment with the aim of further 
defining the relationship of this compartment to other, well characterised, intracellular 
membrane structures. The results provide further evidence for the existence of a 
GLUT4 compartment segregated from the endosomal system, which is devoid of cell 
surface to endosome recycling markers including the TfR and SCAMPs. The 
observation that within this compartment, GLUT4 co-localises with TGN marker 
proteins, y-adaptin and the CD-M6PR, suggests that GLUT4 traffics through the 
TGN as part of its recycling itinerary.
I further exploited this technique to examine the translocation of GLUT4 to the cell 
surface in response to insulin and GTPyS. The results indicate that insulin is still 
capable of stimulating GLUT4 translocation following endosomal ablation under 
conditions where GTPyS-stimulated GLUT4 translocation was effectively inhibited. 
In addition, both insulin- and GTPyS-stimulated GLUTl translocation were blocked 
following ablation of the recycling endosomal system. On the basis of these and other 
data, I propose that insulin stimulates the exocytosis of two distinct compartments, 
one being the post-endocytic storage compartment and the other being the endosomal 
system, which may also be stimulated by GTPyS..
Recent studies have implicated ARF proteins to function as regulators of regulated 
exocytosis. To investigate the role of ARF proteins in insulin-stimulated GLUT4 
translocation, we examined the effect of myristoylated ARF peptides on insulin- 
stimulated GLUT4 translocation and glucose transport in permeabilised 3T3-L1 
adipocytes. A myristoylated peptide corresponding to the N-terminus of ARF6 
markedly inhibited insulin-stimulated GLUT4 translocation and 2-deoxy-D-glucose 
transport, whereas ARF5 and ARFl peptides were without effect. In addition, an 
effective inhibitor of PLD, butan-l-ol was observed to have no effect on insulin- 
stimulated GLUT4 translocation and glucose transport. These results suggest that 
ARF6 plays a crucial role in insulin-stimulated GLUT4 translocation. However, PLD 
does not appear to function as a downstream effector of ARF in this event.
Finally, I have shown that a chimeric protein comprising the signal sequence of the 
human growth hormone and HRP (ssHRP) may be targeted to the exocytic pathway 
and secreted from 3T3-L1 adipocytes. However, due to the time constraints of this 
study, I was unable to use this HRP probe to ablate the TGN, thus enabling me to 
investigate the role of this sorting compartment in GLUT4 trafficking.
Acknowledgements
Firstly, I am indebted to Professor Gwyn Gould for his supervision throughout my 
Ph.D. I wish to thank him for providing me with the opportunity to pursue a career in 
science and for showing gi'eat enthusiasm towards my work. I also wish to thank the 
British Diabetic Association for funding this project.
Special thanks must go to members of Lab C36 past and present, all of which have 
been a great help and a source of entertainment for the last three years. In particular, I 
wish to thank my Ph.D 'soulmate' Derek, a fair player and a great friend. Thanks must 
also go to Valerie for all her help in the latter stages and to Di for her proof reading 
skills.
I wish to thank my parents for providing me with every opportunity to further my 
education, for their constant love and support and for making sure I always did my 
homework! I
Last, but by no means least, I wish to thank Dave for his patience, support and 
encouragement, especially during the writing up of this thesis.
Ill
To mum and dad, 
with all my love.
IV
'Only fools live lives without alternatives.'
Mitchell Wilson
Contents
Page
Abstract i
Acknowledgements ill
Dedication iv
Quotation v
Contents vi
List of Figures xvi
List of Tables xx
Abbreviations xxi
VI
Page
Chapter 1 Introduction 1
1.1 Glucose Transport 2
1.1.1 Insulin Resistance 2
1.1.2 GLUT4 - The Insulin-Responsive Transporter 3
1.2 Subcellular Trafficking - a General Background 4
1.3 The Endocytic System - Receptor-Mediated Endocytosis 5
1.3.1 Clathrin-Coated Pit Formation 6
1.3.2 Non-Clathrin-Mediated Endocytosis 8
1.3.3 Endosomal Compartments 9
1.3.4 Rah Proteins in Vesicle Transport 9
1.4 The Secretory System 11
1.4.1 The/ra«5-Golgi Network (TGN) 12
1.4.2 Vesicle Budding at the TGN 12
1.4.3 Sorting at the TGN 14
1.5 Membrane Targeting and Fusion 21
1.6 The Role of Phosphoinositides in Membrane Trafficking 23
1.7 The Facilitative Glucose Transporter Family 24
1.7.1 The Tissue-Specific Distribution of the Facilitative Glucose 25
Transporters
1.7.2 GLUTl 26
1.7.3 GLUT2 27
Vll
1.7.4 GLUTS 28
1.7.5 GLUT4 29
1.7.6 GLUTS 29
1.7.7 GLUT6 30
1.7.8 The Structure and Membrane Topography of the GLUTs 30
1.8 GLUT4-The Insulin-Responsive Glucose Transporter 32
1.9 GLUT4 Translocation 33
1.10 GLUT4 Subcellular Trafficking 3 5
1.11 The GLUT4 Intracellular Compartment 37
1.12 The Nature and Biogenesis of the GLUT4 Storage Compartment 40
1.13 GLUT4 Trafficking Signals 45
1.14 GLUT4 Trafficking: The Role of SNAREs and Rab Proteins 46
1.15 Signalling Mechanisms that Regulate GLUT4 Translocation 51
1.15.1 1RS Proteins and GLUT4 Translocation 53
1.15.2 PI3-Kinase and GLUT4 Translocation 54
1.15.3 Downstream Targets of PI3-Kinase 56
1.16 Aims of this Study 58
Vlll
Chapter 2 Materials and Methods 83
2.1
2 . 1.1
Materials 
General Reagents
84
84
2.2
2 .2.1
2 .2.2
2.2.3
General Buffers
Phosphate Buffered Saline (PBS) 
Krebs Ringer Phosphate (KRP) Buffer 
HES Buffer
87
87
87
87
2.3
2.3.1
2.3.2
2.3.3
2.3.4
2.3.5
2.3.6 
2.4 
2.4.1
Cell Culture
3T3-L1 Murine Fibroblasts 
Trypsinisation and Passage of 3T3-L1 Fibroblasts 
Differentiation of 3T3-L1 Fibroblasts 
Freezing and Storage of Cells
ResuiTection of Frozen Cell Stocks from Liquid Nitrogen 
Collagen Coating of Cell Culture Plastic Ware 
Antibody Preparations 
Purification of Anti-GLUT4 Antibody
89
90 
90
90
91
2.5 Protein Assay 91
2.6 SDS/Polyacrylamide Gel Electrophoresis 92
2.7 Western Blotting of Proteins 92
2.8
2 .8.1
2 . 8.2
Immunodetection of Proteins 93
Using Autoradiography 93
Using the Enhanced Chemiluminescence (ECL) Detection System 94
IX
2.9
2.9.1
2.9.2
Endosome Ablation 
Preparation of Tf-HRP Conjugate 
Use of Tf-HRP
94
94
96
2.10 Subcellular Fractionation of 3T3-L1 Adipocytes 96
2.11 Immunoadsorption of GLUT4 Vesicles 97
2.12
2 . 12.1
2 . 12.2
Indirect Immunofluorescence Microscopy
Plasma Memebrane Lawn Assay
Whole-Cell Indirect Immunofluorescence Microscopy
99
99
100
2.13 2-Deoxy-D-Glucose Transport Assay 101
2.14 Adipsin Release 102
2.15 Molecular Biology
2.15.1 Preparation of Competent Bacteria
2.15.2 Transformation of Competent Bacteria
2.15.3 Multiple Plasmid Minipreparations
2.15.4 Maxi Preparation of Plasmid DNA
2.15.5 Calculation to Determine the Plasmid DNA Concentration 
and Purity
2.15.6 Restriction Digestion of DNA
2.15.7 Dephosphoiylation of Linearised DNA
2.15.8 Agarose Gel Electrophoresis
2.15.9 Gel Extraction of DNA
103
103
103
104
105
106
106
107
107
108
Chapter 3 Compartment Ablation Analysis of the GLUT4
Intracellular Compartments
109
3.1 Aims 110
3.2 Introduction 111
3.3
3.3.1
3.3.2
3.3.3
3.3.4
Materials and Methods
Ablation of the Intracellular (LDM) Membranes 
Sucrose Density Gradient Analysis 
Whole-Cell Immunoflurescence Microscopy 
Antibodies
113
113
114
115 
115
3.4
3.4.1
3.4.2
3.4.3
3.4.4
Results 116
Subcellular Distribution of Proteins In Basal and 116
Insulin-Stimulated 3T3-L1 Adipocytes
Ablation of Proteins Localised to the Intracellular (LDM) 117
Membranes
Co-Localisaton of y-adaptin, the CD-M6PR and Syntaxin 4 120
with GLUT4“Containing Vesicles
Intracellular Distribution of GLUT4, y-adaptin and the 121
CD-M6PR in 3T3-L1 Adipocytes
3.5
3.5.1
3.5.2
3.5.3
Discussion
SCAMPs, Syntaxin 4 and CSPs: Markers for Exocytosis 
Rab4
y-adaptin and the CD-M6PR: Markers for the TGN
142
143 
146 
148
3.6 Summaiy 152
XI
Chapter 4 Compartment Ablation Analysis of Insulin- and GTPyS- 153
Stimulated GLUT4 Transloaction from Multiple 
Intracellular Pools
4.1 Aims 154
4.2 Introduction 155
4.3 Materials and Methods 157
4.3.1 Transferrin Receptor Externalisation Assay 157
4.3.2 Cell-Surface Transferrin Receptor Internalisation Assay 158
4.3.3 Cell-Surface Transferrin Receptor Externalisation Assay 159
4.3.4 Plasma Membrane Lawn Assay 159
4.3.5 Permeabilisation of 3T3-L Adipocytes 160
4.3.6 Adipsin Release:
Endosome Ablation 161
W ortmannin T reatment 161
4.3.7 Antibodies 162
4.3.8 Statistical Analysis 162
4.4 Results 162
4.4.1 Effect of Endosomal Ablation on Transferrin Receptor 162
Trafficking in 3T3-L1 Adipocytes
4.4.2 Effect of Endosomal Ablation on Insulin-Stimulated 163
GLUT4 and GLUTl Translocation
4.4.3 Effect of Endosomal Ablation on GTPyS-Stimulated 164
GLUT4 and GLUTl Translocation
4.4.4 Effect of Wortmannin on Insulin-and GTPyS-Stimulated 165
GLUT4 Translocation
XU
4.4.5 Effect of Endosomal Ablation on Cell-Surface 166
Transferrin Receptors
4.4.6 Effect of Endosomal Ablation and Wortmannin on 167
Constitutive Secretion in 3T3-L1 Adipocytes
4.5 Discussion 193
Chapter 5 Analysis of the Role of ARF Proteins and 199
Phospholipase D in Insulin-Stimulated GLUT4 
Translocation
5.1 Aims 200
5.2 Introduction 201
5.3 Materials and Methods 202
5.3.1 Permeabilisation of 3T3-L1 Adipocytes 202
5.3.2 2-Deoxy-D-Glucose Transport Assays:
Effect of Myristoylated Peptides 203
Effect of Butan-1 -ol 204
5.3.3 Double-Labelled Immunofluorescence Microscopy 204
5.3.4 Adipsin Release:
Effect of Butan-l-ol 204
5.3.5 Peptide Synthesis 205
5.3.6 Antibodies 205
5.3.7 Statistical Analysis 205
5.4 Results 206
xm
5.4.1 Distribution of ARP Proteins and the Effect of Insulin 206
and Wortmannin in 3T3-L1 Adipocytes
5.4.2 Co-Localisation of ARF5 and GLUT4 within 207
3T3-L1 Adipocytes
5.4.3 Role of ARFs in Insulin-Stimulated GLUT4 Trans location 209
5.4.4 Subcellular Distribution of PLDs and the Effect of Insulin 210
in 3T3-L1 Adipocytes
5.4.5 Role of Phospholipase D In Insulin-Stimulated Trafficking 210
in 3T3-L1 Adipocytes
5.5 Discussion 234
Chapter 6 Constuction of an ssHRP Chimera for Compartment 241
Ablation Analysis in 3T3-L1 Adipocytes
6.1 Aims 242
6.2 Introduction 243
6.3 Materials and Methods 244
6.3.1 Construction of pOP13.ssHRP.aP2
6.3.2 Calcium Phosphate Transfection of 3T3-L1 Fibroblasts 245
and Selection of Stable Transfectants
6.3.3 HRP Assay 246
6.3.4 Ablation of the Intracellular (LDM) Membranes 246
using ssHRP
6.3.5 Antibodies 247
6.4 Results 247
XIV
6.4.1 Restriction Digestion Analysis of pop 13.ssHRP.aP2 247
6.4.2 Secretion of HRP from 3T3-LI Adipocytes and 247
the Effect of Insulin
6.4.3 Ablation of Intracellular (LDM) Membranes using ssHRP 249
6.5 Discussion 262
6.6 Future Work 265
Chapter 7 Overview 266
References 270
XV
List of Figures
Chapter 1 Introduction
Page
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
1.10
Model of the Potential Sites of Insulin Resistance in 63
Adipose Tissue
Model for the Intracellular Organisation of the Endocytic 65
Pathway in a Mammalian Cell
The Proposed Functional Cycle of Rab Proteins 67
Sorting Events at the TGN 69
Models of NSF/a-SNAP Action in SNARE-Mediated 71
Docking and Fusion Reactions
Hypothetical Model for the Structure of the Facilitative Glucose 73 
transporters
Membrane Protein Recycling Models 75
Models for the Biogenesis of the GLUT4 Storage 77
Compartment in Insulin-Sensitive Cells
The Potential Role of SNARE Proteins in GLUT4 Trafficking 79 
Insulin Signalling Pathways 82
Chapter 3 Compartment Ablation Analysis of the GLUT4 Intracellular 
Compartments
3.1 Subcellular Distribution of GLUT4, y-adaptin, SCAMPs, 
the CD-M6PR, Syntaxin 4, CSP and Rab4 in 3T3-L1 
Adipocytes and the Effect of Insulin
125
XVI
3.2
3.3
3.4
3.5
3.6
3.7
3.8
3.9
The Effect of Endosomal Ablation on the Intracellular 127
Levels of GLUT4, TfR, y-adaptin and CD-M6PR in 
3T3-L1 Adipocytes
Sucrose Density Gradient Analysis of y-adaptin 129
Distribution in the Intracellular (LDM) Membranes of
3T3-L1 Adipocytes Before and After Ablation
Sucrose Density Gradient Analysis of Rab4 Distribution 131
in the Intracellular (LDM) Membranes of Basal and
Insulin-Stimulated 3T3-L1 Adipocytes Before and After
Ablation
Sucrose Density Gradient Analysis of GLUT4 and 133
SCAMPs Distribution in the Intracellular (LDM)
Membranes of 3T3-L1 Adipocytes Before and After 
Ablation
Co-Localisation of the CD-M6PR and Syntaxin 4 135
with GLUT4-Containing Vesicles
Co-Localisation of y-adaptin with GLUTd-Containing Vesicles 137 
Double-Labelled Immunofluorescence Analysis of Basal 139
3T3-L1 Adipocytes
Immuno-EM of y-adaptin and GLUT4 in Isolated Vesicles 141
Chapter 4 Compartment Ablation Analysis of Insulin- and GTPyS-
Stimulated GLUT4 Transloaction from Multiple Intracellular 
Pools
4.1 Effect of Endosomal Ablation on Transferrin Receptor 
Exocytosis
170
XVll
4.2A&B
4.3
4.4
4.5
4.6
4.7
4.8
4.9
4.10
4.11
Effect of Endosomal Ablation on Insulin- Stimulated 172-173
GLUT4 Translocation
Effect of Endosomal Ablation on Insulin-Stimulated 175
GLUTl Translocation
Effect of Endosomal Ablation on GTPyS-Stimulated 177
GLUT4 Translocation
Effect of Endosomal Ablation on GTPyS-Stimulated 179
GLUTl Translocation
Effect of Wortmannin on Insulin-Stimulated GLUT4 181
Translocation
Effect of Wortmannin on GTPyS-Stimulated GLUT4 183
Translocation
Effect of Endosomal Ablation on the Internalisation 185
of Cell-Surface Transferrin Receptors
Effect of Endosomal Ablation on the Recycling of 187
Cell-Surface Transferrin Receptors
Effect of Endosomal Ablation on Adipsin Secretion from 189-190 
3T3-L1 Adipocytes
Effect of Wortmannin on Insulin-Stimulated Adipsin 192
Secretion from 3T3-L1 Adipocytes
Chapter 5 Analysis of the Role of ARF Proteins and Phospholipase D 
in Insulin-Stimulated GLUT4 Translocation
5.1
5.2
Subcellular Distribution of GLUT4, ARF 1/3 and ARF6 
in 3T3-L1 Adipocytes and the Effect of Insulin 
Subcellular Distribution of GLUT4, ARF5 and ARF6 
in 3T3-L1 Adipocytes and the Effect of Insulin and 
Wortmannin
214
216
X V lll
5.3
5.4
5.5
5.6
5.7
5.8
5.9
5.10A&B
Immunoadsorption of GLUT4-Containing Vesicles 218
Double-Labelled Immunofluorescence Analysis of GLUT4 220
and ARF5 in Basal and Insulin-Stimulated 3T3-L1 Adipocytes 
Effect of Myristoylated ARF Peptides on Insulin-Stimulated 222
GLUT4 Translocation in Permeabilised 3T3-L1 Adipocytes 
Effect of Myrisoylated ARF Peptides on Insulin-Stimulated 224
2-Deoxy-D-Glucose Transport in Permeabilised 3T3-L1 
Adipocytes
Subcellular Distribution of GLUT4, PLDl and PLD2 226
in 3T3-L1 Adipocytes and the Effect of Insulin 
Effect of Butan-1 -ol on Insulin-Stimulated GLUT4 228
Translocation in 3T3-L1 Adipocytes
Effect of Butan-1 -ol on Insulin-Stimulated 2-Deoxy- 230
D-Glucose Transport in 3T3-L1 Adipocytes
Effect of Butan-l-ol on Adipsin Secretion in 3T3-L1 232-233
Adipocytes
Chapter 6 Construction of an ssHRP Chimera for Compartment Ablation
Analysis in 3T3-L1 Adipocytes
6.1 Structure of ssHRP 250
6.2 Construction ofpOP13.ssHRP.aP2 252
6.3 Restriction Digestion Analysis of the pOP 13.ssHRP.aP2 254
Construct
6.4 Cell-Associated HRP Activity of SS-2 and SS-3 Adipocytes 256
6.5A&B Secretion of HRP Activity from SS-2 and SS-3 Adipocytes 258-259
6.6 Ablation of Intracellular (LDM) Membranes using ssHRP 261
XIX
List of Tables
Page
1.1 Localisation and Functional Properties of Rab Proteins 60
in Mammalian Cells
1.2 Characterised Mammalian SNAREs Hypothesised to be 61
Involved in Golgi to Plasma Membrane Transport
3.1 Analysis of Vesicle Labelling and Co-Localisation of GLUT4 123
with y-adaptin and the CD-M6PR
5.1 Sequence Alignment of ARF Proteins at the Amino Terminus 212
XX
Abbreviations
ANF
AP-1
AP-2
AP-3
ARF
ARL
ARNO
ATB-BMPA
SNAP
ATP
bp
BSA
CD-M6PR
cDNA
CGN
CHO
CI-M6PR
CIP
COPl
cpm
CSP
DAB
DeGlc
DFP
DMEM
DMSG
Atrial natriuretic factor 
Adaptor protein-1 
Adaptor protein-2 
Adaptor protein-3 
ADP Ribosylation Factor 
ARF-like
ARF nucleotide binding-site opener
(2-N-4-(l-azi-2,2,2-trifluoroethyl)- benzoyl 1,3-bis
(D-mannos-4-yloxy)-2-propylamine
Soluble NSF attachment protein
Adenosine 5'-triphosphate
Base pairs
Bovine Serum Albumin
Cation-dependent mannose 6-phosphate receptor 
Complementary deoxyribonucleic acid 
cw-Golgi network 
Chinese Hamster Ovary
Cation-independent mannose 6-phosphate receptor
Calf intestinal phosphatase
Coatomer 1
Counts per minute
Cysteine string proteins
3,3' Diaminobenzidene
2-Deoxy-D-glucose
Diisopropyl fluorophosphate
Dulbecco's modified Eagle's medium
Dimethylsulphoxide
XXI
DNA Deoxyribonucleic acid
DTT Dithiothreitol
ECL Enhanced chemiluminescence
ED TA Diamino ethanetetra-acetic acid, disodium salt
EM Electron microscopy
EGER Epidermal growth factor receptor
ER Endoplasmic reticulum
E64 L-transepoxysuccinyl-leucylamido-4"guanidiniobutane
FCS Foetal calf serum
FITC Fluoroscein isothiocyanate
GDI GDP dissociation inhibitor |
GEF Guanine nucleotide exchange factor
GLUT Glucose transporter
GTP Guanosine 5'-triphosphate
GTPyS Guanosine 5'-[y-thio] triphosphate
HDM High density microsome
HEPES N  -2-hydroxyethylpiperazne-A '-2-ethane sulphonic acid
h Hours
HRP Horseradish peroxidase
IBMX Isobutylmethylxanthine
IC Intermediate compartment
IgG Immunoglobulin gamma
IGs Immature secretory granules
IRS-1 Insulin receptor substrate-1
IRS-2 Insulin receptor substrate-2
KRP Krebs ringer phosphate
lamp 1 Lysosome-associated membrane glycoprotein 1
LDL Low density lipoprotein
LDLR Low density lipoprotein receptor
xxu
LDM
min
mA
MGs
NCS
NIDDM
NSF
O.D.
PA
PAGE
PBS
PDGF
PEG
PH
PI 3-kinase
PIP2
PIP3
PLD
PM
RNase A 
s
SCAMPs
SDS
SDS-PAGE
SNAP25
SNARE
SP
ssv
Staph, a.
Low density microsome
Minutes
Milliamps
Mature secretoiy granules 
New bom calf serum 
Non-insulin-dependent diabetes mellitus 
A-ethylmaleimide sensitive factor 
Optical density 
Phosphatidic acid 
Polyacrylamide gel electrophoresis 
Phosphate buffered saline 
Platelet-derived growth factor 
Polyethylene glycol 
Plectstrin homology 
Phosphatidylinositide 3-kinase 
Phosphatidylinositol 4,5-bisphosphate 
Phosphatidylinositol 3,4,5 -triphosphate 
Phospholipase D 
Plasma membrane 
Ribonuclease A 
Seconds
Secretoiy carrier-associated membrane proteins 
Sodium dodecyl sulphate
Sodium dodecyl sulphate polyaciylamide gel electrophoresis
Synaptosome-associated 25kDa protein
SNAP receptor
Soluble protein
Synaptic Secretory Vesicle
Staphloccociis aureus
xxiu
TAB Tris-acetate EDTA
TBST-1 Tris buffered saline Tween
TCA Trichloroacetic acid
TEMED N, N, TV' TV' -tetramethylenediamine
Tf-HRP HRP-conjugated transferrin
TfR Transfemn receptor
TON Trans-Golgi network
TRITC Tetramethylrhodamineisothiocyanate
Tris T ri s (hy droxy methyl)aminoethane
VAMP Vesicle-associated membrane protein
u v Ultra violet
v/v volume/volume ratio
WT Wild type
w/v weight/volume ratio
XTP Xanthine 5'-triphosphate
XXIV
Chapter 1 
Introduction
1.1 Glucose Transport
1.1.1 Insulin Resistance
Muscle and adipose tissue play a central role in the maintenance of glucose 
homeostasis as they account for the majority of insulin-mediated glucose disposal in 
the post-prandial state. In response to insulin, glucose uptake into these peripheral 
tissues is mediated primarily hy the glucose transporter, GLUT4. Exposure to 
insulin causes a rapid and pronounced increase in cell surface levels of GLUT4 
following translocation of the transporter from an intracellular store(s), resulting in a 
paralleled increase in glucose uptake (reviewed in Rea et al, 1997).
Insulin resistance is defined by a decrease in the ability of insulin to stimulate this 
peripheral glucose utilisation and is characterised by the development of a chronic 
hyperglycaemic state in the presence of a normal or elevated plasma insulin 
concentration. The insulin resistant state is exhibited by patients suffering from a 
range of conditions including non-insulin dependent diabetes mellitus (NIDDM) 
(Livingstone et a l, 1995), and has several serious complications including kidney 
failure, blindness, macrovascular disease and an increased risk of atherosclerosis, thus 
posing a major health problem for the Western world.
At the cellular level, insulin action involves a complex network of molecules. The 
insulin receptor is a cell surface receptor which contains intrinsic tyrosine kinase 
activity. Binding of insulin to its receptor elevates the tyrosine kinase activity, 
which leads to the phosphorylation of insulin receptor substrates such as IRS-1 and 
IRS-2, cytoplasmic proteins with multiple tyrosine phosphorylation sites. Upon 
stimulation, these serve as docking sites for SH2 domain-containing molecules such 
as phosphatidylinositol 3-kinase (PI 3-kinase) or adaptors which link insulin 
stimulation to other signalling pathways such as Grb2. Ultimately, this leads to the 
stimulation of glycogen, lipid and protein synthesis, as well as translocation of
GLUT4 to the surface of muscle and fat cells (Kahn, 1995). The abnormality(s) 
resulting in the decreased ability of insulin to stimulate glucose uptake into muscle 
and fat, thus leading to the insulin resistant state, may lie anywhere along this 
pathway.
As the overall levels of GLUT4 are normal in NIDDM patients (Kahn, 1992) a 
possible cause of the insulin resistant state in these subjects is impaired translocation 
of GLUT4 to the cell surface (Garvey et a l, 1998) (refer to Figure 1.1). Potential 
defects leading to the impairment of translocation include deficient signalling 
upstream of the translocation step, abnormalities within the trafficking machineiy or 
indeed mistargeting of GLUT4 within the cell's intracellular compartments. Thus, 
understanding the expression, regulation and trafficking of GLUT4 will be critical to 
future progress in the treatment of this disease state. It is therefore this mode of 
glucose transport which is the focus of this thesis.
1.1.2. GLUT4 - The Insulin-Responsive Transporter
GLUT4 belongs to a family of homologous facultative glucose transporters which 
transport glucose down a concentration gradient maintaining whole body glucose 
homeostasis (reviewed in Bell et a l, 1993; Gould et a l, 1993). Each transporter 
exhibits distinct kinetics and is expressed in a tissue specific fashion, with GLUT4 
representing the acutely insulin-sensitive transporter of muscle and fat cells.
Although GLUT4 is the predominant transporter in insulin-sensitive tissues, muscle 
and adipose also express another glucose transporter isoform, namely GLUTl 
(James et a l, 1993). Each transporter plays a different role in maintaining glucose 
homeostasis, clearly dictated by their subcellular distribution. Under basal 
conditions, the relatively even distribution of GLUTl between the plasma membrane 
and intracellular compartments denotes this isoform as the 'housekeeping' 
transporter, maintaining basal glucose transport. In contrast, GLUT4 is almost
excluded from the plasma membrane in the absence of insulin with the majority 
residing in an intracellular compartment(s) (Slot et a l, 1991a; Slot et a l, 1991b). 
Insulin produces a 20- to 30-fold and a 7-fold increase in glucose transport in rat 
adipose (Holman et a l, 1990) and muscle cells (Ploug et a l, 1987) respectively, 
corresponding to a similar increase in GLUT4 levels at the plasma membrane. 
GLUTl cell surface levels are also increased by insulin (-5-fold in fat cells) but to a 
significantly lesser extent than GLUT4 (Calderhead et a l, 1990), thus distinguishing 
the latter as the insulin-regulatable glucose transporter, mediating the vast majority of 
insulin-stimulated post-prandial glucose uptake.
A major part of understanding the mechanism by which insulin regulates hexose 
metabolism involves characterising both the GLUT4 intracellular compartment(s) and 
the pathways of subcellular trafficking of this glucose transport protein. In order to 
do this, a full understanding of the individual membrane compartments and the 
movement of proteins between these compartments is required. This introduction 
therefore includes a summary of subcellular trafficking, and reviews how some of 
these general mechanisms are thought to relate to GLUT4 intracellular sequestration 
and trafficking.
1.2 Subcellular Trafficking - a General Background
Compartmentalisation within eukaryotic cells has led to the requirement of vesicle 
mediated transport between morphologically distinct organelles. There are two main 
trafficking systems within cells, namely the endocytic and secretory pathways, both 
of which require special mechanisms to ensure the selective movement of proteins 
and lipids from the donor to the acceptor organelle (refer to Figure 1.2). The 
transport process, in principle, requires the packaging of cargo into a vesicle carrier 
and the transport, docking and fusion of the vesicle intermediate with the appropriate 
target membrane. Each of these processes in the endocytic and secretory systems, 
although distinct, show similarities in terms of the array of proteins, lipids and
enzyme complexes (coats, SNAREs [soluble NSF-attachment protein receptors], 
GTPases, ATPases, kinases and phosphoinositides etc.) involved, each of which will 
be discussed in this chapter.
1.3 The Endocytic System - Receptor-Mediated Endocytosis
Endocytosis of molecules into cells is involved in many processes including: nutrient 
capture, signal transduction, antigen presentation and neurotransmitter uptake 
(reviewed in Knutson et a l, 1996). As many of the molecules required for the 
aforementioned processes are too large to pass through plasma membrane pores and 
water-filled channels by diffusion, receptor mediated endocytosis has developed to 
enable their passage into the cell cytoplasm (Knutson et a l, 1996). The extracellular 
macromolecules bind to specific, high affinity receptors, thereby allowing 
concentration of the ligands at the plasma membrane before internalisation via 
clathrin-coated pits into membrane bound vesicles, endosomes. The ligands are then 
sorted in and transported through a series of distinct endosomal compartments before 
ultimate delivery to the lysosomes (Knutson et a l, 1996) (refer to Figure 1.2).
A well defined example of receptor-mediated endocytosis is the uptake of iron by the 
transferrin receptor (TfR) (Knutson et a l, 1996). Briefly, iron-loaded transferrin 
binds to the TfR on the plasma membrane. Following endocytosis, the endosome 
acidifies to a pH of ~ 5.1. Although this pH favours the release of iron, the 
apotransferrin remains associated with the receptor and is subsequently recycled 
back to the cell surface (Yamashiro et a l, 1984). The endocytic process of the TfR is 
very rapid, with a single cycle being complete in 3-4 min (lacopetta et a l, 1983). 
Other examples of receptor-mediated endocytosis, although generally following the 
same process, exhibit distinct differences. For example, following the uptake of low 
density lipoprotein (LDL) by the low density lipoprotein receptor (LDLR), the 
receptor recycles back to the plasma membrane whereas the LDL is transported to 
the lysosomes to be degraded. The mannose-6-phosphate receptors (cation-
independent [CI-] and cation-dependent [CD-] M6PRs) 'scavenge' ligands with 
terminal mannose or fucose residues and degradation begins within the endosomal 
compartment (Knutson et a l, 1996).
Alternatively, the endocytic system may be used as a sorting mechanism. Following 
the biosynthesis of synaptic vesicle proteins in the endoplasmic reticulum (ER) they 
are transported via the Golgi to the plasma membrane, before being constitutively 
endocytosed and sorted into synaptic vesicles (Knutson et a l, 1996).
1.3.1 Clathrin-Coated Pit Formation
Following binding of cargo molecules to the extracellular domain of a transmembrane 
receptor at the plasma membrane, concentration of receptors occurs via interaction 
with a clathrin coat, required for vésiculation of the membrane. Clathrin provides a 
framework for other proteins which carry out receptor sorting and membrane 
budding. Clathrin-coated pits/vesicles are composed of clathrin, a trimeric scaffold 
protein which organises itself into cage-like lattices (reviewed in Kirchhausen et a l,
1997). Clathrin has the shape of a triskelion, each of the three legs having a heavy 
and light chain.
Clathrin-coat formation is driven by clathrin adaptors, heterotetramers that couple 
pit assembly to the entrapment of membrane receptors (reviewed in Lewin et a l,
1998). Endocytic coated pits contain the AP-2 complex, while coated buds and 
vesicles derived from the trans-Golgi network (TGN) contain the related AP-1 
complex (Pearse et al., 1990). AP-2 comprises two large chains (referred to as 
adaptins), one a chain and one (3l/p2 chain, a medium chain (p2) and a small chain 
(o2). AP-1 contains the adaptins y and (31 together with p2 and a small nl chain 
(reviewed in (Robinson, 1992; Robinson, 1994). A third adaptor-like complex, 
recently identified AP-3, contains 6 and p3 chains together with the smaller g3 and o3 
chains (Simpson et a l, 1997; Dell'Angelica et a l, 1997). Although this complex is
also involved in sorting events at the TGN (refer to Section 1.4.3) it is not thought to 
interact with clathrin.
Initially, AP-2 is recruited from the cytosol to the plasma membrane allowing 
clathrin to bind and form the coated pit. Components of the pit then interact with 
the cytosolic tails of the transmembrane receptors, which have specific signals to 
direct rapid internalisation and other intracellular targeting steps (Kirchhausen et al., 
1997). The signal sequences usually have a critical tyrosine residue or a pair of 
dileucine or bulky hydrophobic residues (known as tyrosine/dileucine based signals) 
(reviewed in Marks et a l, 1997). Tyrosine based signals bind directly to the AP-2 
complex, mediating the concentration of certain plasma membrane proteins within 
clatlirin-coated pits. Examples include: the LDLR, the TfR and the epidermal growth 
factor receptor (EGER), all of which have tyrosine internalisation motifs and are 
efficiently concentrated into clathrin-coated pits (Robinson et a l, 1996). However, 
proteins with these motifs are also found in other compartments suggesting that there 
may be a specific AP-2 receptor on the plasma membrane (and AP-l/AP-3 receptors 
on the TGN), yet to be identified (Kirchhausen et al, 1997; Lewin et a l, 1998).
Another important component of the clathrin-coated vesicle machineiy is dynamin. 
This large GTPase is thought to be involved in severing the neck of the coated pit to 
produce a coated vesicle (reviewed in Kelly, 1995). Concurrent studies by Hinshaw 
and Schmid, and Takei et al have shown that GTP binding regulates the spontaneous 
self assembly of dynamin into rings and stacks of interconnected rings (helical arrays) 
around the neck of the invaginated coated pit. Following GTP hydrolysis, the 
configuration of the helix changes, squeezing the neck frirther until molecular fission 
occurs in a sort of'molecular garotting' (Hinshaw et al, 1995; Takei et a l, 1995).
1.3.2 Non-Clathrin-Mediated Endocytosis
Although clathrin-mediated endocytosis is the most well characterised mechanism for 
gaining entry into the cell, non-clathrin-mediated pathways also exist. Three other 
morphologically distinct pathways which have been characterised include: 
macropinosomes (substantially contribute to constitutive bulk pinocytosis), non­
coated vesicles and caveolae (small lipid-enriched microdomains of the plasma 
membrane) (reviewed in Lamaze et a l, 1995). Each of these pathways, including 
clathrin-mediated endocytosis, may be defined by vesicle size which is tightly 
regulated in each case. Caveolae are 50-80nm in diameter, clathrin-coated vesicles are 
100-150nm in diameter, non-coated vesicles are in between, and macropinosomes are 
0.5-2mm in diameter (Lamaze et a l, 1995; Robinson et a l, 1996). Although 
morphologically characterised, the purpose of these alternative pathways is still not 
clear. However, the inducible overexpression of a temperature sensitive dynamin 
mutant that displays a rapid and reversible block in clathrin-mediated endocytosis, 
has shown that after a shift to the non-permissive temperature, horseradish 
peroxidase (HRP) fluid-phase uptake was only partially inhibited, and recovered to 
wild-type levels within 30 min (Damke et a l, 1995). Based on this and similar 
studies, the prevailing view is that clathrin-mediated and non-clathrin-mediated 
endocytosis occur in parallel and the non-clathrin-mediated pathway may be up- 
regulated when the clathrin-mediated pathway is switched off (Robinson et a l,
1996). However, alternate fluid-phase and receptor-mediated endocytic pathways 
may be required to serve other purposes. As well as controlling the size of the 
plasma membrane, distinct endocytic vesicles provide an opportunity for targeting to 
distinct organelles and such pathways could also be differentially regulated (Lamaze 
e ta l, 1995).
1.3.3 Endosomal Compartments
Following internalisation from the cell surface, membrane proteins (receptors) enter 
early sorting endosomes. This compartment consists of vacuoles, cisternae and 
tubules spread throughout the cytoplasm. From here, some receptors including the 
TfR, may pass through a highly tubulated recycling compartment, located in the peri- 
Golgi region, en route to the plasma membrane (Robinson et a l, 1996). From the 
early endosomes internalised molecules may proceed along the endocytic pathway to 
late endosomes and finally lysosomes (refer to Figure 1.2).
Although trafficking through the endocytic system is complex, many factors required 
to regulate transport along this pathway appear to be used at multiple stages and are 
also found in the secretory system, In particular, two classes of proteins namely 
SNAREs (soluble NSF-attachment protein [SNAP] receptors) (Hay et a l, 1997) and 
Rab proteins (Novick et a l, 1997) have emerged as specific and essential vesicle 
transport components in both endocytic and exocytic processes. SNAREs comprise 
integral membrane proteins, serving as receptors for soluble factors required for 
docking and fusion (refer to Section 1.5). Rab proteins are small GTPases which 
were initially implicated as regulators of SNARE pairing during vesicle docking (see 
below). However, these small GTPases may indeed play a more significant role as 
master regulators of membrane traffic as discussed below.
1.3.4 Rab Proteins in Vesicle Transport
Rab proteins constitute the largest family of small GTPases with almost 40 
mammalian proteins being identified, correlating with the diversity of vesicle 
transport routes in mammalian cells (reviewed in Novick et a l, 1993; Novick et al,
1997). To date many of the Rab proteins identified exhibit compartmentilisation, 
regulating specific transport events. For example, transport from the plasma 
membrane to the early endosomes is controlled by Rab5 whereas Rab4 has been
implicated in trafficking from the early endosomes to the plasma membrane (i.e. the 
recycling pathway) (Novick et a l, 1997). The prevailing view is that a different Rab 
protein may be required for each step of vesicular transport (refer to Table 1.1).
Briefly, the Rab protein is thought to associate with the transport vesicle budding 
from the donor membrane, moves to the acceptor membrane where docking and 
fusion take place and finally recycles back to the donor membrane via a cytosolic 
intermediate, Rab GDP-dissociation inhibitor (GDI). The GDI binds the Rab protein 
in the GDP-bound inactive conformation, thereby regulating membrane binding. In 
turn, GDI is displaced by a GDI-displacement factor, allowing Rab-GDP to bind the 
membrane. Following GDP/GTP exchange the Rab protein is resistant to removal by 
Rab GDI. As guanine nucleotide exchange factors (GEFs), effector molecules and 
GTPase activating proteins (GAPs) determine which nucleotide is bound to the Rab 
protein, these factors therefore regulate GDI accessiblity, thus keeping the proteins 
in a dynamic equilibrium between the cytosol and membranes (Novick et a l, 1997) 
(refer to Figure 1.3).
Although it is well established that Rab proteins are required for membrane docking 
and fusion events, the precise function of the proteins is still unclear. Studies using 
dynamin GTPase deficient mutants clearly indicate the requirement for GTP 
hydrolysis in the 'pinching' off of the invaginated vesicle (refer to Section 1.3.1). 
However, such studies are not as convincing with respect to the Rab proteins as Rab 
function may be inhibited or stimulated depending on the Rab protein studied. For 
example, in the case of Rab3a the GTPase deficient mutant inhibits exocytosis in 
neuroendocrine cells (Sudhof, 1995) whereas the Rab5 GTPase-deficient mutant 
stimulates endosome fusion (Stenmark et a l, 1994). This suggests that GTP- 
hydroysis, although possibly mediating membrane association, may not be directly 
coupled to membrane fusion. Initial studies using mutant Rab proteins with altered 
nucleotide specifity that bind xanthine 5'-triphosphate (XTP) support this view 
(Rybin et a l,  1996). With respect to Rab5, hydrolysis of [^^P] XTP occurred
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constitutively suggesting that hydrolysis serves as a timer to switch off the protein 
and prevent prolonged activation (Rybin et a l, 1996). However, further studies are 
required to determine whether such a mechanism is applicable to other Rab proteins.
1.4 The Secretory System
The secretory pathway of eukaryotes, like the endocytic system, comprises several 
morphologically distinct compartments [endoplasmic reticulum (ER), intermediate 
compartment (IC) and the Golgi complex] through which newly synthesised proteins 
and lipids move en route to the cell surface (reviewed in Lippincott-Schwartz, 1996). 
Briefly, the ER serves as port of entry while the Golgi complex serves as a site where 
membranes and proteins from the ER converge and are processed or sorted before 
transport to different destinations. Membranes of the secretory pathway are 
extremely dynamic exhibiting both anterograde and retrograde transport pathways
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The recent discovery of Rab effector proteins, which function downstream of the 
Rab proteins, also suggests that like other GTPases of the Ras superfamily, Rab 
proteins may act as regulatable membrane anchors. Much in the same way that Ras 
serves as a membrane anchor for Raf kinase in signal transduction, and ARE recruits 
proteins in vesicle budding (refer to Sections 1.4.2 and 1.6), Rab5 recruits rabaptin 5, 
a cytosolic protein onto early endosomes in a GTP-dependent manner (Stenmark et 
a l, 1995). The over-expression of Rabaptin 5 alone, induces the expansion of early 
endosomes, indicating that this protein behaves as a direct Rab effector in the 
endocytic pathway (Robinson et a l, 1996). Although little is known about the 
biochemical activities of the effectors they may serve as down-stream intermediaries 
of a pathway leading to SNARE-complex formation. However, it is more plausible 
that Rab proteins, along with the appropriate effector, control several activities in 
parallel including motors needed for vesicle movement, vesicle-binding proteins 
needed for vesicle docking and, ultimately, the formation of SNARE complexes 
(Novick e ta l, 1997).
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(Lippincott-Schwartz, 1996). However, anterograde vesicle mediated transport to 
the cell surface shall be the focus of this section, in particular trafficking from the 
trans-Go\%{ network (TGN) to the cell surface and/or the endosomes.
1.4.1 The trans-Golgi Network (TGN)
The Golgi complex plays a central role in processing and sorting proteins in the 
secretory pathway. It is a polarised structure of cisternal stacks with two distinct 
faces. The cü-Golgi network (CGN) is the site of entry fi'om the ER, while the TGN 
forms the opposite face of the Golgi stack. As the last compartment of the Golgi 
complex, the TGN plays a pivitol role in directing proteins via the secretory 
pathway to the appropriate cellular destination (reviewed in Traub et a l, 1997). 
Several secretory pathways emerge from the TGN including a constitutive pathway 
which delivers proteins directly to the cell surface and a selective pathway which 
sorts protein traffic into the endosomal membrane system (Traub et a l, 1997) (refer 
to Figure 1.4). It is this selective endosomal route that allows communication 
between the secretory and endocytic pathways. In cells which undergo regulated 
exocytosis, the selective endosomal route may be modified allowing the formation 
and accumulation of mature secretory granules, ready for exocytic release (refer to 
Figure 1.4).
1.4.2 Vesicle Budding at the TGN
In terms of the molecular machinery required for vesicularisation and transport in the 
secretory system, most advances have come about through the study of yeast, with 
many of the homologous proteins also being isolated from mammalian cells, 
indicating a conservation across species. However, these studies have concentrated 
on ER to Golgi and intra-Golgi transport. Briefly, intra-Golgi transport requires 
coatomer (COPI), a large cytosolic protein complex, for vesicle formation and 
budding (reviewed in (Cosson et a l, 1997)). This vesicle coat is formed by the
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polymerisation of COPI, (composed of seven subunits: a-, 3-, p'-, g-, 5-, e- and Ç- 
COP). As the coatomer coat can also specifically concentrate membrane proteins by 
interacting with their sorting motifs in their cytoplasmic domains, they appear to be 
functionally veiy similar to the previously described clathrin coat. Interestingly, one 
of the components of COPI, p-COP, is weakly homologous to p-adaptin, a 
component of the clathrin coat. COPII coat proteins, notably not homologous to 
COPI, mediate vesicle budding and transport in the ER (reviewed in Kuehn et a l,
1997).
The molecular events governing sorting, vesicle budding and transport from the TGN 
are rather ill defined compared to ER trafficking. However, studies with Brefeldin A 
(BFA), a fungal antibiotic, have cast some light on this issue. Treatment of cells with 
BFA reversibly arrests protein transport from the TGN (Miller et a l, 1992). As 
BFA is also known to inhibit a nucleotide exchange factor for ADP-ribosylation 
factor (ARF, a small GTPase) (Peyroche et a l, 1996), it is thought that ARF-GTP 
may regulate multiple TGN export sites. Consistent with this idea, the coatomer 
complexes previously described, cycle between a cytosol and membrane association, 
a process also shown to be mediated by ARF (Cosson et a l, 1997). The transport of 
proteins from the TGN to the endosomes may also be mediated by clathrin. As for 
clathrin-mediated endocytosis, budding requires the recruitment of cytosolic adaptors 
(AP-1) and clathrin onto the Golgi membrane (Pearse et a l, 1990). Again, ARF (in 
this case the ARFl isoform) is implicated as the regulator of coat assembly, 
mediating the association of AP-1 with the membrane (Stamnes et a l, 1993), 
accounting for the sensitivity of this process to BFA. Regulation by this small 
GTPase may explain why clathrin-coated vesicles only assemble on particular 
intracellular membranes, even though other membranes contain suitable cargo. If the 
BFA-sensitive nucleotide exchange factor for ARF is localised to specific membranes, 
AP-1 recruitment and therefore coat assembly are limited (Traub et a l, 1993; 
Stamnes et al, 1993; Seaman et al, 1996b; Traub et al, 1997).
13
1.4.3 Sorting at the TGN
The selective incorporation of cargo into budding vesicles at the TGN is an active 
process with cytosol-orientated sorting signals directing transmembrane proteins to 
the appropriate export site. These signals consist of short, linear stretches of amino 
acids within the cytosolic domain of a protein, and most fall into groups of 
consensus sequences or motifs. The most extensively studied motifs centre on either 
a critical tyrosine residue (Y) within the amino acid sequences NPXY or YXX0 
(where X is any amino acid and 0  is an amino acid with a bulky hydrophobic group) 
(reviewed in Marks et a l, 1997) or a doublet of leucine residues (LL) referred to as a 
di-leucine motif (see Pond et al., 1995 and references there in).
Tyrosine-based sorting signals conforming to the YXX0 motif have been implicated 
in directing protein localisation to various intracellular compartments including 
endosomes, lysosomes and to the basolateral surface of polarised epithelial cells 
(Marks et al., 1996). Furthermore, most of the YXX0-type signals are capable of 
mediating rapid internalisation from the plasma membrane into endosomes regardless 
of the ultimate compartment to which the proteins are eventually targeted (reviewed 
in Mellman., 1996). A subset of of YXX0-type signals are also able to mediate 
other intracellular sorting events (reviewed in Gruenberg and Maxfield,. 1995) 
suggesting that such signals can he recognised differentially at more than one site in 
the cell. Thus, at the plasma membrane YXX0-type signals may confer a rather 
broad specificity, whereas at some intracellular sites they may have a more restricted 
specificity.
The basis of such specificity, may in part depend on interactions between the 
tyrosine-based signals and a component of an organellar protein coat (Figure 1.4). In 
this regard, several laboratories have shown that the AP-1 and AP-2 heterotetrameric 
adaptor complexes that mediate association of clathrin with the TGN and plasma 
membrane, respectively (refer to Section 1.3.1), recognise tyrosine-based signals
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conforming to the YXX0 motif (Ohno et a l, 1996; Nesterov et al., 1995; Heilker et 
al., 1996; Honing et al., 1996). Interaction with AP-2 is likely to mediate rapid 
internalisation from the plasma membrane (Pearse., 1988), whereas interaction with 
AP-1 at the TGN is involved in endosomal and/or lysosomal targeting (Honing et al., 
1996). Specificity at both of these sites (plasma membrane and TGN), is thought to 
be maintained by the selectivity of the homologous p, chains of the adaptor 
complexes, on binding to the tyrosine signals. For example, in a yeast two-hybrid 
assay, the YXX0 motif from the endocytic TfR binds to p2 (medium subunit of the 
AP-2 complex, see Section 1.3.1) but not detectably to p i (AP-1 complex), whereas 
the lysosomal membrane protein, LAMP 1 (lysosomal associated membrane protein 
1), binds to both p2 and p i (Ohno et al., 1996; Ohno et al., 1995). In vitro binding 
studies have also shown that some signals display higher avidity for AP-2 (Boll et 
al., 1995), while others interact equally well with AP-1 and AP-2 (Heilker et a l, 
1996; Honing et al., 1996). Although care must be taken when extrapolating results 
from these types of assays to in vivo models, on the basis of these data it has been 
proposed that differential recognition of tyrosine-based signals by the AP-1 and AP- 
2 complexes may determine, at least in part, the targeting specificity of the signals 
(Marks et al., 1997).
Signals conforming to a di-leucine motif can also mediate internalisation, and targeting 
to lysosomes, endosomal membranes and the basolateral surface of polarised 
epithethial cells (reviewed in Melman., 1996; Matter and Mellman., 1994). Although 
di-leucine- and tyrosine-based signals mediate localisation to similar end 
compartments, they do so through the interaction with different components of the 
sorting machinery (Marks et al., 1996). In this regard, the p2 and p i suhunits of the 
AP-2 and AP-1 adaptor complexes respectively, do not appear to recognise di­
leucine based signals (Ohno et ah, 1995). However, a very recent in vitro study has 
indicated that interaction of di-leucine motifs with AP-1 may be via the (31 subunit of 
the heterotetrameric adaptor complex (Rapoport et ah, 1998), suggesting that distinct 
regions of the adaptor complex may be responsible for recognition of tyrosine- and
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di-leucine based signals. However, further studies are required to firmly establish a 
role for the P subunit of the adaptor complex in di-leucine-based signal recognition.
Additional features may also contribute to the recognition of a given sorting signal by 
specific sorting machinery. For example, binding of adaptor complexes to tyrosine- 
based signals may be influenced not only by the exact sequence of the signal but also 
by the nature of the amino acids in or surrounding the signal and the spacing of the 
signal from the membrane. Such an example has been provided by studies performed 
on LAMP 1 trafficking (Rohrer et aL, 1996). The insertion or the deletion of a single 
amino acid modifying the spacing of its GYXXI sorting motif almost completely 
blocks its lysosomal targeting but does not drastically affect its endocytosis. In the 
yeast two hybrid system, tyrosine-based sorting signals appear to be more 
efficiently recognised by the AP-1 and AP-2 p chains when they are placed at the C- 
terminus of the polypeptide sequence and when it is appropriately distanced from 
the fusion partner domain (Ohno et aL, 1996). These results may predict enhanced 
adaptor binding in vivo to signals that are exposed to the C-terminus or 
appropriately distanced from the membrane, as is the case for several lysosomal 
membrane proteins such as LAMP 1 (Rohrer et ah, 1996).
Post-translational modifications of cytoplasmic domains may also regulate the 
accessibilty of sorting determinants. For example, the cation-dependent-mannose 6- 
phosphate receptor (CD-M6PR), a transmembrane protein required for lysosomal 
enzyme transport, has a casein-kinase II consensus phosphorylation site within an 
acidic cluster adjacent to the di-leucine motif at its C-terminus. The expression of 
CD-M6PRs mutated on this phophorylation site are unable to produce AP-1 coated 
vesicles when expressed in M6PR-negative fibroblasts (see below), suggesting that 
the phosphorylation of the caesin-kinase II consensus site may induce 
comformational changes and modulate the accessibilty of sorting determinants 
(Mauxion et aL, 1996). Palmitoylation is another example of post-translational 
modification. The CD-M6PR is transiently and reversibly palmitoylated on two
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cysteine residues at positions 30 and 34 of its cytoplasmic domain (Schweizer et aL, 
1996). The mutation of Cys-34 results in the accumulation of the mutant receptors 
in the lysosomes and a loss of its sorting function at the Golgi (Schweizer, et aL, 
1996). These observations indicate that the anchoring of this region of the CD- 
M6PR tail in the lipid bilayer is essential for the normal trafficking of the receptor 
and further suggest that palmitoylation may confer a given conformation to the 
cytoplasmic tail necessary for the recognition of the tyrosine- and di-leucine-based 
sorting determinants. Finally, interactions with other proteins such as ARFl, the 
small GTP-binding protein thought to be involved in the association of AP-1 with 
the TGN (refer to Section 1.4.2) may also influence the interactions between sorting 
signals and the adaptor complexes (Traub et aL, 1993;Traub et aL, 1997), although 
this has not been formly demonstrated.
Several studies indicate that transmembrane proteins play some role in coat 
assembly. In the TGN, the two distinct but related M6PRs (cation-dependent and 
cation-independent M6PRs) involved in lysosomal enzyme targeting (reviewed in 
Ludwig et aL, 1995), appear to be key components required for AP-1 coat assembly 
(Figure 1.4). As for many transmembrane proteins, the M6PRs contain multiple 
sorting determinants in their cytoplasmic domains including tyrosine- and di-leucine- 
based motifs (reviewed in Sandoval and Bakke., 1994). Several studies have 
illustrated the importance of the carboxyl terminal di-leucine motif in efficient 
intracellular targeting of the M6PRs (Lobel et aL, 1989, Johnson and Kornfield., 
1992). However, recent studies indicate that it is the acidic cluster motif containing 
the casein kinase II phosphorylation site which is critical for the interaction of AP-1 
with its target membranes and the adjacent di-leucine motif appears to be more 
important for a post AP-1 step in the CD-M6PR cycling pathway (Mauxion et aL, 
1996). Support for the role of the M6PRs in AP-1-coat assembly at the TGN comes 
from biochemical studies performed on mouse MPR-negative fibroblasts re­
expressing physiological levels of either M6PR. Subcellular fractionation of these 
cells has revealed that M6PR-negative cells contain -  70% less AP-1 bound to the
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TGN membranes than M6PR-positive cells or M6PR-negative cells re-expressing 
physiological levels of either M6PR (Le Borgne et a l,  1996). Furthermore, 
experiments carried out on the same cells has shown that the concentration of 
M6PRs determines the number of clathrin-coated vesicles formed in the TGN (Le 
Borgne et a l,  1997). Taken together, these observations strongly suggest that 
transmembrane protein sorting and AP-1 coat assembly are indeed coupled 
processes.
Some membrane proteins, although utilising the AP-1 sorting machinery at the TGN, 
contain sorting motifs that do not bind adaptors directly. For example, the 
endoprotease furin has an acidic cluster containing a pair of casein kinase II 
phosphorylation serines and a tyrosine motif in its cytosolic domain (Molloy et aL, 
1994; Schafer et aL, 1995). Recent studies have shown that the phosphorylation of 
the furin acidic cluster is required for the the TGN localisation of the endoprotease 
and enhances its association with AP-1 (Ditte et aL, 1997), suggesting that TGN 
localisation of furin, like the M6PRs is mediated by an AP-1 sorting step. However, 
direct binding of AP-1 to the furin TGN localisation signal has not been 
demonstrated. Indeed, recent studies have shown that the acidic cluster sorting motif 
of furin requires a cytosolic connector protein, namely PACS-l (phosphofurin acidic 
cluster sorting protein 1), to connect it to the clathrin sorting machinery (Wan et aL,
1998). PACS-l is a partially membrane-associated cytosolic protein that binds 
phosphorylated furin, resulting in the localisation of the endoprotease to the TGN. 
In vitro binding assays and in vivo coprecipitation studies show that PACS-l 
localises furin to TGN by connecting it to the AP-1 sorting machinery (Wan et aL,
1998). However, further studies involving furin mutants demonstrated that the 
cytosolic domain tyrosine motif but not the acidic cluster containing the 
phosphorylatable casein kinase II serine residues was required for budding at the 
TGN (Wan et aL, 1998). Together, these studies argue that PACS-l localises furin to 
the TGN by a phosphorylation-dependent retrieval mechanism. This 
phosphorylated acidic cluster-dependent retrieval step is consistent with the AP-1-
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associated removal of phosphorylated furin from clathrin-coated immature secretory 
granules (Ditte et aL, 1997).
Interestingly, in the same study Wan et al also showed a requirement for PACS- for 
the correct localisation of the CI-M6PR, suggesting that PACS-l may direct the 
routing of a potentially large number of membrane proteins containing acidic cluster 
motifs within their cytosolic domains. This may also explain why Mauxion et al 
(see above; Mauxion et aL, 1996) found the casein kinase II consensus site to be 
important for AP-1 binding at the TGN and not the di-leucine-based motif, as the 
latter may he involved in budding whereas the casein kinase II consensus motif may 
be involved in retrieval and therefore localisation to the TGN.
Several other transmembrane proteins such as the lysosomal-associated membrane 
proteins (LAMP I, LAMP II), or the lysosomal integral membrane proteins (LIMP 
I, LIMP II) are also sorted in the TGN and follow an intracellular route to the 
endosomes/lysosomes (reviewed in Sandoval and Bakke., 1994; Mellman., 1996). 
Their lysosomal targeting depends on either a critical tyrosine-based (LAMP I, 
LAMP II, LIMP I) or di-leucine-based sorting determinants present in their 10-20- 
amino acid long cytoplasmic domains (Harter and Mellman., 1992; Guarnieri et aL, 
1993; Honing et aL, 1996; Ogata and Fukuda., 1994). The presence of LAMP I in 
AP-1-coated structures suggests that their exit form the TGN, like that of the 
M6PRs may depend on such a pathway (Honing et aL, 1996). However, following 
the identification of the adaptor-like complex AP-3 (refer to Section 1.3.1), recent 
studies suggest that this heterotetrameric complex also functions in the intracellular 
targeting of transmembrane glycoproteins to lysosomes, consistent with the presence 
of this protein complex on buds/vesicles associated with the TGN (Simpson et aL, 
1996).
A role for the AP-3 complex in recognition and sorting of lysosomal proteins is 
supported by recent in vivo studies which demonstrate that the overexpression of
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LAMP I and LIMP II, promotes AP-3 recruitment onto perinuclear membranes (Le 
Borgne et al., 1998). Furthermore, the expression of chimeric proteins mutated on 
the tyrosine residue of LAMP I and on the di-leucine based signal of LIMP II, failed 
to promote AP-3 recruitment onto membranes both in vivo and in vitro, suggesting 
that AP-3 may recognise the tyrosine- and di-leucine-based sorting signals of the ;
transmembrane proteins (Le Borgne et aL, 1998). In the same study, inhibition of the 
synthesis of the |i3, the subunit intercating with tyrosine-based signals in the yeast
' ' Îtwo-hybrid system (Dell'Angelica er a/., 1997), by antisense oligonucleotides, 
resulted in the selective mis-routing of LAMP I and LIMP II to the plasma 
membrane (Le Borgne et aL, 1998). These data strongly indicate that AP-3 is 
essential for the proper intracellular targeting of LAMP I amd LIMP II to the 
lysosomes.
.,1
There is also accumulating evidence to suggest that AP-3 is involved in sorting cargo 
proteins to storage/secretory granules or lysosome-related organelles such as the {
melanosomes (reviewed in Odorizzi et aL, 1998). In this regard, a tailess mutant of 
tyrosinase, a membrane protein of melanosomes which contains a di-leucine motif, is 
delivered to the plasma membrane instead of melanosomes (Viyayasadhi et aL, 1995)
Recent in vitro studies have also shown the cytoplasmic tail of tyrosinase to interact 
with AP-3 (Honing et aL, 1998). Synaptic vesicle recycling is also thought to involve 
protein sorting by AP-3 from the TGN to secretory granules in PCI2 cells (Faundez j
et aL, 1998). Together, the above data suggest that the AP-3 complex is involved in 
sorting cargo proteins to hoth lysosome and lysosome-related storage/secretory 
granules, possibly through a common intermediate (Figure 1.4).
The existence of multiple coat complexes and their differential ability to bind to 
sorting determinants provide a framework for a hypothetical model in which the coat 
complexes act like filters for transmembrane proteins with one or more sorting signals 
on their cytoplasmic tails (see Marks et aL, 1997). In this model the TGN is the 
initial sorting sorting station for newly synthesised membrane proteins.
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Transmembrane proteins with AP-1 or AP-3 directed di-leucine or tyrosine signals 
will he caputured by the appropriate coat complex (AP-1 or AP-3) and sorted to an 
endosomal/lysosomal or lysosomal-related storage compartment. Other 
transmembrane proteins will pass onto the plasma membrane. Those with AP-2 
directed signals will be re-internalised. It should be noted that none of these steps are 
absolute with efficiencies depending on relative affinities for various signals.
1.5 Membrane Targeting and Fusion
Once transport intermediates have been formed in both the endocytic and secretory 
systems, they are targeted to the appropriate acceptor membrane where fusion 
occurs. The Rab family of proteins (refer to Section 1.3.4) are thought to play a 
major role in the regulation of this process, with additional components for the actual 
fusion process functioning further downstream.
Based on a linkage between ER and Golgi transport, and synaptic vesicle fusion in 
neurons, a model of vesicular fusion termed the SNARE (SNAP receptor) hypothesis 
was proposed (reviewed in (Rothman, 1994; Sudhof, 1995; Bennett, 1995; Hay et 
a l, 1997)). The model postulates that the specificity of vesicle targeting is generated 
by complexes which form between membrane proteins on the transport vesicle (v- 
SNAREs) and membrane proteins on the target membrane (t-SNAREs) (refer to 
Table 1.2). In the case of regulated exocytosis in neurons, the v- and t-SNAREs are 
VAMP2 (vesicle-associated membrane protein/synaptobrevin) and syntaxin 
1 A/SNAP-25 (synaptosome-associated protein, 25kDa), respectively (Rothman, 
1994; Sudhof, 1995). Since the proposal of this model, studies have shown that the 
originally identified VAMP, SNAP-25 and syntaxin appear to represent protein 
families with homologues throughout the secretory pathway (Hay et a l, 1997). 
Originally, it was proposed that the assembly of the core complex in which the v- 
and t- SNAREs bound together exhibiting a 1:1:1 stoichometry, provided a receptor 
for a-SNAP (soluble NSF attachment protein, not related to SNAP-25). In turn this
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created a receptor site for NSF (N-ethylmaleimide-sensitive factor), an ATPase 
which was thought to catalyse the fusion reaction by either disrupting the SNARE 
complex or conformationally destabilising it (Sudhof, 1995). However, recent studies 
have resulted in the migration of the proposed role of NSF from the last to an 
increasingly early step in the membrane fusion process. Convincing evidence for this 
altered role of NSF has heen provided by a study of homotypic fusion in yeast 
carried out by Mayer et al (Mayer et a l, 1996). In this system, they have shown 
that both NSF and a-SNAP co-operate to activate v- and t-SNAREs independently 
into a docking competent state, implying that the major function of NSF occurs 
before vesicle docking (Mayer et a l, 1996) (refer to Figure 1.5).
The fundamental requirement for SNARE proteins in vesicular transport is illustrated 
by the treatment of neurons with botulinum and tetanus toxins resulting in the 
irreversible inhibition of synaptic vesicle exocytosis by specific proteolysis of 
VAMP2, syntaxin lA and SNAP-25 (Sudhof, 1995). However, although these 
SNARE proteins have been characterised as the key components in vesicle fusion, 
additional molecules have been identified which act to either positively or negatively 
regulate the assembly of the SNARE complex. Under steady state conditions in the 
neuron, VAMP2 is bound to synaptophysin (a v-SNARE binding protein) (Johnston 
et a l, 1990) and at least some of syntaxin lA is bound to Munc 18a (a syntaxin 
binding protein) over the entire plasma membrane (Hata et a l, 1993). Binding of 
Munc 18a to syntaxin lA inhibits its interaction with SNAP-25, and VAMP2 is 
unable to bind to the SNAP-25/syntaxin complex when bound to synaptophysin 
(Sudhof, 1995). Thus, these proteins prevent the spontaneous assembly of the 
SNARE complex (Sudhof, 1995). The identification of many of these proteins in 
non-neuronal cells (refer to Section 1.13) has allowed the SNARE hypothesis to 
serve as a model for the docking, targeting and fusion of vesicles in many different 
trafficking pathways.
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1.6 The Role of Phosphoinositides in Membrane Trafficking
As the generation, transport and fusion of vesicles clearly involves significant 
alterations in the membrane structure it is reasonable to assume that the 
transformation of lipid components either accompany or help to induce this 
processes. Indeed in mammalian cells, signal transduction pathways involving lipid 
second messengers not only stimulate regulated secretion but also affect the activity 
of constitutive tiunsport pathways (reviewed in Roth et a l, 1997).
Studies in both yeast and mammalian cells suggest a role for phophatidylinositol 3- 
kinase (PI 3-kinase) in constitutive vesicle trafficking (reviewed in Shepherd et al, 
1996b). In S. cerevisiae the PI 3-kinase Vps34p is complexed to another protein 
VpslSp, and is required for the sorting of vacuolar proteins fi'om the Golgi (Stack et 
a l, 1995). Recently, the mammalian homologues for both of these proteins have 
been identified, suggesting that yeast and mammalian cells share a common 
mechanism of regulation from the Golgi to endosomes (Volinia et a l, 1995). 
Furthermore, treatment of mammalian cells with wortmannin, an irreversible inhibitor 
of PI 3-kinase, has had adverse effects on TfR recycling, indicating that PI 3-kinase is 
involved in multiple sorting events in the receptor's membrane trafficking pathway 
(Spiro et a l, 1996; Martys et a l, 1996; Shpetner et al, 1996).
Although clearly implicated in trafficking, the functional role of phosphoinositides 
remains to be determined. One possibility is the regulation of ARF proteins, 
monomeric GTP binding proteins required for secretory processes (reviewed in 
Boman et a l, 1995). Recently, the proteins required for guanine nucleotide exchange 
on ARFs have been identified in both yeast and mammalian cells (Peyroche et a l, 
1996; Chardin et a l, 1996). Such proteins contain a sec7 homology domain (yeast 
sec7p is a protein required for transport to and from the Golgi complex). The 
mammalian guanine nucleotide exchange factor (GEF), ARNO (ARF nucleotide- 
binding-site opener) also contains a pleckstrin homology (PH) domain that mediates
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stimulation of its exchange activity by phosphatidylinositol 4,5-bisphosphate (PIP2)
(Chardin et a l, 1996). Thus, a likely role for phosphatidlyinositols is activation of 
ARF through acceleration of its rate of GTP binding either through increased avidity 
of the exchange proteins for ARF or through localisation of the GEFs to membrane 
environments that are sites of ARF action (Roth et a l, 1997).
Further downstream, the stimulation of phospholipase D (PLD) activity by ARF 
proteins suggests a potential role for this enzyme in vesicularisation and transport. |
PLD hydrolyses phospholipids into phosphatidic acid (PA) and their respective j
polar head group, using PIP2 as a co-factor (Roth et a l, 1997). Although several 
lines of evidence support this concept, Ktistakis et al employed a direct method by 
using ethanol to divert the action of PLD from PA production to the production of 
phophatidylethanol through a transphosphatidylation reaction (Ktistakis et a l,
1996). This treatment prevented the formation of coated vesicles from Golgi 
membranes in the presence of ARF. In the same study, treatment of Chinese 
Hamster Ovary (CHO) cell Golgi membranes with bacterial PLD to induce ARF- 
independent production of PA, also stimulated coatomer binding (Ktistakis et a l ,
1996). Thus, these experiments suggest a role for PA or its metabolites in the 
binding of coat proteins to Golgi membranes and production of transport vesicles.
Furthermore, a recent study using a permeabilised cell system and immunoaffinity 
purified PLDl has shown that ARF regulation of PLD activity plays an important 
role in the release of nascent secretory vesicles from the TGN (Chen et a l, 1997b).
Although the exact role of ARF is still unclear, together these studies suggest that the 
main role of the small GTP-binding protein in vesicle budding may be to stimulate 
PLD activity locally to 'prime' the membrane for coat binding.
1.7 The Facilitative Glucose Transporter Family
As glucose plays a fundamental role in cellular homeostasis and metabolism, the 
transport of this sugar across the plasma membrane of mammalian cells represents 
one of the most important cellular nutrient transport events. In most mammalian
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cells, glucose transport is mediated by a family of proteins referred to as the 
facilitative glucose transporters, or GLUTs. These transporters allow uptake of 
glucose by the passive process of facilitated diffusion, which is driven solely by the 
concentration gradient existing across the plasma membrane. The transporters are 
specific for the D-enantiomer of glucose and are not coupled to any energy-requiring 
components, such as ATP hydroylsis or an H+ gradient (reviewed in Baldwin., 1993; 
Gould and Holman., 1993).
The functional purification of the first member of this family of transporters was 
reported in 1977 by Kasahara and Hinkle (Kasahara and Hinkle., 1977). The 
transporter, isolated from erythrocyte membranes, was a heavy glycosylated, integral 
membrane protein that migrated as a broad band on SDS-PAGE with an average 
apparent molecular mass of 55kDa, which was reduced to a mass of 46kDa upon 
treatment with Endoglucosidase H. In 1985, this transporter (designated GLUTl) 
was sucessfully cloned and sequenced by Mueckler et al (Mueckler et ah, 1985). In 
turn the availability of GLUTl cDNA clones resulted in the rapid identification of 
the facilitative glucose transporter family through the low stringency screening of the 
appropriate cDNA libraries. To date six glucose transporters have been characterised 
and are referred to as GLUTs 1-6, in chronological order of the isolation of their 
cDNAs (Gould and Homan., 1993).
1.7.1 The Tissue-Specific Distribution of the Facilitative Glucose 
Transporters
The isolation and functional expression of a family of glucose transporter cDNAs 
subsequently lead to the realisation that the transporters were expressed in a tissue 
specific manner, exhibited distinct kinetics and were products of different genes 
(Gould and Holman., 1993). Indeed, the tissue specific expression of the GLUTs 
reinforced earlier findings which demonstrated that different tissue types exhibited 
distinct kinetics to D-glucose uptake (for review see Gould and Holman., 1993).
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Such tissue specific expression may be explained in part on the basis of their 
functional properties as outlined below.
1.7.2 GLUTl
Following the isolation of a cDNA clone for GLUTl (see above), the utilization of 
both eDNA and antibody probes demonstrated that both the GLUTl protein and its 
mRNA are present in many different tissues and cell types (Gould and Beil,. 1990). 
Although expressed at high levels in brain and erythrocytes, it is also particularly 
abundant in endothelial and epithethial cells that form blood-tissue barriers such as 
the brain/nerve barrier, the placenta, the retina etc. (Froehner et al,. 1988). GLUTl is 
also found at low levels in muscle and fat tissue. Flowever, the bulk of glucose 
transport in these tissues is carried out by the insulin-regulatable transporter isoform, 
GLUT4 (see below). Low levels of GLUTl are also present in the liver, which also 
has high levels of GLUT2 (see below). The fact that these tissues, which play a 
major role in maintaining whole body glucose homeostasis express high levels of 
other transporter isoforms, suggests that GLUTl is probably of secondary 
importance. Indeed, GLUTl is thought to fulfill a housekeeping function, 
maintaining a constant low level of glucose in muscle and fat required for resting 
cellular homeostasis. It has also been demonstrated that cultured cell lines possess 
elevated levels of GLUTl protein and mRNA levels (reviewed in Gould and 
Holman,. 1993).
Kinetic studies on human erythrocytes have shown that GLUTl has a very broad 
specificity, transporting a wide range of aldoses, including both pentoses and 
hexoses. Transport rate is determined by both the Vmax, maximal velocity and the 
Km ,which inversely reflects the affinity for substrate. The high affinity of GLUTl 
for glucose (Km ~7mM) at physiological temperature, ensures that GLUTl will 
function close to its Vmax under normal physiological conditions (Lowe and 
Walmsley,. 1986).
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Following the cloning and sequencing of GLUTl, low stringency screening of the 
appropriate cDNA libraries led to the rapid identification of homologous 
transporters from other tissues. The isoforms identified so far in this way are 
between 40 and 80% identical in amino acid sequence. Furthermore, hydropathy 
plots of their sequences are essentially super-imposahle, suggesting that they must 
all be very similar in secondary structure to GLUTl.
1.7.3 GLUT2
The observation that GLUTl was expressed at low levels in liver, coupled to the fact 
that the kinetics of glucose transport in hepatocytes were radically different from 
those in erythrocytes (Elliot and Craik., 1983) suggested the presence of a distinct 
transporter. Application of the aforementioned low stringency screening approach 
of human (Fukamoto et al., 1988) and rat (Thorens et a/.,1988) hepatocyte libraries 
led to the isolation of GLUT2 clones. The resulting human cDNA clone exhibited 
55% sequence identity and 80% homology to GLUTl.
Subsequent immuno cy to chemical studies have shown that GLUT2 is expressed at 
highest levels in hepatocytes, in p cells of the Islets of Langerhans of the pancreas 
(Thorens et al., 1988; Orel et al., 1989) and in the absorptive epithelia of the small 
intestine and the kidney proximal tubule (Thorens et ah, 1988). Functional analysis 
of this transporter has shown that this protein has a supra-physiological for 
glucose, a high transport capacity and exhibits the ability to transport D-fructose in 
addition to D-glucose.
The physiological role of glucose transport in the liver differs from that in most 
other tissues, as this organ may take up and release glucose in order to maintain 
blood glucose levels. The high Km of GLUT2 may reflect a specific adaptation for 
this role, allowing glucose flux into or out of the hepatocyte to respond to changes in 
glucose concentration. The high transport capacity of GLUT2 compared to other
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transporters may also provide a rationale for the localisation of this protein to the 
basolateral membranes of the absorptive epithelia of the small intestine and kidney 
(Thorens et al, 1988). Glucose transport in both the intestine and kidney is a two 
step process, with the active accumulation of glucose via a Na+-dependent 
transporter on the apical membrane of the small intestine transporting glucose against 
its CO centration gradient (Heiger et al., 1987). The accumulated glucose is 
subsequently released into capillaries via the high capacity GLUT2 which is present 
at the basolateral borders.
1.7.4 GLUT3
Further low stringency hybridisation studies resulted in the isolation of GLUT3 from 
human foetal muscle (Kayano et a l, 1988) and mouse (Nagamatsu et al., 1992) 
cDNA libraries. The encoded proteins were found to share ~64% identity with the 
GLUTl transporters from the same species. Northern blot analysis revealed that in 
humans, this transporter was barely detectable in adult skeletal muscle, but was 
rather expressed at high levels in the brain and neural tissues and at lower levels in 
fat, kidney, liver and placenta. However, subsequent immunological studies of 
human tissues only showed high levels of expression in the brain with much lower 
GLUT3 levels in the other tissues suggesting that post-transcriptional regulation of 
the transporter may occur in non-neuronal tissues (Shepherd et al., 1992).
Thus, localisation of GLUT3 to tissues which exhibit a high glucose demand, such 
as the brain and CNS suggests that this transporter may be specialised to meet the 
high energy demands of such tissues. In this regard, GLUT3 exhibits the lowest 
for hexoses of the facilitated glucose transporter family enabling glucose uptake by 
the brain under conditions of either high glucose demand or hypoglycemia where the 
extracellular glucose concentration may be very low (Gould et al., 1991).
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1.7.5 GLUT4
Following the sucessful identification of the GLUT2 and GLUTS isoforms it was 
soon realised that insulin-regulatable transport exhibited in muscle and fat tissue may 
be due to a fourth isoform. By 1989, five independent groups (Fukumoto et a l, 
1989; James et a l, 1989; Birnbaum,. 1989; Charron et al., 1989; Kaestner et al., 
1989) reported the cloning and sequencing of GLUT4 which was predominantly 
expressed in insulin-responsive tissues including adipose, heart and skeletal muscle.
An important feature of GLUT4 is that in the absence of insulin this transporter is 
sequestered into a subcellular compartment, a property not shared with the other 
family members. In response to insulin there is a rapid and large mobilisation of the 
sequestered transporter to the plasma membrane, resulting in large increases in the 
number of GLUT4 transporters at the cell surface and glucose uptake. As this 
transporter is the focus of this study the properties of GLUT4 are examined in 
greater detail in the following sections of this thesis.
1.7.6 GLUTS
In 1990, another putative glucose transporter cDNA was isolated from human small 
intestine (Kayano et al., 1990). Immunological analysis using specific anti-peptide 
antibodies showed that the transporter appears to be localised to the apical brush 
border on the luminal side of absoiptive epitheial cells (Davidson et a l, 1992). As 
glucose transport from the lumen into epithelial cells was believed to be mediated 
predominantly by the unrelated Na+-dependent glucose transporter, it was not 
immediately obvious as to what role this isoform may play as a hexose transporter. 
However, subsequent studies revealed that GLUTS has a high affinity for fructose 
and a low affinity for glucose (Burant et al., 1992), suggesting that the primary role 
for GLUTS in the small intestine is the uptake of dietary fructose. GLUTS is 
expressed in a range of tissues including muscle, brain and adipose, where it is
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thought to supply these tissues with fructose. However,it is not clear if other 
fructose transporters also exist.
1.7.7 GLUT6
The homology screening approach led to the identification of a further transporter­
like transcript with a ubiquitous tissue distribution (Kayano et ah, 1990). This 
cDNA clone has a high level of base homology with GLUTS. However, as the 
cDNA was found to contain mutliple stop codons and frameshifts it is unlikely to 
encode a functional transporter (Kayano et ah, 1990). The extensive identity of the 
GLUT6 cDNA with the GLUTS cDNA sequence suggests that the glucose 
transporter-like region of the the GLUT6 transcript may have arisen by the insertion 
of a reverse transcribed copy of GLUTS into the non-coding region of a ubiquitously 
expressed gene (Kayano et ah, 1990).
1.7.8 The Structure and Membrane Topography of the GLUTs
Analysis of the predicted amino acid sequences of the GLUTs shows that they are a 
highly homologous family. Furthermore, they possess high levels of sequence 
identity with transporters found in many species including cyanobacteria, E. coli, 
yeast, algae and protozoa (reviewed in Walmsley et ah, 1998). This high level of 
sequence similarity is thought to relate to a common mechanism of transport 
catalysis and the transport of a common type of substrate.
Sequence alignment analysis of the GLUTs has revealed a common structure 
composed of 12 predicted amphipathic helices arranged so that both the N- and C- 
termini are at the cytoplasmic surface. There are large loops between helices land 2 
and betwen helices 6 and 7 (Figure 1.6). The intracellular loop between helices 6 and 
7 divides the transporter into two halves, denoted the N- and C-terminal domains.
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The short loops between the remainder of the helices on the cytoplasmic surface are 
very short and are a conserved feature of the whole family. The length of these loops 
also places restrictions upon tertiary structure suggesting that the transporter may he 
composed of two groups of six helices in a bi-molecular structure as observed with 
low resolution electron microscopic images of E. coli lactose permease (Kaback,. 
1996). The length and sequence idenitity of the loops at the extracellular surface are 
more varied and are generally longer in length than the cytoplasmic loops. This may 
potentially result in a less compact helical packing at the external surface allowing the 
protein some flexibility of movement during transport.
The two-dimensional topography with the N-and C-termini on the cytoplasmic 
surface as described above was confirmed using several different methods. Anti­
peptide antibodies against peptides representing the C-terminal tail were found to 
bind to GLUTl in inside-out vesicles (Davies et a l, 1987). Similarily, side-specific 
tryptic digestion of GLUTl yields peptide fragments corresponding to the C- 
terminal tail and large central loop only when erythrocytes are permeabilised (Cairns 
et al., 1987). However, perhaps the most convincing evidence in favour of the twelve 
membrane spanning domain model has been provided by glycosylation scanning 
mutagenisis. By introducing the GLUT4 glycosylation site into each of the short 
loops of a GLUTl mutant lacking its native glycosylation sequence, followed by the 
analysis of their glycosylation status, Mueckler and colleagues could confirm the 
location of each loop (Hresko et al., 1994). A change of mobility on SDS-PAGE 
after glycosidase digestion indicated that the inserted sequence was presented to the 
lumen of the ER and Golgi apparatus. Insertions into each predicted exofacial loop 
produced proteins which were glycosylated, the converse being true for insertions 
into predicted endofacial loops, thus, confirming the predicted twelve transmembrane 
helices model.
Protein secondary structure may be investigated using infra-red spectroscopy, a 
technique used to assess the relative proportions of a-helical, p-strand and random
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coil confirmations. Fourier-transforming infra-red (FTIR) studies, which allow the 
the analysis of protein structure in dilute aqueous media, have shown that the 
GLUTl protein in lipid bilayers contains predominantly a-helical structure, but also 
a proportion of p-sheet, p-turns and random coil conformation (Alvarez et ah, 1987). 
Polarised FTIR spectroscopy results suggest that the a-helices are preferentially 
oriented perpendicular to the plane of the lipid bilayer (Chin et al., 1986). The 
above studies are consistent the twelve transmembrane a-helix structure and together 
with further experimental analysis (reviewed in Gould., 1997) suggest that D-glucose 
is transported across the lipid bilayer via a hydrophobic pore formed by bundle of 
helices which span the bilayer.
1.8 GLUT4 - The Insulin-Responsive Glucose Transporter
Although muscle is quantitatively the most important tissue for glucose disposal, 
many of the studies of the mechanism of GLUT4 translocation have been based on 
fat cells. This is due to a variety of reasons including the availability of adipocytes 
from rat epididymal fat pads and their experimental reliability with regard to 
hormone responsiveness, membrane fractionation and biochemical analysis (reviewed 
in Gould, 1997). In contrast, muscle myofibrils have posed problems in the 
fractionation techniques so readily used on adipocytes. In addition, the murine fat 
cell line, 3T3-L1, is insulin responsive and expresses quantitatively significant 
amounts of GLUT4. However, no comparable muscle cell line exists, a fact which 
has severely hampered studies of this tissue with regard to insulin-stimulated glucose 
transport. Thus, the following sections will refer to work based mainly on 
adipocytes, and studies of GLUT4 trafficking and translocation in muscle will not be 
discussed in any further detail.
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1.9 GLUT4 Translocation
Insulin-sensitive tissues (muscle, heart and adipose) have the ability to rapidly 
augment their glucose transport rate in response to insulin by as much as 30-fold 
(James et al,  1994). Initially, it was thought that insulin might alter the intrinsic 
catalytic activity of glucose transporters localised at the plasma membrane. However, 
in 1980, two independent groups reported that in basal adipose cells, most of the 
glucose transporters were located in an intracellular (microsomal) membrane 
compartment of the cells, and upon insulin stimulation the transporters translocated 
to the plasma membrane (Suzuki et a l,  1980; Cushman et a l ,  1980). This 
transporter was subsequently shown to be GLUT4 (James et a l,  1988). Further 
studies involving immunoelectron microscopic analyses, photoaffinity labelling of 
GLUT4 by membrane impermeable reagents and subcellular fractionation, have 
formally demonstrated that insulin-stimulated increase in glucose uptake in fat, 
muscle and heart is a result of GLUT4 translocation to the cell surface in response to 
insulin (Gould et al, 1993; James et al, 1994).
Using immunoelectron microscopy Slot et al studied the cellular distribution of 
GLUT4 in brown adipose tissue in basal and insulin-stimulated states. Cryosections 
of fixed rat tissue were incubated with specific antibody for GLUT4, which was 
subsequently identified with Protein A /gold and examined by electron microscopy. 
In the basal state, the majority of GLUT4 was shown to be located in tubulo- 
vesicular elements clustered either in the trans~Go\g\ network (TGN) or in the 
cytoplasm often close to the cell surface. Upon insulin treatment there is a marked 
shift in GLUT4 from these sites to the plasma membrane, resulting in an increase of 
GLUT4 at the cell surface of rat brown adipose tissue by at least 40-fold (Slot et al, 
1991b). Further work by Slot et al in cardiac myocytes, showed that increased 
glucose transport in muscle may also be accounted for by the translocation of 
GLUT4 from intracellular tubulo-vesicular elements to the plasma membrane (Slot et 
al, 1991a).
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Studies using a bismannose photoaffinity labelling reagent, ATB-BMPA (2-N-4-(l- 
azi- 2,2,2-trifluroethyl) -benzoyl-1,3-bis (D-mannos-4-yloxy)-2-propylamine) have 
also played a major role in the elucidation of GLUT4 trafficking/translocation. Since 
the reagent is membrane impermeable it only labels the glucose transporters that are 
localised at the plasma membrane. Therefore, when photolabelling is carried out on 
intact cells, only those GLUT4 molecules at the cell surface become tagged (Holman 
et al, 1994a). Experiments in which cell-surface glucose transporters in rat adipose 
cells in the basal and insulin-stimulated states have been labelled and 
immunoprecipitated show that cell-surface GLUT4 is increased 15- to 20-fold in 
response to insulin, whereas the level of cell-surface GLUTl is only increased 3- to 
5-fold, thus indicating that GLUT4 translocation accounts for the majority of insulin- 
stimulated glucose transport (Holman et al, 1990; Calderhead et al, 1990).
Further evidence for translocation has been provided by subcellular fractionation 
studies. Calderhead et al carried out studies involving immunoblotting of membrane 
fractions separated from plasma membranes on a sucrose gradient in conjunction with 
photoaffrnity labelling. With respect to subcellular fractionation, insulin treatment 
caused GLUT4 to shift from the intracellular to the plasma membrane fraction 
(Calderhead et al, 1990). However, the increase of GLUT4 in the plasma membrane 
containing fraction is considerably less than that found by the ATB-BMPA labelling 
method. This may be due to the contamination of these fractions with intracellular 
membranes containing the transporter. As previously mentioned the translocatable 
GLUT4 is thought to be located in the TGN and possibly also the endosomes. 
However, to date there is no known marker for the intracellular membranes 
containing the insulin-responsive transporters that may be used to assess the 
contamination of the plasma membrane fractions (Calderhead et al, 1990).
Recent studies have also shown GLUT4 to be expressed in various cell types not 
considered to be insulin-responsive including neuronal tissue (hippocampus, medulla 
oblongata, ventricle and thalamus) (Kobasyashi et al, 1996), endothelial cells of the 
blood brain barrier (McCall et a l,  1997) and specific parts of the kidney (distal
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tubule, juxtaglomerular apparatus and afferent arterioles) (Rea et a l,  1997). 
However, GLUT4 is sequestered in intracellular tubulo-vesicular elements 
irrespective of the tissue type in which it is expressed, a unique property not shared 
with the other transporter iso forms which are localised at the cell surface (Rea et a l , 
1997). Thus, it is possible that the translocation of GLUT4 may require different 
stimuli in brain and kidney tissue, yet to be determined.
1.10 GLUT4 Subcellular Trafficking
Immunocytochemical studies have shown the majority of GLUT4 molecules (-60%) 
to reside in tubulo-vesicular elements clustered in the cytoplasm often close to the 
cell surface (Slot et al,  1991b). However, localisation of GLUT4 in clathrin-coated 
veiscles and endosomes (Slot et al, 1991a; Slot et al, 1991b) indicates that GLUT4 
recycles via the endosomal system both in the absence and presence of insulin. 
Further evidence for the constitutive recycling of GLUT4 in basal and insulin- 
stimulated adipocytes, is provided by kinetic studies using impermeable photolabels. 
In these experiments, the photolabelling technique is used to study the transfer of 
tracer-tagged glucose transporters between the plasma membrane and the intracellular 
membranes. As only the cell-surface pool of transporters is labelled, the half-times 
for internalisation of tracer-tagged glucose transporters can be used to calculate both 
endocytosis and exocytosis rate constants, since the net loss of tagged transporters 
from the plasma membrane is dependent on both of these parameters (Yang et al, 
1993; Jhun et a l,  1992). Using the same approach, studies in rat adipose cells by 
Satoh et al (Satoh et al, 1993) and 3T3-L1 adipocytes by Yang et al (Yang et al, 
1993), have shown that insulin primarily increases the exocytic rate constant while 
only slightly reducing the endocytic rate constant, providing further evidence for the 
translocation hypothesis.
However, the fact that there are multiple subcellular locations of GLUT4 (TGN, 
tubulo-vesicular elements and endosomes), each of which contribute to the
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redistribution of GLUT4 to the cell surface in response to insulin, as revealed by 
immunocytochemical studies (Slot et a l,  1991b), suggests that the recycling of 
GLUT4 between the plasma membrane and a single intracellular compartment is an 
oversimplified model. Also, kinetic studies by Satoh et al have shown that the half- 
time for recycling in the continuous presence of insulin is significantly slower than 
the half-time for insulin-stimulated trafficking from the hasal state (Satoh et al, 
1993). With only one intracellular pool, these processes should have the same half- 
times as both are are dependent on the same insulin-stimulated rate constants for 
trafficking between the two pools. Thus, these studies are not consistent with a 
single intracellular compartment.
Using mathematical analysis coupled with computer simulations, Holman et al have 
shown how trafficking through multiple pools can account for these experimental 
observations (refer to Figure 1.7) (Holman et a l,  1994b). The trafficking models 
employed included: a 3-pool model (with a plasma membrane pool and two 
intracellular compartments representing the tubulo-vesicular and early endosomal 
compartments), and 4 and 5-pool models (accounting for the presence of occluded 
pools in the plasma membrane). The 3-pool model is consistent with the possibility 
that most of the GLUT4 in the basal state is associated with the tubulo-vesicular 
compartment, thought to represent a storage pool, from which insulin stimulates a 
rapid GLUT4 exocytosis. At steady state, recycling from this compartment to the 
plasma membrane, followed by trafficking via the endosomes and sequestration into 
the storage compartment, can be slower than the initial rate of exocytosis, thus 
accounting for the slow steady-state recycling of cell surface GLUT4 in the presence 
of insulin and the fast initial insulin stimulation of the appearance of GLUT4 at the 
plasma membrane observed by Satoh et al (Satoh et a l,  1993). The 4-pool model 
takes into account the presence of occluded plasma membrane glucose transporters 
before or after the pool in which proteins are participating in glucose transport. The 
model in which there is a pool of vesicles which have docked with the plasma 
membrane but have yet to fuse is likely to account for the lag observed between the
36
appearance of GLUT4 at the plasma membrane and its participation in glucose 
transport as observed by Satoh et al (Satoh et al, 1993). In the 5-pool model, two 
occluded plasma membrane pools are included occurring both before and after the 
fully functional plasma membrane form of the protein (Holman et al, 1994b).
Taken together, these studies demonstrate that GLUT4 subcellular trafficking in 
isolated rat adipose cells and 3T3-L1 adipocytes exibits many of the properties 
observed in regulated secretory processess and neurosecretion. The rapid 
translocation of GLUT4 to the plasma membrane in response to insulin, and 
subsequent recycling resulting in sequestration into a storage pool, is analagous to the 
exocytosis of synaptic vesicles and their retrieval from the plasma membrane via 
clathrin-coated vesicles into endosomes, and sorting into a specialised secretory pool 
which is then available for further stimulated exocytosis (refer to Section 1.3).
1.11 The GLUT4 Intracellular Compartment
Although mathematical analysis of GLUT4 trafficking kinetics suggest that the 
tubulo-vesicular elements observed by immuno cy to chemical studies represent a 
distinct GLUT4 compartment, it must be noted that a mechanism by which GLUT4 
is specifically sequestered within the endosomal system and then escorted to the cell 
surface in response to insulin would also be consistent with the data obtained. 
Insulin also causes a 2- to 4-fold increase in cell surface levels of many recycling 
proteins in adipocytes including the TfR, the CI-M6PR and the a2-macroglobulin 
receptor (Tanner et a l,  1987; Oka et al., 1985). Thus, the insulin-dependent 
movement of GLUT4 in adipocytes may simply represent an efficient adaptation of 
this pathway. However, although it has been difficult to distinguish the GLUT4 
compartment from other elements of the constitutive recycling pathway, there is 
increasing evidence to suggest that there is a separate GLUT4 storage compartment. 
A technique which has played a major role in several of the following studies is 
vesicle immunoisolation, a method initially described by Biber and Lienhard (Biber et
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a l ,  1986) in which vesicles are immunoadsorbed onto a solid support such as 
Staphloccocus aureus cells coated with an appropriate antibody such as a 
monoclonal antibody against the carboxy terminal of GLUT4.
Direct evidence for the existence of a GLUT4 storage compartment, which is 
separate from the recycling endosomal system has recently been demonstrated by 
means of a technique referred to as compartment ablation analysis (Livingstone et al,
1996). This method employs loading of the recycling pathway of the TfR (refer to 
Section 1.3) with transferrin conjugated to horseradish peroxidase (Tf-HRP). In the 
presence of peroxide (H2O2) and 3,3'-diaminobenzidine (DAB), the HRP converts 
DAB into a dense polymer. Integral membrane proteins present in the Tf-HRP 
containing endosomes become cross-linked by the DAB polymerisation reaction and 
are subsequently ablated. Using endosomal ablation in conjunction with vesicle 
immunoisolation in 3T3-L1 adipoctyes, Livingstone et al have shown that some 
40% of the GLUT4 is localised to the early endosomal/ recycling system, but a larger 
proportion of GLUT4 (-60%) resides in a distinct 'non-ablatable' pool which is 
devoid of transferrin receptors and other endosomal recycling proteins (Livingstone 
et al,  1996). Glycerol gradient analysis has also been used to identify a population 
of GLUT4 vesicles in adipocytes that are segregated from endosomal markers 
(Herman et al, 1994; Laurie et al, 1993).
GLUTl also recycles between an intracellular pool and the plasma membrane. Co­
localisation of this isoform with both the TfR and the CI-M6 PR suggests that this 
occurs via the endosomal system (Tanner et a l,  1989), consistent with the 
quantitative ablation of GLUTl following endosomal ablation (Livingstone et al,
1996). As GLUT4 also constitutively recycles via the endosomal system (refer to 
Section 1.9), it is therefore not surprising that GLUTl and GLUT4 were found to 
co-localise upon the isolation of GLUTl and GLUT4 vesicles from bulk membranes 
of 3T3-L1 adipoctyes (Calderhead et al, 1990). However, double-labelled immuno­
fluorescence microscopy in 3T3-L1 adipoctyes has revealed differential intracellular
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targeting of GLUTl and GLUT4 (Piper et al,  1991). Also, the immunoisolation of 
GLUT4 vesicles from intracellular membranes in rat cardiac myoctyes has recently 
identified two GLUT4 pools, only one of which is enriched in GLUTl (Fischer et 
al,  1997). Kinetic studies in which both GLUT4 and GLUTl in 3T3-L1 adipocytes 
have been tracer-tagged by photolabelling, suggest that the rates of endocytosis of 
both transporters are very similar, but in the basal state the rate constant for 
exocytosis of GLUT4 is much slower than that of GLUTl. The slow exocytosis of 
GLUT4 in the basal state results in increased intracellular retention of GLUT4 
relative to GLUTl, suggesting that the former isoform possesses additional 
intracellular retention signals, providing a possible explanation for the differential 
targeting of the two transporters (Yang et al, 1993).
Recently, Malide et al have studied the subcellular distribution of GLUT4 and its co­
localisation with compartment markers in rat adipose cells in situ using confocal 
microscopy and 3-D image reconstruction (Malide et al, 1997a). Three-dimensional 
analysis of GLUT4 immuno staining in basal cells revealed an intracellular punctate 
distribution both in the perinuclear region and throughout the cytoplasm. VAMP2 
was found to be co-localised with GLUT4 in many of these punctate structures with 
a small fraction of the transporter also overlapping with TGN38, y-adaptin and the 
M6 PR in the perinuclear region, corresponding to the late endosome and TGN 
structures. However, co-localisation was not observed with either the TfR or lgpl20 
(a lysosomal membrane protein), suggesting that in the basal state GLUT4 resides in 
a post-endosomal VAMP2-positive compartment, distinct from the recycling 
endosomes (Malide et al,  1997a), a result in striking agreement with the data from 
Tf-HRP ablation analysis (Livingstone et al, 1996). The co-localisation of GLUT4 
with the v-SNARE, VAMP2, has been shown in several other studies (Cain et al, 
1992; Martin et al,  1996), the relevance of which shall be discussed later in this 
chapter.
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Several other observations also support the idea that the GLUT4 storage 
compartment is a separate entity from the endosomal recycling system. The 
aminopeptidase vpl65, completely co-localises with GLUT4 in muscle and fat cells 
(Kandror et a l,  1994; Martin et a l,  1998; Ross et al,  1996) and exhibits similar 
insulin-stimulated trafficking kinetics to GLUT4 in 3T3-L1 adipocytes (Ross et al, 
1997), suggesting that the GLUT4 storage compartment contains other proteins aside 
from GLUT4. Although insulin causes a 2- to 4-fold increase in cell surface levels of 
many recycling proteins, the translocation of GLUT4 and vpl65 is considerably 
greater (10- to 40-fold) (James et al, 1994). This dichotomous behaviour suggests 
that the major function of the GLUT4 storage compartment is to sequester GLUT4 
and other resident proteins in the basal state and to facilitate their rapid access to the 
cell surface in response to insulin. Finally, GLUT4 is enriched in regulated secretory 
granules when expressed in endocrine cells, indicating that the transporter must 
contain sorting signals which enable it to be distinguished from other recycling 
proteins (Hudson, 1993).
1.12 The Nature and Biogenesis of the GLUT4 Storage Compartment
Taken together, these studies provide compelling evidence for the existence of a 
GLUT4 storage compartment. However, the nature of this compartment is still 
poorly understood and it is not known whether the storage compartment resides in 
an extension of a previously identified organelle such as the TGN or a specialised 
entity, yet to be identified. The aforementioned studies clearly show poor co­
localisation between GLUT4 and the TfR, a marker of the endosomal system, 
probably excluding this compartment as being a possibility for the sequestration of 
GLUT4. Although GLUT4 shows partial co-localisation with the CI-M6PR (also 
known as the insulin-like growth factor II receptor [IGFIIR]) this is thought to be 
within the recycling endosomal system, and the majority of the CI-M6PR (Kandror 
et al, 1996) and lgpl20 (lysosomal membrane protein) (Malide et al,  1997a) show 
no co-localisation with GLUT4, ruling out the late endosomes and the lysosomes.
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respectively. As previously reported, early studies by Slot et al showed a small 
fraction of GLUT4 (-13%) to be associated with the TGN (Slot et al,  1991a; Slot et 
a l,  1991b), consistent with the recent confocal studies observing partial overlap 
between the transporter and the putative TGN markers, TGN38 and y-adaptin (a 
component of the AP-1 complex) (Malide et al, 1997a). However, it has recently 
been shown by vesicle isolation that only - 10% of the intracellular complement of 
GLUT4 is present within TGN38 vesicles isolated from 3T3-L1 adipocytes (Martin 
et a l,  1994), suggesting that the GLUT4 storage compartment does not reside in the 
TGN. However, the TGN is a heterogenous compartment organised into discrete 
subdomains and therefore GLUT4 may be localised to certain regions devoid of 
TGN38 and vice versa. Thus, it is not possible to exclude a subdomain of the TGN 
as being a major site for intracellular GLUT4 storage until further studies regarding 
the nature of such a compartment are carried out.
An experimental approach exploited by several laboratories has been to elucidate the 
composition of GLUT4-rich vesicles in order to identify a 'reporter' protein that may 
be instructive in understanding their regulation by insulin. The rationale for this 
approach is based on the assumption that the insulin-induced biochemical changes 
which result in GLUT4 translocation are not directed to GLUT4 per se, but rather, 
take place in one or more regulatory proteins that are part of the GLUT4 vesicles. 
To date, several proteins have been identified in GLUT4 vesicles from adipocytes 
including: vpl65 (Keller et a l,  1995), sortilin (Morris et a l ,  1998), SCAMPs 
(secretory carrier-associated membrane proteins) (Laurie et al,  1993), VAMPs (Cain 
et a l,  1992), phosphatidylinositol-4-kinase (Del Vecchio et a l,  1991) and Rab4 
(Cormont et al, 1991). As the aminopeptidase vpl65 has been found to completely 
co-localise with GLUT4 and exhibit similar kinetics to the transporter both in the 
basal state and in response to insulin (Kandror et al, 1994; Ross et al, 1996; Ross et 
a l ,  1997), this protein may prove to be a key component in the regulation of 
GLUT4 vesicles. However, the requirement for aminopeptidase activity in insulin- 
responsive cells is unknown. Interestingly, the vasopressin-sensitive, water channel-
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containing vesicles from kidney are also rich in aminopeptidase activity (Sabolic et 
al,  1992; Harrison et al, 1994). In a similar way to GLUT4, these water channels 
translocate from a vesicular storage pool in a hormone-dependent manner, thus 
suggesting that aminopeptidases may be involved in hormone-sensitive vesicular 
traffic (Stephens et al, 1995). As sortilin has only recently been identified, little is 
known about this novel membrane protein (Morris et a l,  1998). However, the 
relatively small increase in cell surface levels of this protein ( - 2 -fold) in response to 
insulin, suggests that sortilin may associate with GLUT4 in the recycling endosomal 
system, in a manner similar to the TfR (Morris et a l,  1998). As the other proteins 
are ubiquitous in their expression, their identification has not provided any further 
clues towards the insulin-dependent regulation of GLUT4. However, the 
identification of SCAMPs (Laurie et a l,  1993), VAMPs (Cain et al, 1992) and Rab4 
(Cormont et al, 1991) as constituents of GLUT4 vesicles supports the concept that 
GLUT4 translocation exhibits many similarities to secretory phenomena such as 
neurotransmitter release at synapses and hormone release from endocrine cells.
Using confocal microscopy, Malide et al have recently proposed that GLUT4 resides 
in a post-endocytic compartment (Malide et al, 1997a). However, the nature of this 
compartment is ill-defined and it is still not clear whether or not it represents a 
specialised secretory compartment. Although GLUT4 has been localised to 
secretory granules in neuroendocrine cells, such cell lines do not express this 
transporter endogenously and therefore care must be taken when interpreting the 
results (Hudson, 1993). However, a recent study in rat atrial cardiomyocytes, a 
regulated secretory cell type in which GLUT4 is endogenously expressed, has shown 
a large proportion of GLUT4 (50-60%) to be localised in the atrial natriuretic factor 
(ANF)-containing secretory granules (Slot et al, 1997). It must be noted that the 
effect of insulin on GLUT4 distribution was too small to measure shifts of GLUT4 
labelling from the ANF granules and therefore it is still unknown whether this 
compartment contributes to the translocation of GLUT4. Further studies in other
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The second model proposes that GLUT4 may traffic back to the TGN, with the 
subsequent budding of the storage compartment from this organelle. The partial 
overlap of GLUT4 with the M6 PR-, TGN38- and y-adaptin-positive structures 
observed using confocal microscopy, suggests the possibility that in the recycling 
pathway GLUT4 may indeed return as 'far back' as the TGN before reaching the 
storage compartment (Malide et al,  1997a), consistent with electron microscopy 
studies showing GLUT4 to be localised to the TGN in insulin-sensitive cells (Slot et 
al,  1991a; Slot et al, 1991b). Also, the aforementioned ANF-secretory granules in
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insulin-responsive cell lines may provide insight into the physiological basis for the 
targeting of GLUT4 to a secretoiy organelle.
Relatively little progress has also been made in determining the biogenesis of the 
intracellular storage compartment. However, based on our current knowledge of 
GLUT4 and/or general trafficking systems, three possible models for the entry of ;
GLUT4 into the intracellular storage compartment after leaving the plasma membrane i
■ffhave been proposed (refer to Figure 1.8) (reviewed in Rea et al,  1997). The first f
model postulates that the GLUT4 storage compartment may bud directly from the
:endosomes. This is supported by the partial overlap between endosomal proteins 
and GLUT4 (Martin et al, 1996) and electron microscopy studies which have clearly !
shown GLUT4 to be clustered in tubulo-vesicular elements adjacent to sorting /
endosomes (Slot et a l,  1991a;Slot et al,  1991b), consistent with a specific sorting |
step at this location. Furthermore, the PI 3-kinase inhibitor wortmannin disrupts 
both GLUT4 and endosomal trafficking (Shepherd et a l,  1996b), suggesting a 
common mode of action. The co-localisation of Rab4 with GLUT4 vesicles,
suggesting a potential role for this endosomal GTP-binding protein in GLUT4
trafficking (Cormont et a l,  1996; Shibata et al,  1996) (see below), and the recent ; i
■vldiscovery of unique coat proteins involved in vesicle budding from the endosomes |
(Stoorvogel et al, 1996), also support the idea that the storage compartment may be j
of endosomal origin. , |
atrail cardiomyocytes were found to become GLUT4-positive in the TGN (Slot et 
a l ,  1997). Cyclohexamide treatment had no effect on the TGN localisation of 
GLUT4 in these cells, suggesting that a large proportion of GLUT4 recycles via the 
TGN (Slot et al, 1997). However, it is not known whether GLUT4 returns back to 
the endosomal system from the TGN or whether the storage compartment buds 
directly from this organelle. Clatlnin-coated vesicles (containing the AP-1-complex) 
budding from the TGN are thought to fuse with endosomes (refer to Section 1.4.2). 
However, AP-1-containing coated vesicles have also been observed on immature 
secretoiy granules following budding from the TGN (refer to Section 1.4.3) (Traub et 
al,  1993; Seaman et al,  1996b). Further studies on GLUT4 trafficking are required 
to differentiate between these two possible processes. It is also possible that the 
GLUT4 storage compartment may emanate from both the endosomes and the TGN. 
This is supported by recent studies which have shown that sorting signals regulating 
the internalisation of membrane proteins from the cell surface may also facilitate 
sorting in the Golgi (Marks et a l,  1997). Similarly, the GLUT4 signal which 
mediates its entry into the storage compartment may operate both at the TGN and 
endosomes (Rea et al, 1997). Also, the gross architecture of the cell may dictate the 
pathway followed by the recycling vesicles. For example, the specialised structure 
of the neurite dictates the need for a Golgi-independent vesicle recycling system. 
Both adipocytes and muscle cells are highly compartmentalised and therefore in some 
regions of the cell, the GLUT4 storage compartment may occur independently of the 
Golgi, analagous to the reformation of synaptic vesicles in neurons (Rea et al, 1997).
Finally, the third model proposes that GLUT4 may be internalised via a separate 
endosome, compared with other recycling proteins. This model has recently been 
proposed for the re-formation of synaptic vesicle-like membranes in PCI2 cells 
(Schmidt et al,  1997). A characteristic feature of the specialised endosome in these 
cells is that traffic out of the compartment is blocked at low temperature. 
Interestingly, insulin-stimulated GLUT4 translocation is inhibited in adipocytes 
following a prolonged incubation at 18°C, consistent with this model (Robinson et
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al,  1992a). However, the specific sorting of GLUT4 out of the recycling endosome 
may also be blocked at a low temperature. In addition, a 20°C incubation is known 
to reversibly block the transport of proteins from the TGN (Matlin et a l,  1983) and 
therefore this phenomenon may be explained by all three models. The co-localisation 
between GLUT4 and recycling proteins also casts doubt upon the viability of this 
last model.
1.13 GLUT4 Trafficking Signals
When considering the subcellular trafficking of GLUT4 there are at least three 
separate stages which may require a signalling motif including; internalisation of 
GLUT4 via clathrin-coated pits, sorting at the TGN and sorting and /or retention into 
the storage compartment. To date, two such motifs have been identified through 
studies involving the use of chimeric, truncated or mutated transporters.
The first motif is an aromatic-based signal (F^QQI) located in the N-terminus while 
the second signal comprises a dileucine motif (LL489-490) located in the C-terminus. 
Interestingly, both motifs resemble well described targeting signals identified in 
numerous other recycling proteins (refer to Section 1.4.3) (Marks et al,  1997). In 
the N-terminus, mutation of the phenylalanine to alanine results in the accumulation 
of GLUT4 at the cell surface, thought to be due to impaired entry into clathrin- 
coated pits (Piper et a l ,  1993). Furthermore, the construction of chimeric 
transporters between GLUT4 and the transferrin receptor has shown that the F^QQI 
internalisation motif promotes effective internalisation of the chimera in CHO cells 
(Garippa et al, 1994). Mutation of the leucine residues to alanines in the C-terminus 
also leads to the accumulation of GLUT4 at the cell surface under steady state 
conditions. However, although it is apparent that mutation of this motif impairs 
GLUT4 internalisation, in contrast to to the F^QQI mutant, a high level of 
expression of the transporter is required (Verhey et a l, 1995; Marsh et al, 1995). 
Based on the above data and other studies it is unlikely that either the F^QQI or di-
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leucine motifs regulate entry of GLUT4 into the storage compartment. Thus, there 
must be a separate motif which faciliates this function.
Recently, Lee et al have demonstrated the importance of the C-terminal cytoplasmic 
domain of GLUT4 in its intracellular sequestration (Lee et al, 1997). By introducing 
a synthetic peptide corresponding to the C-terminal cytoplasmic domain of GLUT4, 
redistribution of GLUT4 from the intracellular pool to the plasma membrane was 
observed in basal adipocytes. Not only does this study underscore the importance 
of the C-terminal domain in GLUT4 targeting, it also suggests the existence of a 
regulatory protein that interacts with this domain, thus participating in GLUT4 
sequestration (Lee et al,  1997). As vpl65 is also targeted to the GLUT4 storage 
compartment, a similar targeting motif might be expected to exist in this protein. 
Interestingly, the cytoplasmic tail (N-terminus) of vpl65 contains two di-leucine 
motifs and several acidic regions similar to those which occur in the extreme GLUT4 
C-terminus (Ross et a l,  1996). Furthermore, the introduction of a glutathione S- 
fusion protein containing the cytosolic portion of vpl65 results in GLUT4 
translocation to the plasma membrane in basal 3T3-L1 adipocytes, suggesting that 
the N-terminus of vpl65 interacts with a retention/sorting protein that also regulates 
the distribution of GLUT4 (Waters et al,  1997). Collectively, these studies suggest 
that the sorting of GLUT4 and vpl65 within the cell is carried out by a common 
mechanism. The similarity between the C-terminus of GLUT4 and the N-terminus 
of vpl65 indicates that this mechanism may act via a signalling motif within these 
domains. Further studies are required to define the nature of such a motif and also to 
identify cellular proteins that interact with this region.
1.14 GLUT4 Trafficking: The Role of SNAREs and Rah Proteins
The segregation of GLUT4 in a separate storage compartment and its translocation to 
the cell surface in response to insulin, shares many morphological and biochemical 
features with synaptic secretory vesicle (SSV) exocytosis in neurons. As several
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molecules involved in targeting, docking and fusion of SSV with the presynaptic 
membrane have been characterised (refer to Section 1.5) this catalysed the search for 
SNAREs and other SSV proteins in insulin-sensitive tissues. Recently, homologues 
of these molecules have been identified in adipocytes and myocytes implying that 
the trafficking of the GLUT4 storage compartment is highly analagous to SSV 
exocytosis. Thus, the SNARE hypothesis also provides a working model for studies 
of vesicle targeting and fusion in adipocytes (refer to Figure 1.9).
The expression of neuronal VAMP analogues in adipocytes was first reported by 
Lienhard and colleagues (Cain et a l,  1992). Subsequent studies, have shown 
adipocytes to express both VAMP2 and an additional v-SNARE cellubrevin, both of 
which were surprisingly found to co-localise with GLUT4 in adipoctyes (Volchuk et 
a l ,  1995; Martin et a l,  1996). However, using endosomal ablation analysis to 
further define their intracellular distribution in 3T3-L1 adipocytes, Martin et al have 
shown that the majority of cellubrevin resides in the endosomes whereas a large 
fraction of VAMP2 (-90%) was targeted to the 'non-ablatable' GLUT4 storage 
compartment, suggesting a specific role for VAMP2 in GLUT4 trafficking (Martin et 
a l,  1996). In the same study, immuno-electron microscopy of intracellular vesicles 
revealed co-localisation between VAMP2 and GLUT4, again, in striking agreement 
with GLUT4 localisation in a VAMP2-positive post-endocytic compartment 
recently observed by confocal microscopy (Malide et al,  1997a).
Although providing conflicting data, the specific proteolytic cleavage of VAMP2 and 
celluhrevin by neurotoxins has been used to determine the role of these molecules in 
GLUT4 trafficking. Studies in 3T3-L1 adipocytes using Botulinum neurotoxins 
(BoNT) B and D specific for VAMP and cellubrevin, resulted in a 64% inhibition of 
insulin-evoked glucose uptake and a 61% inhibition of GLUT4 translocation to the 
plasma membrane, respectively (Chen et al,  1997a; Macaulay et al,  1997). In 
contrast, the introduction of tetanus toxin into rat adipocytes by electroporation, 
resulting in complete loss of cellubrevin and VAMP2 expression, had no effect on the
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ability of insulin to stimulate glucose transport (Hajduch et a l,  1997). However, 
recently it has been shown that the introduction of synthetic peptides that comprise 
VAMP2 domains into 3T3-L1 adipocytes inhibit insulin-stimulated translocation by 
-50% (Macaulay et a l,  1997), thus providing more conclusive evidence of the 
involvement of VAMP2 in GLUT4 trafficking . Taken together with the differential 
distribution of VAMP2 and cellubrevin in 3T3-L1 adipocytes, it is plausible that 
VAMP2 regulates insulin-dependent GLUT4 trafficking whereas cellubrevin may 
mediate the endosomal trafficking of the transporter.
As it became evident that insulin-sensitive cells employed the same v-SNARE as 
neurons, further investigations were carried out to determine whether they also 
utilised the same t-SNAREs, namely syntaxin-lA and SNAP-25 and other regulatory 
proteins. Among the syntaxins thought to regulate recycling through the endosomal 
system, only syntaxins 1A and 4 have been shown to bind to VAMP2. Syntaxin 1A 
is predominantly expressed in neurons and is absent from insulin-sensitive cells. 
Syntaxin 4, however, is expressed at high levels in fat and muscle cells and is 
predominantly targeted to the plasma membrane (Olson et al,  1997; Tellam et al, 
1997). By the introduction of either the cytoplasmic domain of syntaxin 4, a GST- 
syntaxin 4 fusion protein or antibodies directed against syntaxin 4, insulin-stimulated 
GLUT4 translocation was found to be inhibited in 3T3-L1 adipocytes, thus 
establishing a role for the t-SNARE in GLUT4 trafficking (Olson et a l,  1997;Tellam 
et a l,  1997). Furthermore, the introduction of a mutant cytoplasmic domain of 
syntaxin 4 in which the putative VAMP binding domain was deleted had no 
significant effect on insulin-stimulated GLUT4 translocation, suggesting that the 
inhibition observed was specific for the interaction of syntaxin 4 with VAMP2 
(Olson et al, 1997).
The inability to detect significant expression of the t-SNARE SNAP-25 in 
adipocytes, has led to the recent identification of a SNAP-25 homologue, designated 
SNAP-23 (Araki et a l,  1997). SNAP-23 is located primarily at the plasma
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membrane in 3T3-L1 adipocytes, exhibiting a similar distribution to that of syntaxin 
4. In vitro, SNAP-23 has also been shown to associate strongly with syntaxin 4, 
analagous to the association of syntaxin lA  to SNAP-25 in neural cells (refer to 
Section 1.5). Furthermore, by expressing SNAP-23, syntaxin 4 and Munc 18c (a 
syntaxin binding protein, see below) in COS cells, syntaxin 4 was shown to bind to 
both SNAP-23 and Munc 18c, and as expression of Munc 18c increased the amount 
of SNAP-23 associated with syntaxin 4 decreased, suggesting that Munc 18c may 
regulate the formation of the SNAP-23-syntaxin 4 SNARE complex (Araki et al, 
1997). However, the role of SNAP-23 in the trafficking of GLUT4 in insulin- 
sensitive cells has yet to be established.
Upon establishing a role for syntaxin 4 as the functional t-SNARE in GLUT4 
trafficking, subsequent studies have led to the identification of the syntaxin binding 
protein involved in the regulation of v-SNARE and t-SNARE interactions in GLUT4 
exocytosis. Of the three Munc 18 isoforms participating in the endosomal recycling 
system of adipocytes (Munc 18a-c), Munc 18c is primarily targeted to the cell 
surface, again with a distribution indistinguishable from that of syntaxin 4 (Tellam et 
a l,  1997). In addition, in vitro studies by Tellam et al have recently shown that 
Munc 18c reduces the interaction between syntaxin 4 and VAMP2 (Tellam et al, 
1997), similar to the effect observed for Munc 18a on the interaction between 
syntaxin 1A and VAMP2 (Sudhof, 1995).
Collectively, these data provide further support for the similarity between the 
regulation of GLUT4 exocytosis in fat cells and synaptic vesicles in neurons. 
Modulation of the syntaxin binding proteins by insulin, thereby regulating the 
availability of the t-SNARE syntaxin 4 for the v-SNARE VAMP2, provides an 
attractive model for insulin-stimulated GLUT4 exocytosis, as shown in Figure 1.8.
The Rab family of small GTP-binding proteins are also known to play an important 
role in vesicle trafficking (refer to Section 1.3.4). Initial studies showing the
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association of Rab4 with GLUT4 vesicles in adipocytes (Cormont et al, 1993), in 
addition to the tight correlation observed between the subcellular redistribution of 
GLUT4 and Rab4 in response to insulin (Ricort et al, 1994), suggested that this 
member of the Rab family may be important in GLUT4 trafficking. Recent studies 
have provided further evidence for a specific role for Rab4 in the insulin-stimulated 
translocation of GLUT4.
Le Marchand-Brustel and colleagues have shown that the transient co-expression of 
Rab4 with an epitope tagged GLUT4 in rat adipocytes leads to the enhanced 
intracellular retention of GLUT4 in the basal state (Cormont et a l,  1996). The 
overexpression of Rab4 at high endogenous levels, in addition to decreasing the levels 
of GLUT4 at the plasma membrane also blocked the insulin-induced recruitment of 
GLUT4 to the cell surface, suggesting that Rab4 is involved in both the biogenesis of 
the GLUT4 compartment and also translocation to the cell surface in response to 
insulin. Moreover, as the overexpressed protein was found to be mainly cytosolic, 
the inhibitory effect may be due to the sequestration of some protein/factor required 
for insulin action. The moderate expression of a Rab4 mutant lacking the 
geranylgeranylation sites required for membrane anchorage had the same effect as the 
wild type Rab4 when overexpressed at high levels, consistent with this idea 
(Cormont et al, 1996). Two independent studies support the work carried out by 
Le Marchand-Brustel and colleagues. First, Shibata et al have inhibited insulin- 
induced GLUT4 translocation by -50% by introducing a peptide corresponding to 
the hypervariable carboxy terminal of Rab4 into rat adipocytes (Shibata et al, 1996). 
Second, by co-expressing Rab4 and GLUT4 in Xenopus oocytes, Mora et al have 
also observed an increase in the intracellular retention of GLUT4, similar to that 
observed in rat adipocytes (Mora et a l,  1997). Thus, both of these studies support 
the notion that Rab4 is involved in both insulin-induced GLUT4 translocation and 
the biogenesis of the storage compartment.
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Recently, Shibata et al have shown that Rab4 may indeed be one of the possible 
intracellular targets of insulin action on intracellular vesicle traffic in rat adipocytes 
(Shibata et a l,  1997). By showing that insulin stimulates guanine nucleotide 
exchange on Rab4, Shibata et al have proposed that insulin may activate as yet 
unidentified guanine nucleotide exchange factor(s) (GEFs) for Rab4 (Shibata et al, 
1997). Furthermore, inhibition of this insulin-stimulated nucleotide binding by 
wortmannin, a specific inhibitor of phophatidylinositol 3-kinase (PI 3-kinase), 
suggests that insulin targets Rab4 via a FI 3-kinase-dependent signalling pathway 
(Shibata et a l,  1997). However, the exact mechanisms involved in the activation of 
Rab4 by FI 3-kinase remain to be explored.
1.15 Signalling Mechanisms that Regulate GLUT4 Translocation
The signalling cascade that results from the binding of insulin to its receptor is one of 
the most extensively studied signal transduction pathways (reviewed in Shepherd et 
al,  1996a; Holman and Kasuga,. 1997). Insulin has a dual role as it is both a weak 
mitogen and a regulator of glucose metabolism. There is growing evidence to suggest 
that two divergent signalling pathways result from the activation of the insulin 
receptor and that these pathways separately regulate the mitogenic response and 
metabolic effects, the latter of which includes the GLUT4 trafficking pathway 
(Haruta et a l,  1995; Van Den Berghe et a l,  1994). The divergence of mitotic 
stimulation and metabolic stimulation is clearly necessary in insulin-responsive 
tissues such as fat and muscle where there is a requirement for an acutely regulatable 
metabolic flux without a concomitant stimulation of cell growth and division.
The cascades leading to stimulated glucose transport and activation of cell growth and 
mitosis begin at the insulin receptor, an a2/p2 tetramer (reviewed in Hausdorff et al, 
1997). The a-subunit is located entirely at the extracellular surface of the plasma 
membrane and contains the insulin binding site. The p-subunit is a transmembrane 
peptide that possesses tyrosine-specific protein kinase activity in the intracellular
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domain. Insulin binding to the a-subunit leads to the phosphorylation of the p- 
subunit of the receptor on tyrosine residues. This auto-phosphorylation process is 
associated with increased tyrosine kinase activity toward intracellular substrates. 
The major substrates of the kinase include the adaptor protein Src-homology- 
collagen-like protein (She) (Skolnik et al,  1993) and four related insulin receptor 
substrate (1RS) proteins (White,, 1998) (Figure 1.10). Tyrosine-phosphorylated She 
recruits the small adaptor protein growth factor receptor-binding protein 2 (Grb2) 
which in turn recruits and activates the ras-GDP exchange factor mammalian son-of- 
sevenless protein (m-sos). Recruitment of m-sos into a receptor tyrosine kinase- 
induced complex at the plasma membrane results in the activation of the small GTP- 
binding protein ras. This in turn results in the activation of the mitogen-activated 
protein (MAP)-kinase cascade which is associated with the induction of many 
important events in mitogenesis. Thus, in this cascade a key switch in signalling 
occurs between tyrosine kinase activation and serine/threonine kinase activation 
through the G-protein Ras. However, such a switch has not been demonstrated for 
the reactions leading to the stimulation of glucose transport and it appears that the 
MAP-kinase cascade is not involved in the activation of this process (for review see 
Denton and Tavare., 1995).
Multisite tyrosine phosphorylation of 1RS proteins appears to be the major 
mechanisn by which insulin transmits signals to regulate metabolic events including 
glucose transport (White., 1998). Phosphorylation of specific tyrosine residues on 
the 1RS proteins allows the protein to recruit a number of signalling molecules 
through their src-homology-2 (SH2) domains. These include Grb2, the small adaptor 
protein Nek, the tyrosine phosphatase SH-PTP2 and the p-85-pllO PI 3-kinase 
(reviewed in Holman and Kasuga, 1997; Hausdorff et ah, 1997) (Figure 1.10). Since 
the identification of 1RS signalling complexes, considerable effort has been made to 
determine which, if any, of these molecules mediate the acute insulin-stimulated 
increase in glucose uptake.
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1.15.1 IRS Proteins and GLUT4 Translocation
As insulin causes very little recruitment of PI 3-kinase activity directly to the insulin 
receptor, the 1RS proteins appear to provide a means of coupling the insulin receptor 
tyrosine kinase activity with the activation of intracellular PI 3-kinase activity. Four 
members of the 1RS family have now been identified, namely IRS-1 (Sun et al., 
1991), IRS-2 (Sun et al., 1995), IRS-3 (Lavan et ah, 1997a) and IRS-4 (Lavan et ah, 
1997b). All the 1RS proteins have the same overall architecture, sharing highly 
homologous N-terminal pleckstrin homology (PH) and phosphotyrosine-binding 
domain (PTB) domains. The PTB domain binds directly to the juxtamembrane 
region of the insulin receptor at an NPXY motif (He et al., 1995; Wolf et al., 1995), 
whereas the PH domain is thought to allow the interaction of 1RS-1 with membrane 
phosphoinositides (Rameh et al., 1997). The 1RS proteins also contain multiple 
potential tyrosine phophorylation sites, of which the majority are in YMXM or 
YXXM motifs. As YMXM motifs have been shown to be the preferred substrate of 
the insulin receptor tyrosine kinase, the 1RS proteins are ideally structured for the 
insulin-dependent recruitment and activation of PI 3-kinase (Shoelson et al., 1992; 
Songyang a/., 1995).
However, whether 1RS proteins are required for PI 3-kinase signalling to act on 
GLUT4 translocation is unclear at present. Quite conflicting data have resulted fi'om 
two differing experimental methods utilised thus far. Microinjection or expression of 
the PTB domain of 1RS-1 in insulin-sensitive cultured adipocytes is able to block the 
mitogenic and membrane ruffling effects of insulin but not the stimulation of glucose 
transport (Sharma et al., 1997). This dominant inhibitory construct is expected to 
block binding of all 1RS protein isoforms to the insulin receptor through binding to 
the insulin receptor juxtamembrane sequence surrounding Tyr 960, the docking site 
for 1RS and She protein PTB domains. Indeed, nearly complete inhibition of 1RS-1 
tyrosine phophorylation by insulin was observed in these studies (Sharma et al.,
1997).
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In contrast, studies in animals in which the 1RS-1 or the IRS-2 gene has been ablated 
provide support for a role of these proteins in glucose transport regulation. Mice 
lacking IRS-1 exhibit some insulin resistance although no diabetes (Araki et al., 1994; 
Tamemoto et al., 1994), and heterozygotes for loss of both IRS-1 and insulin 
receptor genes are both insulin resistant and develope diabetes (Bruning et al., 1997). 
IRS-2 ablation in mice causes both impaired insulin signalling to glucose uptake and 
diabetes (Withers et al., 1998) despite the presence of a functional insulin receptor 
and normal IRS-1 expression. It has been suggested that the insulin action observed 
on glucose uptake in adipocytes from animals lacking IRS-1 may involve the IRS-3 
isoform, which is tyrosine phosphorylated in response to insulin (Kaburagi et al.,
1997). Such redundancy may account in part for some of these conflicting results. 
Thus, studies involving 1RS knockout mice provide compelling evidence for a role for 
these proteins in insulin-stimulated glucose transport, with the caveat that unrelated 
changes changes in response to 1RS loss during development may contribute to the 
phenotypes observed. Taken together, the above data do not provide conclusive 
proof for the role of 1RS proteins in insulin-stimulated GLUT4 translocation, but 
instead suggest that the PI 3-kinase-IRS complexes are necessary but not sufficient 
for GLUT4 translocation in response to insulin.
Another IRS-1 binding protein is the protein tyrosine phosphatatse, SH-PTP2. SH- 
PTP2 associates with IRS-1 following stimulation by insulin (Kuhne et al., 1993), 
However, micro injection of SH-PTP2 SH2 domains or antibodies to SH-PTP2 into 
3T3-L1 adipocytes blocks insulin-induced but not insulin-stimulated GLUT4 
translocation. Over longer incubations, increased expression of GLUTl is observed 
and this leads to an increase in glucose transport activity (Hausdorff et al., 1995).
1.15.2 PI 3-Kinase and GLUT4 Translocation
A family of PI 3-kinases phosphorylate the inositol ring at the D-3 position to give 
PI 3-phosphate from PI, PI 4,5-bisphosphate from PI 4-phosphate and PI 3,4,5-
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trisphosphate from PI 4,5-bisphosphate. The only PI 3-kinases currently known to 
be stimulated by insulin are the class I heterodimeric p85/pllO PI 3-kinases. In this 
class, the p85 subunit acts as an adaptor, linking the p i 10 catalytic subunit to 
tyrosine phophorylated motifs on 1RS proteins, resulting in the activation of the 
holoenzyme (reviewed in Shepherd et al., 1998).
There is growing evidence to suggest that the p85-pllO PI 3-kinase plays a pivotal 
role in insulin-stimulated GLUT4 translocation, consistent with the concept that PI 
3-kinase activity is a rate limiting step in various membrane trafficking events 
(reviewed in Shepherd et al, 1996b). Initial studies using two structurally distinct PI 
3-kinase inhibitors, namely wortmannin and LY294002, showed that these inhibitors 
blocked both the insulin-stimulated translocation of GLUT4 and consequently, the 
increase in glucose uptake in adipocytes (Cheatham et al,  1994; Clarke et al,  1994; 
Yang et a l,  1996). Kinetic studies by Yang et al have shown that treatment with 
wortmannin dramatically reduces the GLUT4 exocytic rate constant with no marked 
perturbation of the endocytic rate constant (Yang et al, 1996) . The same study also 
showed a slow reduction of basal glucose transport activity in wortamnnin-treated 
cells, consistent with a wortmannin effect on constitutive recycling as well as insulin- 
regulated exocytosis (refer to Section 1.6) (Yang et al, 1996).
However, following concerns regarding the specificity of wortmannin and LY294002, 
recent studies have provided more conclusive evidence of the involvement of p85- 
pl 10 PI 3-kinase in GLUT4 trafficking. Expression of a mutant of the p85 subunit 
of PI 3-kinase which is unable to bind the p i 10 catalytie subunit results in a parallel 
blockade of insulin-stimulated glucose transpoter translocation and insulin-stimulated 
PI 3-kinase activity in 3T3-L1 adipocytes (Kotani et a l,  1995). Furthermore, 
microinjection of the SH2 domains of p85 expressed as fusion proteins, into 3T3-L1 
adipocytes, blocks insulin stimulation of glucose transport (Haruta et a l,  1995), 
coupled with the induction of glucose transporter translocation following the 
overexpression of a constitutively active form of PI 3-kinase (Tanti et al,  1996),
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provide strong evidence that insulin stimulation of PI 3-kinase is linked to the 
stimulation of GLUT4 translocation.
However, there is evidence to suggest that p85-pl 10 PI 3-kinase is also involved in 
the mitogenic pathway (Cheatham et al,  1994) and is not exclusively part of the 
GLUT4 translocation machinery. Indeed, platelet-derived growth factor (PDGF) 
also stimulates cellular PI 3-kinase activity in 3T3-L1 adipocytes, but only insulin 
significantly stimulates glucose transport (Navé et al,  1996). A possible explanation 
for this discrepancy is the differential subcellular targeting of PI 3-kinase activity as 
insulin stimulates PI 3-kinase in the microsomal fraction from which the glucose 
transporters translocate, while PDGF stimulates PI 3-kinase activity almost 
exclusively in the plasma membrane fraction of 3T3-L1 adipocytes (Ricort et al,  
1996). The inability to recmit PI 3-kinase activity to the correct intracellular location 
may also explain why the introduction of phosphopeptides containing the two 
tyrosine phophorylation motifs corresponding to the p85 association sites on IRS-1 
in 3T3-L1 adipocytes, results in the activation of cellular PI 3-kinase but only 
produces a small stimulation in glucose transport (Herbst et al,  1995).
1.15.3 Downstream Targets of PI 3-Kinase
The elements downstream of PI 3-kinase in the insulin-stimulated signalling 
pathways regulating GLUT4 translocation are poorly understood. A potential 
mechanism by which PI 3-kinase may affect membrane trafficking is the activation of 
members of the Ras superfamily of small GTP-binding proteins via GEFs (refer to 
Section 1.6). Interestingly, the stimulatory effect of guano sine 5'-[y- 
thio]triphosphate (GTPyS) on glucose transport activity can overcome the 
wortmannin induced inhibition of insulin-stimulated glucose transport in 3T3-L1 
adipocytes, suggesting that a GTP-binding protein lies downstream of PI 3-kinase 
activity (Clarke et al,  1994). An obvious candidate for sueh a role is Rab4 as Shibata 
et al have recently shown Rab4 to lie downstream of PI 3-kinase activity (refer to
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Section 1.13) (Shibata et al, 1997). It is also possible that PI 3-kinase activation 
may enhance the budding of GLUT4 vesicles in response to insulin by promoting 
nucleotide exchange on an ARF-like small GTPase required for 'coaf formation (refer 
to Sections 1.4.2 and 1.6) (Seaman et al, 1996a). Recently, GRPl, a molecule which 
specifically binds the product of PI 3-kinase, phosphoinositide-3,4,5-trisphosphate 
(PIP3), and contains pleckstrin and sec7 homolgy domains which may be involved in 
nucleotide exchange (refer to Section 1.6) has been identified in adipocytes (Klarlund 
et a l,  1997). Furthermore, GRPl has been shown to catalyse guanine nucleotide 
exchange of ARFs 1 and 5 in vitro (Klarlund et a l,  1998), consistent with the 
possibility that GLUT4 trafficking may indeed be regulated by ARF proteins. 
However, further in vivo studies are required to determine a role for both GRPl and 
ARFs in GLUT4 trafficking.
Recent research has also focused on serine/threonine kinases downstream of PI 3- 
kinase that may regulate GLUT4. A prime candidate is Akt/protein kinase B (PKB), 
which has been found to be inhibitable by wortmannin (Burgering et al, 1995) and 
activatable by insulin (Kohn et a l, 1995). Recent studies also suggest that insulin 
causes the recruitment of the p isoform of PKB to GLUT4-containing microsomal 
vesicles (Calera et a l,  1998). Furthermore, constitutively active PKB stimulates 
GLUT4 translocation in a range of cell types (Kohn et al,  1996; Cong et al, 1997; 
Hajduch, 1998), and it is claimed that a dominant inhibitory construct blocks this 
process (Cong et al, 1997). However, in well controlled experiments using a mutant 
PKB with alanines substituted at phosphorylation sites threonine 308 and serine 473 
as a dominant inhibitory construct in both CHO cells and 3T3-L1 adipocytes, 
protein synthesis but not insulin-stimulated transport was inhibited (Kitamaru et ah,
1998).
Other possible downstream targets include the protein kinase C Ç and X, however 
studies are on going to determine whether these kinases contribute to glucose 
transport regulation. Taken together, there is not a clear consensus of data that any
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of the known protein kinases downstream of PI 3-kinase directly mediates insulin 
action on glucose transport.
The characterisation of PI 3-kinase as a mediator of insulin-regulatable glucose 
transport has been a major advance as it acts as a point of convergence of signalling 
and membrane trafficking processes. However, the link between PI 3-kinase and the 
effector molecules that have been suggested as facilitating the complex process of 
insulin-stimulated GLUT4 translocation is incomplete at present but is subject to 
intense investigation.
1.16 Aims of this Study
The basis of this study was to further define the nature of the non-ablatable GLUT4 
storage compartment and to characterise the mechanism of translocation of GLUT4 
from this compartment to the plasma membrane in response to insulin.
To address these issues, I employed a technique referred to as compartment ablation 
analysis (refer to Section 1.10) to examine the protein composition of the non- 
ablatable storage compartment with the aim of further defining the relationship of 
this compartment, to other well characterised, intracellular membrane structures. I 
also used this technique to examine insulin-stimulated translocation of GLUT4 from 
the endosomal and non-ablatable post-endocytic compartments to the cell surface in 
response to insulin. The purpose of this was to determine whether insulin stimulates 
the translocation of GLUT4 to the cell surface independently of the recycling 
endosomal pathway.
It should be noted that some aspects of the above studies were carried out in 
collaboration with D. E. James and colleagues (University of Queensland, Australia). 
However, data provided by this group is included for comparative purposes only and 
is clearly indicated.
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In addition, I analysed the role of ARF proteins and phospholipase D in insulin- 
stimulated GLUT4 translocation. As these proteins are known to be involved in 
regulated exocytosis, I wished to examine whether they may be components of the 
insulin-regulatable GLUT4 trafficking machinery.
Finally, as an extension of the compartment ablation studies, I set out to eonstruct a 
chimeric cDNA comprising the signal sequence of the human growth hormone and 
horseradish peroxidase with the intention of targeting the resultant protein to the 
exocytic pathway in 3T3-L1 adipocytes. This would enable me to carry out ablation 
studies on the secretory pathway in these cells.
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Table 1.1
Localisation and Functional Properties of Rab Proteins in Mammalian Ceils
A summary of the involvement of Rab proteins in membrane traffic in mammalian 
cells is shown below (Novick et al, 1997) (refer to Section 1.3.5).
Proteins Localisation Function
Rab lA, IB ER-Golgi intermediate ER to Golgi transport,
compartment intra-Golgi transport
Rab 2 ER-Golgi intermediate 
compartment
ER to Golgi transport
Rab3A Synaptic vesicle, Regulated exocytosis in
chromaffin granules pancreatic acinar cells, 
adrenal chromaffin cells 
and mast cells
Rab3B Tight junction region in 
polarised epithelial cells
n.d
Rab3C Synaptic vesicles n.d
Rab 3D Zymogen granules in 
pancreatic acinar cells
n.d
Rab 4A, 4B Early endosomes Recycling pathway from 
endosomes to plasma 
membrane
Rab 5A, 5B, 5C Plasma membrane; Plasma membrane to early
clathrin-coated vesicles; endosome transport and
early endosomes homotypic fusion 
between endosomes
Rab 6 Middle Golgi-TGN Intra-Golgi retrograde 
transport?
Rab 7 Late endosomes Transport from early to 
late endosomes and 
lysosomes
Rab 8 Post-Golgi exocytic Golgi to plasma membrane
vesicles; tight junction in 
epithethial cells
transport
Rab 9 Late endosomes and TGN Transport from late 
endosomes to TGN
Rab 10 Golgi complex n.d
Rab 11 TGN; constitutive Transport through
secretory vesicles; 
secretory granules; 
recycling endosomes
recycling endosomes
n.d not determined
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Table 1.2
Characterised Mammalian SNAREs Hypothesised to be Involved in Golgi to 
Plasma Membrane Transport
A summary of the SNARE proteins and the steps in membrane traffic between the 
Golgi and the plasma membrane in which they are thought to be involved, are shown 
below (Hay et al., 1997) (refer to Section 1.5).
Name Function or localisation V- or t- SNARE?
Syntaxin lA, B Neurotransmission t
VAMPl, 2 Neurotransmission & 
GLUT4 trafficking
V
SNAP25 Neurotransmission t
Syntaxin 4 GLUT4 trafficking t
Syntaxin 2, 3 Plasma membrane t
SNAP23 Plasma membrane? 
Constitutive
t
Cellubrevin endocytosis/exocytosis & 
GLUT4 trafficking
V
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Figure 1.1
Model of the Potential Sites of Insulin Resistance in Adipose Tissue
Under basal conditions, approximately 95% of GLUT4 is sequestered within an 
intracellular compartment(s), the nature of which is poorly understood. GLUT4 
undergoes a slow rate of constitutive recycling between the plasma membrane and the 
intraeel lular site, a process which is thought to occur through clathrin-coated pits and 
entry into the endosomal system. Upon insulin-stimulation, 40-50% of the 
intracellular pool translocates rapidly, giving rise to 20- to 30-fold inereases in cell 
surface GLUT4 levels, and so accounting for the large inerease in glucose transport 
under such conditions. As circulating glucose and insulin levels fall, GLUT4 is 
sequestered in the intracellular compartment. Potential sites of insulin resistance 
shown are as follows: (1) Reduced binding of insulin to the plasma membrane insulin 
receptor (ÏR) or impaired activation of the receptor associated tyrosine kinase. (2) 
Impaired intracellular insulin signalling pathway. Both defects would render cells 
insulin-resistant for glucose transport independently of any defects in transporter 
expression or function. (3) Defective translocation of GLUT4 to the cell surface. In 
this case, normal levels of GLUT4 are present in the intracellular compartment, but a 
defect in the mechanism responsible for moving this pool to the cell surface results in 
a reduced insulin-stimulated transport. (4) Reduction in the level of GLUT4 in the 
intracellular compartment. In this scenario, translocation of GLUT4 occurs as 
normal, but there is a reduced level of insulin-stimulated glucose transport due to a 
profound reduction in the GLUT4 available for translocation. (5) Mistargeting of 
GLUT4 to a non-translocatable compartment. This mislocalisation of GLUT4 to a 
site from which it cannot be targeted would have the effect of reducing insulin- 
stimulated glucose transport.
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Figure 1.2
Model for the Intracellular Organisation of the Endocytic Pathway in a 
Mammalian Cell
Entry into the cell is mediated by caveolae, non-clathrin-coated vesicles (N-CCV), 
clathrin-coated pits and vesicles (CCP and CCV) and macropinosomes. The clathrin- 
coated vesicles that bud from the plasma membrane are coated with AP-2 adaptors as 
well as clathrin, and their formation is regulated by the GTPase dynamin. These 
vesicles deliver their cargo to early endosomes (EE), a process controlled by the small 
GTPase Rab5. Receptors that recycle back to the plasma membrane transit through 
a recycling endosome (RE) that is enriched in TfRs and in the SNARE protein 
cellubrevin. Whether this is a subcompartment of the early endosome or a distinct 
compartment, as drawn here, is not clear. Rab4 is proposed to control access into 
the recycling endosome. M6PRs (MPR), together with the small GTPase ARFl, 
promote the recruitment of AP-1 adaptors onto the TGN to drive assembly of CCVs 
from this compartment. Transport from the early endosome to the late endosome 
(LE) is mediated by endosomal carrier vesicles (ECVs).
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Figure 1.3
The Proposed Functional Cycle of Rab Proteins
Rab-GDP is shown as a black circle labelled GDP with zigzagged lines indicating the 
attached isoprenyl lipid moieties; Rab-GTP is shown as a black oval labelled GXP 
with zigzagged lines attached; and Rab proteins that are in a state of nucleotide 
exchange/hydrolysis are shown as unlabelled black circles with zigzagged lines 
attached, (a) In the cytosol, Rab proteins are maintained in the GDP-bound inactive 
confirmation by Rab GDI. Rab GDI prevents indiscriminate membrane binding by 
Rab. (b) As Rab-GDP binds to the membrane of the donor organelle compartment or 
vesicle, GDI is displaced by a GDI displacement factor (GDF). (c) Exchange of 
GDP for GTP on Rab is catalysed by a GEE. Nucleotide exchange serves to activate 
the Rab protein and render it resistant to removal from the membrane by Rab GDI. 
(d) The transport vesicle buds from the donor compartment, (e) Binding of transport 
vesicles to acceptor compartments is mediated by Rab-GTP on the transport vesiele 
and probably an effector on the acceptor compartment. GTP hydrolysis is mediated 
by GAP. The release of vesicle contents (represented by dots) into the acceptor 
compartment is shown, (f) GDI can release Rab-GDP from the acceptor 
compartment and the cycle can begin again.
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Figure 1.4
Sorting Events at the TGN
Biochemicaly distinct coats are likely to specify protein sorting at the TGN. To 
attempt to distinguish the different sorting routes from each other, these coats are 
indicated by coloured symbols. The AP-1 complex (red) associates with clathrin at 
the TGN and sorts M6 PRs to the endosome, whereas the AP-2 complex (green) 
associates with clathrin at the plasma membrane to mediate endocytosis. The AP-3 
complex (red) is depicted as having a role in vesicle formation and anterograde 
transport from the TGN to sort cargo proteins such as LIMP II to lysosomes. In 
some specialised cells, AP-3 also appears to be involved in transport to lysosome- 
related storage granules such as melanosomes (Odorizzi et al., 1998).
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Figure 1.5
Models of NSF/a-SNAP Action in SNARE-Mediated Docking and Fusion 
Reactions
(a) Original proposal, in which NSF/a-SNAP assembles onto the docked complex 
and rearranges protein-protein interactions to allow membrane fusion. This proposal 
suggested that the motion created by NSF/a-SNAP-dependent events directly 
triggered membrane fusion, (b) New model, which is consistent with vacuolar 
assembly, in which NSF/a-SNAP is required prior to SNARE docking. NSF/a- 
SNAP may be required to activate SNAREs for docking interactions. Although their 
role is not well understood, it is believed that Rab proteins may function to promote 
SNARE-complex assembly.
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Figure 1.6
Hypothetical Model for the Structure of the Facilitative Glucose Transporters
The protein is predicted to contain 12 transmembrane helices (1-12), with both the 
N- and C-termini intracellularly disposed. N-linked glycosylation can occur in the 
intracellular loop between helices 1 and 2. Conserved amino acids are indicated by 
the appropriate single letter code.
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Figure 1.7
Membrane Protein Recycling Models
In the 2-pool model, the fully functional plasma membrane protein (Tp) is in 
equilibrium with only one intracellular pool (Tee). In the 3-pool model, two distinct 
intracellular pools are designated, the early endosome pool (Tee) and the 
tubulovesicLilar compartment (Ttv). In the 4-pool models, occluded forms are added 
to the plasma membrane occuning either before (Tpo, the 4a-pool model) or after 
(Tpc, the 4b-niodel) the fully functional plama membrane pool. In the 5-pool model, 
two occluded plasma membrane pools are included occurring both before (Tpo) and 
after (Tpc) the fully functional plasma membrane form of the protein (Tp). Two 
intracellular pools are also included, one associated with the early endosomes (Tee) 
and the other associated with a tubulovesicular system (Ttv).
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Figure 1.8
Models for the Biogenesis of the GLUT4 Storage Compartment in Insulin- 
Sensitive Cells
Each model (a-c) compares the trafficking of GLUT4 to a constitutively recycling 
protein such as the transferrin receptor (TfR) throughout the endosomal (E) and/or 
Golgi (G) systems. While models (a) and (b) suggest that GLUT4 and the TfR 
traffic through the same endosome, model (c) suggests that each molecule may traffic 
via distinct endosomes.
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Figure 1.9
The Potential Role of SNARE Proteins in GLUT4 Trafficking
Based on the neuronal system, the following scheme of events is proposed for the 
insulin-dependent translocation of GLUT4 to the cell surface. A; in the non-insulin 
stimulated state, the core SNARE proteins VAMP2, syntaxin 4 and SNAF23 are 
prevented from interacting. Additional molecules predicted to be important for 
directing the interaction of SNAREs are also in an inactive state. Numbers include 
potential sites of insulin action and include; 1) activation of a GLUT4 vesicle specific 
Rab GTP exchange factor (GEF); 2) release of a putative VAMP2 blocking protein; 
3) modulation of the affinity of Munc 18c for syntaxin 4; 4) release of a putative 
SNAP23 blocking protein. B: following the action of insulin, NSF and a-SNAP 
prime v- and t-SNAREs into a docking competent state in an ATP-dependent 
manner. GEF loads the GLUT4 vesicle Rab with GTP and the latter protein adopts 
an activated confirmation and/or recruits additional molecules to the vesicle surface 
(not shown). C; GLUT4 vesicles are actively transported to the cell surface where a 
SNARE complex is assembled. GTP-Rab displaces Munc 18c from syntaxin 4. This 
may be the rate limiting step in the formation of the SNARE complex. D; following 
SNARE docking, several additional steps may be necessary for lipid mixing and 
bilayer fusion. Lipid kinases and other GTPases are probably involved. Ultimately, 
insulin leads to an increase in the number of GLUT4 molecules at the cell surface and 
to the net rate of glucose transport into the cell. Question marks (?) refer to 
unidentified and/or hypothetical steps and proteins.
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Insulin Signalling Pathways
Schematic diagram showing the role of receptor substrates such as IRS-1 as a 
multisite docking protein for SH-2 containing proteins and the progression of both 
mitogenic and metabolic signals (Yenush and White., 1997).
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Chapter 2 
Materials and Methods
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2.1 Materials
All reagents used in the course of the project were of a high quality and were 
obtained from the following suppliers:
2.1.1 General Reagents
Bio-Rad Laboratories Ltd, Hemel Hempstead, Hertfordshire, UK
Cellophane membrane backing
N, N, N', N'-tetramethylethylenediamine (TEMED)
Bio-Rad protein assay dye reagent concentrate
New England Biolabs (UK), Ltd, Hitchin, Hertfordshire, UK
Prestained protein marker, broad range (6-175kDa)
Fisons, Loughborough, Leicestershire, UK
Ammonium persulphate
Glucose
Glycerol
Glycine
N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES)
Hydrochloric acid (HCL)
Methanol
Potassium chloride (KCl)
Sodium dodecyl sulphate (SDS)
Sodium chloride (NaCl)
Sodium dihydrogen orthophosphate dihydrate (NaH2P0 4 .2 H2 0 )
Sodium diaminoethanetetra-acetic acid (EDTA)
Sodium hydrogen carbonate (NaHCOg)
Trichloroacetic acid
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Gibco BRL, Paisley, Lanarkshire, UK
Tris base
30% acrylamide/bisacrylamide
Kodak Ltd, Heme! Hempstead, Hertfordshire, UK
X-Omat S film
Merck Ltd (BDH), Lutterworth, Leicestershire, UK
Calcium chloride hexahydrat’e 
Dimethyl sulphoxide 
Magnesium chloride hexahydrate
Packard Instrument B.V. -Chemical Operations, Groningen, The Netherlands
Ultima-Flo scintillation fluid
Premier Brands UK, Knighton Adbaston, Staffordshire, UK
Marvel powdered milk
Schleicher & Schuell, Dassel, Germany
Nitrocellulose membrane (pore size:0.45|iM)
Whatman International Ltd, Maidstone, UK
Whatman No. 1 filter paper 
Whatman No.3 filter paper
Amersham International Pic, Aylesbury, Buckinghamshire, UK
Horseradish peroxidase (HRP)-conjugated donkey anti-rabbit IgG antibody 
Horseradish peroxidase (HRP)-conjugated sheep anti-mouse IgG antibody 
ECL Western blotting detection reagents
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East Acres Biologicals, Southbridge, Massachusetts, USA 
Rabbit anti-human GLUT-1 antibody
NEN Dupont (UK) Ltd, Stevenage, Hertfordshire, UK
pH] 2-deoxy-D-glucose 
[l^C] sucrose
[I25i] conjugated goat anti-rabbit IgG antibody 
['25i] transferrin
Calbiochem-Novabiochem (UK) Ltd, Nottingham, UK
a-toxin, Staphlococcus aureus
2.1.2 Cell Culture Materials
American Type Culture Collection, Rockville, USA
3T3-L1 fibroblasts
Gibco BRL, Paisley, Lanarkshire, UK
Foetal calf seiaim (FCS)
Sigma Chemical Company Ltd, Poole, Dorset, UK
Dulbecco's modified Eagle's medium (without sodium pyruvate, with 4500mg/L 
glucose) (DMEM)
lOOOOU/ml penicillin, lOOOOU/ml streptomycin 
New bom calf serum (NCS)
Trypsin/EDTA solution 
Collagen
AS Nunc, DK Roskilde, Denmark
50 ml centrifuge tubes
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Costar
6 cm cell culture plates 
7 5cm2 cell culture flasks
Falcon
10 cm cell culture plates
6 -well cell culture plates
Bibby Sterilin Ltd, Stone, Staffordshire, UK
Sterile pipettes
13.5 ml centrifuge tubes
Bayer pic, Newbury, Berkshire, UK
Ciproxin
2.2. General Buffers
2.2.1 Phosphate Buffered Saline (PBS)
150mM NaCl, lOmM NaH2? 0 4 .2 H2 0 , pH 7.4.
2.2.2 Krebs Ringer Phosphate (KRP) Buffer
64mM NaCl, 2.5mM KCl, 2.5mM NaH2P0 4 .2 H2 0 , 0.6mM MgS0 4 . 7  H2O, 
0.6mM CaCl2, pH 7.4.
2.2.3 HES Buffer
255mM sucrose, 20mM N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid 
(HEPES) and ImM EDTA, pH 7.4.
Unless otherwise indicated, all remaining chemicals were supplied by Sigma Chemical 
Company Ltd, Poole, Dorset, UK.
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2.3 Cell Culture
2.3.1 3T3-L1 Murine Fibroblasts
3T3-L1 fibroblasts were cultured in 75cm^ flasks containing DMEM/10% (v/v) 
newborn calf semm and 1% (v/v) penicillin and streptomycin. 1% (v/v) ciproxin was 
added to the media when required to prevent bacterial infection. Cells were cultured 
at 37°C in a humidified atmosphere of 10% CO2 and the media was replaced every 
48 h. When subconfluent (showing 80% confluency) the cells were passaged into 6 - 
well or 10cm culture plates and a 75cm^ carry over flask. Cells were cultured to 4 
days post confluency and then differentiated into adipocytes.
2.3.2 Trypsinisation and Passage of 3T3-L1 Fibroblasts
Following aspiration of media from a 75cm^ flask, 1ml of trypsin/EDTA solution 
was added to wash the remaining media from the monolayer of cells. In turn, this 
was aspirated and 3ml of trypsin/EDTA solution was added and the flask was 
incubated at 37°C in a humidified atmosphere of 10% CO2 for 5 min. Careful 
agitation of the flask resulted in the cells being lifted from the surface of the flask. 
This cell suspension was then added to a maximum volume of 230ml DMEM/10% 
(v/v) newborn calf serum and 1% (v/v) penicillin and streptomycin. With continuous 
agitation the cells were split between 10cm culture plates and /or 6 -well culture 
plates and 2 x 75cm^ flasks.
2.3.3 Differentiation of 3T3-L1 Fibroblasts
Differentiation media of DMEM/10% (v/v) foetal calf serum, 1% (v/v) penicillin and 
streptomycin, 0.25|u,M dexamethasone, 0.5mM methyl isobutylxanthine and Ipg/ml 
insulin was prepared as outlined below.
A stock of 2.5mM dexamethasone (in ethanol) was diluted 1:20 with DMEM/ 10% 
(v/v) foetal calf serum, 1% (v/v) penicillin and streptomycin immediately prior to use 
yielding a 500X stock solution. A 500X sterile solution of methyl isobutylxanthine 
(IBMX) was prepared by dissolving 55.6mg IBMX in 1ml of 2M KOH and passing 
the solution through a 0.22 micron filter. Insulin (1 mg/ml) was prepared in O.OIM 
HCL and filter sterilised using a 0.22 micron filter as before. Differentiation media 
was prepared by adding both the dexamethasone and IBMX solutions to a IX 
concentration in DMEM/10% (v/v) foetal calf serum, 1% (v/v) penicillin and 
streptomycin and then adding insulin to a final concentration of lp,g/ml.
3T3-L1 fibroblasts were cultured on 6 -well or 10cm culture plates until 4 days post 
confluency. The growth media was aspirated and replaced with differentiation 
media. After 48 h, this media was replaced with DMEM/10% (v/v) foetal calf 
serum, 1% (v/v) penicillin and streptomycin and Ipg/ml insulin. The cells were 
incubated in this media for a further 48 h. Following differentiation, the media was 
replaced with DMEM/10% (v/v) foetal calf serum, 1% (v/v) penicillin and 
streptomycin. The media was changed every 48 h and the cells were used 8-14 days 
post differentiation.
2.3.4 Freezing and Storage of Cells
Cells were cultured to 80% confluency, the media was aspirated and 1ml of 
trypsin/EDTA solution was added to wash the remaining media from the monolayer 
of cells. In turn, this was aspirated and 3ml of trypsin/EDTA solution was added 
and the flask was incubated at 37°C in a humidified atmosphere of 10% CO2 for 5 
min. Careful agitation resulted in the cells being lifted from the surface of the flask. 
3ml of DMEM/10% (v/v) newborn calf serum, 1% (v/v) penicillin and streptomycin 
was added to the cell suspension and gently triturated over the surface of the flask. 
The cell suspension was then transferred to a sterile falcon tube and centrifuged at 
2000 X g for 4 min. Following aspiration of the supernatant the pellet was 'flicked'
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gently and then resuspended in 1ml of DMEM/10% (v/v) newborn calf serum, 1% 
(v/v) penicillin and streptomycin and 10% (v/v) DMSO. The suspension was then 
transferred to a 1.8ml polypropylene cryo-vial and placed at -80°C overnight to 
freeze slowly before being stored in a liquid nitrogen vat.
2.3.5 Resurrection of Frozen Cell Stocks from Liquid Nitrogen
A vial of cells was removed from from liquid nitrogen, transferred immediately to a 
37°C water bath and thawed. The cell suspension was then pipetted into a 75cm 
culture flask containing DMEM/10% (v/v) newborn calf serum, 1% (v/v) penicillin 
and streptomycin and ciproxin which had previously been equilibrated at 37°C in a 
humidified atmosphere of 10% CO2. The media was replaced after 48 h and the cells 
were cultured as described above.
2.3.6 Collagen Coating of Cell Culture Plastic Ware
Collagen-coated plates were often used for permeabilisation experiments, PM lawn 
assays and stable transfectants to enhance adhesion of the cells to the plate surface 
upon differentiation. A solution of collagen in acetic acid was used to wash the 
plates leaving a thin film coating. Plates were then dried in a sterile flow hood and 
irradiated with U.V light overnight. Prior to use, plates were washed with serum-free 
DMEM to remove any traces of acetic acid.
2.4 Antibody Preparations
The anti-GLUT4 antibodies used were either a mouse monoclonal antibody (1F8) 
(James et a l, 1988) provided by Professor David James (University of Queensland, 
Australia), or rabbit polyclonal antibodies against a peptide comprising the C- 
terminal 14 amino acid residues of the human isoform of GLUT4 .
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2.4.1 Purification of Anti-GLUT4 Antibody
This procedure required the use of an affinity column consisting of Sepharose beads 
to which an antigenic peptide (C-terminal 14 amino acid residues) of the human 
GLUT4 isoform was covalently attached (Brant et ai, 1993).
Following equilibration of the column with approximately 20ml of PBS (see Section 
2.2.1) 300p,l of lOX PBS was added to 2.7ml antisera (raised against the GLUT4 C- 
terminal peptide) and applied to the column. The column was incubated for 15 min 
at room temperature and then washed with PBS until all the brown coloured eluant 
had been collected. The eluant was reapplied and again incubated in the column for 
15 min at room temperature. This procedure was repeated a further four times 
allowing the antibodies which recognised the Sepharose-conjugated peptide to bind. 
Following the final incubation, the column was washed with PBS, until the eluant 
gave an O.D. reading at 280nm of zero. The GLUT4 antibody was eluted with 2M 
glycine, pH 2, collected in 1ml fractions and the O.D. reading at 280nm determined 
for each fraction. The fractions with the highest O.D. readings were pooled and IM 
Tris (pH 6 .8) was added to pH 7.0. This was dialysed overnight against PBS, at 4°C 
and finally, aliquoted, snap frozen and stored at -80°C.
2.5 Protein Assay
Protein concentration was measured using the Bradford assay. Protein samples were 
made up to a final volume of 25p,l with distilled H2O in plastic cuvettes. A standard 
curve was produced by preparing a series of BSA samples 0, 1 ,2 ,5 , 10, 12, 15 and 
20jig (i.e 0, 1, 2, 5, 10, 12, 15 and 20pl of BSA 1 mg/ml in 25|il). Bio-Rad protein 
assay reagent concentrate was diluted 1:4 with distilled H2O and 1ml was added to 
each sample. The cuvettes were covered with parafilm and inverted to ensure mixing 
before the absorbance was read at 495nm. A standard curve was plotted and the 
concentrations of the unknown protein samples determined.
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2.6 SDS/Polyacrylamide Gel Electrophoresis
SDS/polyacrylamide gel electrophoresis was carried out using Bio-Rad mini- 
PROTEAN II or Hoefer large gel apparatus. The percentage of aery lam ide in each 
gel ranged between 7.5% - 15%, according to the molecular weight of the protein to 
be detected. All reagents were of electrophoresis grade.
On assembly of either Bio-Rad mini-PROTEAN II or Hoefer large gel units, the 
separating gel was prepared using 30% aciylamide/bisacrylamide, lOOmM Tris-HCL 
(pH 8 .8), 10% (w/v) SDS, polymerised with 0.1% (w/v) ammonium persulphate and 
0.019% (v/v) N,N,N',N'-tetramethylethylenediamine (TEMED). The stacking gels 
of 2 and 5cm respectively, were prepared using 30% acrylamide/bisacrylamide, 
150mM Tris-HCL (pH 6 .8 ), 10% (w/v) SDS polymerised with 0.1% (w/v) 
ammonium persulphate and 0.019% TEMED.
Protein samples were resuspended in IX SDS PAGE sample buffer (93mM Tris-Cl 
pH6 .8 , 20mM dithiothreitol [added immediately before use], ImM sodium EDTA, 
10% (w/v) glycerol, 2% (w/v) SDS, 0.002% (w/v) bromophenol blue) and loaded 
onto the wells in the stacking gel. Broad-range pre-stained molecular weight markers 
[Mr 6-175 kDa (Biolabs)] were used routinely. Gels were electrophoresed in 
electrode buffer (120mM Tris, 40mM glycine and 0.1% (w/v) SDS, pH 8.3) at a 
constant voltage to ensure good separation of the molecular weight markers.
2.7 Western Blotting of Proteins
Proteins were separated by SDS/polyacrylamide gel electrophoresis as previously 
described. A sponge pad, two sheets of Whatman 3mm filter paper and a sheet of 
nitrocellulose membrane (pore size 0.45mM), cut to size and previously soaked 
with transfer buffer (25mM NaH2P0 4 .2 H2 0 , pH 6.5) were placed on the black plate 
of the gel cassette holder. The gel was then placed on top of the nitrocellulose
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membrane and any air bubbles were gently removed. The 'sandwich' was completed 
with two more sheets of filter paper and a sponge pad as before. Transfer was 
carried out using a Bio-Rad mini or Bio-Rad trans-blot electrophoretic cell containing 
transfer buffer at a constant current of 250mA for 3 h. The efficiency of transfer was 
determined by staining the nitrocellulose with Poneeau S solution prior to blocking.
2.8 Immunodetection of Proteins
Following transfer, non-specific binding sites on the nitrocellulose membrane were 
blocked by shaking for 1 h in 5% (w/v) dried skimmed milk (see section 2.1.1) in 
TBST-1 buffer (20mM Tris, 150mM NaCl, 0.2% Tween-20, pH 7.4).
The nitrocellulose membrane was then transferred to a plastic pocket containing 
primary antibody in 1% (w/v) dried skimmed milk in TBST-1 buffer at the 
appropriate dilution and shaken overnight at room temperature. Following five 
washes with TBST-1 buffer over a period of 1 h, the membrane was incubated in 1% 
(w/v) dried skimmed milk in TBST-1 buffer with secondary antibody, either 
labelled goat anti-rabbit IgG (l|LiCi/20ml) or the appropriate HRP-linked IgG (1:1000 
dilution) for 1 h at room temperature. The membrane was then washed a further five 
times as before.
2.8.1 Using Autoradiography
Following incubation with ^^^I-labelled goat anti-rabbit and subsequent washing, the 
membrane was dried overnight between two sheets of Bio-Rad cellophane membrane 
backing at room temperature. The dried membrane was then mounted in an autorad 
holder and exposed to Kodak X-Omat S film for 12-24 h at -80'^C. The film was 
developed using an X-OMAT processor.
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2.8.2 Using the Enhanced chemiluminescence (ECL) Detection System
Following incubation with the appropriate HRP-linked IgG and subsequent washing, 
the membrane was washed in distilled H2O. Equal volumes of Amersham 'detection 
reagent 1' and 'detection reagent 2 ' were mixed and the membrane was immersed and 
shaken in this mixture for 90 s. The membrane was then 'blotted' dry with blue roll, 
wrapped in cling film and exposed to Kodak film. The film was developed using an 
X-OMAT processor.
2.9 Endosome Ablation
2.9.1 Preparation of Tf-HRP Conjugate
Preparation of Tf-HRP protein conjugate was carried out as described by Kishida et 
al (Kishida et al, 1975)
Buffer 1 (O.IM NaCl/lOmM NaP0 4 , pH7.2) was prepared by adding acid 
(NaCl/NaPQPOa) to alkali (NaCl/Na2HP0 4 ) to pH7.2. 150mg of horseradish
peroxidase (HRP) was dissolved in 7.5ml of buffer 1, transferred to dialysis tubing 
(previously boiled in 2% NaHCO], lOmM EDTA and stored in 50% ethanol:50% 
H2O) and dialysed at 4°C overnight against 2-4 litres of the same buffer. Following 
dialysis, 3g of succinate (disodium salt) was added to the protein solution at room 
temperature. At 0°C, 1.05g of crushed succinic anhydride was added and the mixture 
was stirred for 30 min at 0°C and then for a further 30 min at room temperature.
Meanwhile, 4 X 20ml G-50 sephadex columns were prepared. Buffer 2 (O.IM 
NaCl/lmM NaP0 4 ) was prepared by adding acid (NaCl/NaH2 P0 4 ) to alkali 
(NaCl/Na2HP0 4 ) to pH7.2. 9g of G-50 sephadex'was slowly added to 100ml of 
buffer 2 and 4 X 20ml syringes, plugged with glass wool, were packed with this 
sephadex and equilibrated with the same buffer.
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The mixture was then resolved using 3 of the columns (the remaining column being 
stored at 4°C to be used later) and eluted with buffer 2. The elutant was then 
concentrated using Centriprep 3 columns (Amicon Ltd, UK) by centrifugation at 
2000 X g, at 4°C to a final volume of 1.5-3ml. At 0°C, 375mg of N-hydroxy 
succinimide and 600mg of N-ethyl-N-(3-dimethylaminopropyl) carbodi-imide 
hydrochloride (EDAC) were added and the mixture was stirred at 0°C for 3 h. The 
resultant solution was then resolved using the remaining G-50 sephadex column as 
before.
At this stage the 'active' HRP was ready to be coupled to transferrin. This was 
carried out immediately to prevent hydrolysis of the active NHS esters. 6 ml of 
25mg/ml apo-transfenin (in buffer 2 ) and lO^ -lO^  ^cpm ^^^I-transferrin were added to 
the elutant and stirred at 2°C for 48 h. The solution was then quenched with glycine 
and either stored at 2°C with the addition of azide or snap frozen and stored at 
-80°C.
Meanwhile, a sephaciyl S-300 column (Im in length) was equilibrated overnight with 
buffer 2 at lOml/h. The conjugate was concentrated to 2-3ml as before and applied to 
the column. When the brown band of conjugate reached approximately half way 
down the column, 0.5ml fractions were collected. The fractions were then counted 
using a y-counter and a graph of cpm versus fraction number was plotted. The 
fractions representing the first two peaks were pooled (the first two being the 
smallest of three peaks, with the third peak corresponding to unconjugated 
transferrin) and concentrated to 3-4ml as before. The conjugate was reapplied to the 
column and fractions were collected and counted as before. On plotting a graph, the 
fractions representing the largest peak were pooled and concentrated to 3 -4 ml as 
before. The protein concentration was determined by a Bradford assay (see Section
2.5) before the conjugate was iron loaded by adding 375 |l i 1 FeSOq and 112.5pl 
KHCO3 . The conjugate was then filtered through Whatman No. 1 paper, aliquoted, 
snap frozen and stored at -80°C.
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2.9.2 Use of Tf-HRP
Ablation of the recycling endosomal system was carried out as described by 
Livingstone et al (Livingstone et ai, 1996).
During a 2 h incubation in serum-free DMEM, 3T3-L1 adipocytes were incubated 
with Tf-HRP conjugate (20|U,g/ml final concentration) for 60 min at 37°C. The cells 
were then placed on ice, washed gently three times over a period of 10 min with ice- 
cold isotonic citrate buffer (150mM NaCl, 20mM Tri-sodium citrate, pH 5.0) and 
once with ice-cold PBS (see Section 2.2.1). Chilling the cells prevented any further 
vesicle trafficking during the DAB cytochemistry while acid washing with citrate 
buffer removed any cell-surface-attached Tf-HRP. 3,3'-diaminobenzidine (DAB) 
(2mg/ml stock prepared freshly in PBS, vortexed thoroughly and filtered through a
0 .2 2  pm-pore-size-filter) was added at 100  pg/ml to all cells and H2O2 (final 
concentration 0.02% v/v) was added to experimental plates only. After a 60 min 
incubation at 4°C in the dark the reaction was stopped by washing the cells with ice- 
cold PBS.
2.10 Subcellular Fractionation of 3T3-L1 Adipocytes
Subcellular fractions (PM, HDM, LDM and SP) were obtained as described for the 
fractionation of rat adipocytes by Piper et al (Piper et al, 1991), modified by Martin 
et al (Martin et al, 1994).
Cells cultured on 10cm plates were incubated at 37°C in serum-free DMEM for 2 h. 
For the last 15 min of the incubation insulin (IpM) was added to experimental plates 
only. Following the transfer of plates onto ice the cells were washed 3 times with 
ice-cold HES buffer (see Section 2.2.3). On addition of 5ml HES buffer containing 
proteinase inhibitors (Ipg/ml pepstatin A, 0.2mM di-isopropylflurophosphate 
[DFP] and 20pM L-transepoxysuccinyl-leucylamido-4-guanidiniobutane [E64]) the
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cells were scraped and then homogenised with 20 hand strokes in a Dounce 
homogeniser. Homogenates were transfeiTed to pre-chi lied Oakridge centrifuge tubes 
and centrifuged at 19,000 x g for 20 min at 4°C.
The resulting pellet was resuspended in 1ml ice-cold HES buffer and layered onto 
1ml of 1.12mM sucrose in HE buffer in an Ultra-clear Beckman tube and centrifuged 
at 100,000 X g for 60 min at 4°C in a swing out rotor. The upper layer was 
aspirated off to leave a brown band at the interface (plasma membrane) and a brown 
pellet (mitochondria/nuclei fraction). The plasma membrane fraction was transfened 
to an Oakridge centrifuge tube, resuspended in 15ml HES buffer and pelleted at
41,000 X g  for 20 min at 4°C.
Meanwhile, the supernatant from the initial spin was centrifuged at 41,000 x g for 20 
min at 4°C, yielding a pellet designated as the high density microsomal fraction 
(RDM). The resulting supernatant was centrifuged at 100,000 x g for 60 min at 4°C 
yielding a pellet designated the low density microsomal fraction (LDM). The soluble 
protein fraction was precipitated from the resulting supernatant with 1.5ml TCA and 
centrifliged at 41,000 x g for 20 min at 4°C. All fractions were resuspended in HES 
buffer, snap frozen in liquid nitrogen and stored at -80°C prior to analysis.
2.11 Immunoadsorptioii of GLUT4 Vesicles
3T3-L1 adipocytes were fractionated as above with minor modifications. For 
preparation of intracellular (LDM) membranes for immunoadsorption, cells cultured 
on 10cm plates were incubated at 37°C in serum-free DMEM for 2 h at 37°C. The 
plates were transferred onto ice and washed 3 times with ice-cold HES buffer (see 
Section 2.2.3). On addition of 1ml of the same buffer containing proteinase inhibitors 
(1 jig/ml pepstatin A, 0.2mM DTP and 20]liM E64), the cells were scraped and then 
homogenised in a Dounce homogeniser as before. Homogenates were transferred to 
pre-chilled Oakridge centrifuge tubes and centrifuged at 41,000 x g for 20 min at 4°C
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to remove plasma membranes, mitochondria, nuclei and high-density microsomes. 
The resulting supernatant was centrifuged at 100,000 x g for 60 min at 4°C to yield a 
pellet containing the low density microsomal (LDM) membranes, which was 
resuspended in HES buffer (200jiil HES per plate of cells) containing NaCl (lOOmM 
final).
Meanwhile, formaldehyde-fixed Staph, a cells (~50p,l cells per two plates) were 
washed twice in HES buffer containing 1% bovine serum albumin (BSA), and loaded 
with either a monoclonal GLUT4 antibody 1F8 (see Section 2.4.1), affinity purified 
polyclonal anti-GLUT4 (see Section 2.4.1) or non-specific IgG as a control by 
incubation for 1 h at room temperature with occasional agitation. Staph, a. cells were 
then washed three times with HES/1%BSA by centrifugation at 10,000 x g for 30 s 
in a microfuge to remove unbound antibody .
For immunoadsorption, 400pl of resuspended LDM (two 10cm plates of cells) was 
placed in an Eppendorf tube and incubated with the immunoadsorbent for 2-4 h at 
4°C with slow end-over-end rotation. Samples were then centrifuged in 13.5ml 
centrifuge tubes for 5 min at 2000 x g to pellet the immunadsorbent. The 
immunoadsorbent was resuspended in 1ml HES/NaCl, transferred to an Eppendorf 
and centrifuged at 10,000 x g for 30 s in a microfuge. Following a further two 
washes, the pellet was resuspended in 90pl of 1% Triton X-100 in PBS, vortexed 
briefly and the vesicle proteins were solubilised by incubation with occasional 
agitation for 20 min at room temperature. The Staph, a. cells were pelleted by 
centrifugation at 10,000 x g for 30 s using a microfuge. The supernatant was 
collected to a fresh tube and again centrifuged for 30 s before carefully removing the 
supernatant. Samples for electrophoresis were prepared by the addition of 30pl of 
4X SDS-PAGE sample buffer (see Section 2.6) directly to this supernatant.
The supernatant recovered from the initial centrifugation of the Staph, a. cells 
following the 2 h rotation at 4°C was centrifuged at 2000 x g for 10 min to remove
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any remaining cells. The resulting supernatant was added to 5ml Beckman Ultra- 
clear tubes and centrifuged at 100,000 x g for 60 min at 4°C. The resulting pellet was 
resuspended in 120pl IX SDS-PAGE sample buffer (see Section 2.6). All fractions 
were snap frozen in liquid nitrogen and stored at -80*^0 prior to analysis.
2.12 Indirect Inimunoflourescence Microscopy
2.12.1 Plasma Membrane Lawn Assay
The plasma membrane lawn assay was carried out as described by Robinson et al 
(Robinson et al,  1992c; Robinson et al,  1992b) to generate highly purified plasma 
membrane (PM) fragments in order to determine the relative levels of different 
proteins at the cell surface.
3T3-L1 adipocytes cultured on collagen-coated coverslips on 6 -well plates were 
treated as described by the individual experiments. At the conclusion of the 
experiment, cells were rapidly washed once with ice-cold buffer A (50mM HEPES 
(pH7.2) and lOmM NaCl) and then twice with ice-cold buffer B (20mM HEPES 
(pH7.2), lOOmM KCl, 2mM CaCh, ImM MgClz, pepstatin A (Ipg/ml), Trypsin 
inhibitor (2pg/ml) and 0.5mM Benzamide). While immersed in buffer B, the cells 
were sonicated using a 0.8mm tapered Dawa Ultrasonics probe at 50 watts for 3 s to 
generate a lawn of PM fragments attached to the coverslip.
Lawns were washed three times with PBS (see Section 2.2.1) and then fixed to the 
coverslips for 15 min by using freshly prepared 2% paraformaldehyde in PBS (see 
Section 2 .2 .1). Cells were then washed three times with PBS and the reaction was 
quenched with 50mM NH4CI/PBS over a period of 10 min. Cells were washed a 
further three times in each case with PBS, PBS/0.2% gelatin (PBS, 0.2% fish-skin 
gelatin and 0.1% goat serum, to block non-specific binding sites) and again with PBS 
over a 5 min period each time.
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An aliquot of primary antibody was centifuged in a microfuge, diluted to required 
concentration in PBS/0,2% gelatin and stored on ice prior to use. Following the 
addition of lOOjxl of antibody solution on parafilm, the coverslips were placed cells 
down on the solution and incubated at room temperature for 1-2 h. PM lawns were 
washed three times sequentially with PBS/0.2% gelatin and PBS over a 5 min period.
Due to fluorescent dyes on secondary antibodies the preparation of PM lawns is 
continued in the dark from this point. Secondary antibody, fluoroscein 
isothiocyanate (FITC)-conjiigated goat anti-rabbit IgG was prepared as for primary 
antibody and staining was carried out as described above. Coverslips were covered 
with aluminium foil during the 1-2 h incubation to avoid bleaching of dyes. As 
before, the PM lawns were washed three times sequentially with PBS/0.2% gelatin 
and PBS over a 5 min period. Coverslips were then mounted onto slides by placing 
them lawn down onto a 15pl drop of movioi. Again, to prevent bleaching the slides 
were covered with aluminium foil and allowed to dry overnight. The slides were 
stored in the dark prior to analysis.
Coverslips were viewed using x 40 and x 63/1.4 Zeiss oil immersion objectives on a 
Zeiss Axiovert fluorescence microscope (Carl Zeiss, Germany) equipped with a 
Zeiss LSM4 laser confocal imaging system.
2.12.2 Whole-Cell Indirect Immunofluorescence Microscopy
3T3-L1 adipocytes cultured on coverslips on 6 -well plates were incubated in serum- 
free DMEM for 2 ha t 37°C, washed three times in PBS (see Section 2.2.1) and then 
fixed in 2% paraformaldehyde in PBS for 15 min at room temperature. 
Subsequently the cells were washed three times with PBS, quenched with 50mM 
NH4CI/PBS over a period of 10 min, and then washed a further three times with 
PBS. The cells were then permeabilised with 0.1% Triton X-100 in PBS for 4 min at 
room temperature. After this time, the cells were washed three times with PBS and a
100
further five times with PBS/0.2% gelatin. The cells were incubated with primary and 
secondary antibodies and mounted on glass slides as described above.
In double-labelling experiments, pairs of anti-GLUT4 antibody and the 
corresponding secondary antibody were used in conjunction with pairs of primary 
and secondary antibodies required for detection of the other protein. The primary 
and secondary antibodies were applied in two steps as described above, with the 
two primary antibodies being mixed together in PBS/0.2% gelatin and applied 
simultaneously, followed by the wash steps as described above and then the 
application of the secondary antibodies.
2.13 2-Deoxy-D-Glucose Transport Assay
Glucose transport was measured by the uptake of 2-deoxy-D-glucose according to 
the method of Gibbs et al (Gibbs et ai,  1988) and Frost and Lane (Frost et al, 1985).
3T3-L1 adipocytes cultured on 6 -well plates were treated as described by the 
individual experiments. Following 2 washes with 2ml of KRP buffer (see Section
2.2.2) warmed to 37°C, the cells in three of the wells per plate were incubated in 
950pl of KRP while the remaining cells were incubated in KRP and lOpM 
cytochalasin B (to determine non-specific association of 2-deoxy-D-glucose with the 
cell monolayer) on a hot plate at 37°C. Cells were then stimulated with or without 
IpM insulin for 15 min at 37°C. Glucose transport was initiated by the addition of 
50pl of pH] 2-deoxy-D-glucose (final concentration of 50pM and 0.5pCi/ml).
After 3 min, the transport was terminated by 'flipping' the plates rapidly to remove 
the incubation buffer and then 'dipping' them sequentially into 3 volumes of ice-cold 
PBS (see Section 2.2.1). The plates were left to air dry and 1ml of 1% Triton X-100 
in H2O was added to each well. Following incubation for 1 h at room temperature,
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the detergent solubilised [^H] 2-deoxy-D-glucose was determined by liquid 
scintillation counting.
It has been calculated by members of this lab and others that one well of a 6 -well 
contains 2.1 million cells and as a result the rate of 2-deoxy-D-glucose transport is 
expressed as pmol/min/million cells which is the standard unit used within the field of 
glucose transport.
2.14 Adipsin Release
The release of adipsin from 3T3-L1 adipocytes was measured as described exactly 
by Kitagawa et al (Kitagawa et al, 1989).
3T3-L1 adipocytes cultured on 10cm plates were treated as described by in the 
individual results chapters and conesponding figure legends. Thereafter, the cells 
were washed twice with KRP buffer (see Section 2.2.2) at 37°C and then incubated 
in 10ml of KRP/BSA (lOpg/ml) ± IjiM insulin at 37°C. 1ml aliquots of media were 
removed at defined times (0, 2, 5, 10 and 30 min) and the protein was precipitated by 
adding 1 lOpl of 70% trichloroacetic acid and 20)U.l of deoxycholate as a earner. The 
samples were incubated on ice for 10 min and centrifuged at 10 ,000  x g for 10 min in 
a microfuge. The protein pellets were resuspended in 40pl IX SDS-PAGE sample 
buffer (see Section 2.6) and lOpl 2M Tris, snap frozen and stored at -80°C prior to 
analysis. Adipsin release into the media was quantitated by immunoblotting and 
subsequent detection with goat anti-rabbit IgG and is therefore expressed in 
arbitrary units.
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2.15 Molecular Biology
2.15.1 Preparation of Competent Bacteria
To revive the cells a splinter of ice was scraped off with a wire loop from a glycerol 
stock of XLl-Blue E. coli bacteria stored at -80°C. The bacteria were then streaked 
out on a minimal plate (L-broth and agar containing the appropriate antibiotie - in the 
case of the XLI-Blue strain tetracycline) and incubated at 37°C overnight. A single 
colony was picked and used to innoculate a universal tube containing 5ml L-broth 
(1% peptone, 1% NaCl and 0.5% yeast extract). This was cultured overnight at 
37°C. The 5ml culture was then added to 100ml L-broth and incubated at 37°C for 
-1.5-1.75 h until the optical density at 550nm was 0.48 The cells were then chilled 
on ice for 5min before being transferred to 50ml sterile Nunc centrifuge tubes and 
spun at 2000 x g for lOmin at 4°C. On discarding the supernatant each pellet was 
resuspended in 20ml buffer 1 (IM KAc, IM RbCl2, IM CaCl2, IM MnCl2 and 80% 
glycerol) by gently pipetting up and down. The cells were then chilled on ice for 
5min and spun as before. Each pellet was then resuspended in 2ml buffer 2 (lOOmM 
MOPS, pH 6.5, IM Ca CI2 , IM RbCl2 and 80% glycerol) by pipetting. The cells 
were placed on ice for 15min, divided into 2 2 0 jil aliquots, snap frozen using liquid 
nitorgen and stored at -80°C.
2.15.2 Transformation of Competent Bacteria
On thawing an aliquot of competent bacterial cells, 50pl per transformation was 
added to a sterile 13.5ml conical based tube and placed on ice. l-5pl of DNA (~1- 
lOng) was added and the cells were placed on ice for 15 min. The tubes were then 
placed in a water bath at 42°C for 90 s in order to induce heat shock. The cells were 
returned to ice for 2 min before 450pl of L-broth (see Section 2.14.1) was added and 
the tubes were placed in an orbital shaker at 37°C for 45 min. lOOpl of cells was 
plated out on the appropriate antibiotic plate and incubated at 37°C overnight.
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2.15.3 Multiple Plasmid Miiiipreparations
To perform multiple plasmid minipreparations the QIAprep® 8 Turbo Miniprep kit 
was used as described below. It should be noted that details of the individual buffers 
used below were not available (refer to manufacturer's handbook).
Following transformation of competent XLl-Blue E.Coll, single colonies of interest 
were picked from an agar plate and dispensed into 3ml of L-Broth (see Section 
2.14.1) in a Universal tube containing 50pg/ml ampicillin. The cultures were shaken 
overnight at 37°C and then 1.5ml was transferred to Eppendorf tubes which were 
centrifuged at 10,000 x g for 5 min in a microfuge. The supernatant was discarded 
and the pellet of bacterial cells was resuspended in 250|ul of Buffer P moving all 
visible cell clumps. 250|li1 of Buffer P2 was then added and the tubes were gently 
inverted 4-6 times to ensure mixing before incubation at room temperature for 5 min. 
As the solutions became viscous and slightly clear 350pl of Buffer N3 was added to 
each sample and again the tubes were inverted immediately but gently 4-6 times. The 
cloudy lysates (850pl) were then pipetted into the wells of the TurboFliter strips 
and the vacum was applied until all the samples had passed through the TurboF liter 
into the QIAprep® strips below. On turning the vacum off, the TurboFilter strips 
were discarded and replaced with the now filled QIAprep® strips with the waste 
tray being positioned below. Again the vacum was applied allowing the flow 
throughs to be collected as waste. With the aid of the vacum the QIAprep® strips 
were washed two times by the addition of 1ml of Buffer PE to each well (the vacum 
being switched off before Buffer PE was added for a second time). At the end of the 
second wash the vacum was left on for an additional 5 min to dry the membrane. 
The QIAprep® strips were then rapped on a stack of absorbent paper until no drops 
were observed and the nozzles were blotted dry.
To elute DNA, lOOpl of sterile H2O was added to the centre of each well of the 
QIAprep® strips and left to stand for 1 min. The waste tray was replaced with
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collection microtubes and then the vacum was applied for 5 min allowing elution of 
bound DNA. The DNA was stored at -20°C.
2.15.4 Maxi Preparation of Plasmid DNA
500ml of sterile L-broth (containing the appropriate antibiotic) was innoculated with 
500pl of culture previously prepared by the innoculation of a small volume of L- 
broth (see Section 2.14.1) with a single colony of XL 1-blue E. Coli. The culture was 
shaken overnight at 37°C. The cells were then pelleted by centrifugation in Beckman 
250ml polypropene bottles at 4000 x g for 10 min at 4°C. On discarding the 
supernatant, the pellets were pooled and resuspended in 25ml total volume of ice- 
cold glucose buffer (50mM glucose, lOmM EDTA, 25mM Tris, pH6 .8 ). Keeping 
the cells on ice, 25ml of alkaline lysis buffer (1% SDS, 0.2M NaOH) was added 
slowly with continual swirling and then 25ml of 5M potassium acetate buffer, pH5.5 
was added. The bottle was then shaken vigorously before centrifugation at 4000 x g 
for 10 min at 4°C. The supernatant was filtered through 2 layers of muslin into a 
fresh 250ml Beckman polypropene bottle, mixed with 100ml propan-2-ol and 
incubated at -20°C for lOmin. After centifugation at 4000 x g for 10 min at 4°C, the 
supernatant was discarded and the pellet was resuspended in 7.5ml TE buffer 
(lOmM Tris, ImM EDTA, pH8 .8) and transferred to a 50ml Beckman polypropene 
tube. Following the addition of 10ml of 5M LiCl, the solution was incubated on ice 
for 2-5 min and then centrifuged at 3000 x g for 10 min at 4°C. The supernatant was 
then transferred to a fresh 50ml Beckman polypropene tube, mixed with an equal 
volume of 100% ethanol and incubated for 30 min at -20°C. After centrifugation at 
3000 X g for 20 min at 4°C, the supernatant was discarded and the pellet was washed 
with 95% ethanol and allowed to dry. The pellet was then resuspended in 0.6ml TE 
buffer and transferred to an Eppendorf tube. Following the addition of RNAse 
(2 0 |ig/ml), the solution was incubated at 37°C for 15 min. After the addition of 0.5 
volumes of polyethylene glycol (PEG), the solution was incubated on ice for 15 min 
and spun in a microfuge at 10, 000 x g for 10 min. On discarding the supernatant the
105
pellet was resuspended in 0.6ml TE buffer. The DNA was subsequently cleaned by 
phenof.chloroform extraction. An equal volume of phenol: chloroform ( 1:1) was 
added to the sample and vortexed vigorously. The aqueous (top) layer was carehilly 
removed with the aid of a pipette and transferred to a clean Eppendorf. This was 
repeated and then followed by two chloroform extractions, again with the aqueous 
layer being removed each time. 2.5 volumes of absolute ethanol and 0.1 volumes of 
3M NaOAc were added and the DNA was precipitated overnight at -20°C. The 
sample was then spun at 1 0 ,0 0 0  x g for 20  min in a microfuge, the supernatant 
decanted off and the pellet' was washed with 70% ethanol and allowed to air dry 
before resuspension in 100-200pl H2O. The DNA concentration and purity was 
determined by reading the absorbance at 260 and 280nm.
2.15.5 Calculation to Determine the Plasmid DNA Concentration and Purity
absorbance value of 1.0 at 260nm = 50pg of double stranded DNA 
absorbance value of "y" at 260nm = "y" X 50|ug of double stranded DNA
absorbance at 260nm
______________  = "Z"
absorbance at 280nm
DNA has a lower protein concentration and has a higher purity when Z is nearer to 
2 .0 .
2.15.6 Restriction Digestion of DNA
Approximately lOjUg of DNA was used for a large scale digest in a reaction volume of 
lOOpl. lOpg of DNA, lOpl of I OX buffer (optimising salt and pH for individual 
enzymes) and 10 units of enzyme were added with sterile water to lOOpl to a 1.5ml 
Eppendorf tube and incubated at 37°C for 2 h. For digestions with more than one
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enzyme, the reaction was carried out as before with the first enzyme (the one which 
utilises a lower salt concentration), and then salt added to the reaction to optimise 
conditions for the second digest which is subsequently carried out. Alternatively, if 
both enzymes utilised similar optimum reaction conditions, both digests could be 
carried out simultaneously. Following the addition of 5X DNA loading buffer 
(0.25% bromophenol blue, 30% (v/v) glycerol/H2 0 ), the sample was electrophoresed 
on a 1% agarose gel.
2.15.7 Dephosphorylation of Linearised DNA
For plasmids linearised with a single restriction endonuclease or cut to receive an 
insert, de-phosphorylation was carried out to reduce the efficiency of re-ligation of 
sticky ends. lOp-g of DNA, 5p,l of I OX buffer and 5 units of enzyme were added 
with sterile water to 50{Lil to a 1.5ml Eppendorf tube and incubated at 37°C for 1 h as 
before. lOpl of lOX de-phosphorylation buffer, 1 unit of alkaline phosphatase with 
sterile water to lOOp.1 were added and incubated at 37°C for a further 2 h. A fraction 
of the sample was electrophoresed as before to verify linearisation and the remaining 
DNA was cleaned by phenol:chloroform extraction (refer to Section 2.15.4). 2.5 
volumes of absolute ethanol and 0.1 volumes of 3M NaOAc were added and the 
DNA was precipitated overnight at -20°C. The sample was then spun at 10,000 x g 
for 2 0  min in a microfuge, the supernatant decanted off and the pellet was washed 
with 70% ethanol and allowed to air dry before resuspension in 20pl H2O.
2.15.8 Agarose Gel Electrophoresis
For standard 1% gels, agarose was dissolved by boiling in distilled water. On cooling 
to a hand hot temperature, 5OX TAB buffer (2mM Tris, 50mM EDTA, 5.7% (v/v) 
glaeeial acetic acid) was added to produce a final concentration of IX TAB. 
Ethidium bromide (lOmg/ml) was added, mixed thoroughly and the gel solution was 
then poured into a horizontal electrophoresis gel cartridge (with a comb inserted) and
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allowed to set at room temperature. The gel cartridge was transferred to an 
electrophoresis tank containing IX TAB buffer and the comb was carefully removed. 
The DNA samples were then loaded adjacent to a sample of either Bst E Il-digested 1 
DNA or 1Kb DNA ladder, required to determine the size of the digested DNA 
fragments. Electrophoresis was carried out at 50-100mA until the dye front had 
migrated two thirds of the way along the gel towards the anode. DNA was visualised 
under U.V using an Ultraviolet Products Inc. transilluminator and photographs were 
taken using a Mitsubushi video copy processor.
2.15.9 Gel Extraction of DNA
This was carried out using materials from a W iz a r d ^ M  pius Minipreps DNA 
Purification system.
Following agarose gel electrophoresis, the appropriate DNA fragments were excised 
as gel slices and transferred to a 1.5ml micorcentrifuge tube. 1ml o f  W iz a r d ^ M  
Minipreps DNA Purification Resin (thoroughly mixed) was added and the gel slice 
was incubated at 55°C for 5-10 min to allow the gel to melt. The 1.5ml 
microcentrifuge tube was agitated several times during the incubation to ensure mixing 
of the DNA and resin. A Wizard^f^ Minicolumn was prepared by removing the 
plunger from a 3ml syringe and attaching the syringe barrel to a Luer-Lok® extension 
of the Minicolumn. The 1ml of'slurry' was then pipetted into the barrel and pushed 
into the Minicolumn with the aid of the syringe plunger. The syringe was detached 
from the column before removing the plunger. The syringe barrel was reattached and 
2X 2ml of isopropanol was used to wash Minicolumn. On removal of the syringe, 
the Minicolumn was transferred to a 1.5ml microcentrifuge tube and centrifuged at
10,000 xg in a microfuge for 2 min to dry the column. The Minicolumn was 
transferred to a fresh 1.5ml microcentrifuge, 50|li1 of H2O was added. After 1 min, 
the Minicolumn was centrifuged at 10, 000 xg for 20 s to elute the DNA. The DNA 
was stored in the microcentrifuge tube at -20°C prior to further analysis.
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Chapter 3
Compartment Ablation Analysis 
of the
GLUT4 Intracellular Compartments
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3.1 Aims
1. To examine the subcellular distribution of SCAMPs (secretory carrier 
associated membrane proteins), syntax in 4, CSPs (cysteine string proteins), 
syntaxin 4, Rab4, y-adaptin and the cation-dependent mannose-6 -phosphate 
receptor (CD-M6 PR) in basal and insulin-stimulated 3T3-L1 adipocytes.
2. To examine the effect of endosome ablation on the proteins localised to the 
intracellular (LDM) membranes enriched in GLUT4.
3. To determine the extent of co-localisation of the proteins localised to the 
non-ablatable compartment with GLUT4.
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3.2 Introduction
The acute stimulation of glucose transport in adipose and muscle tissue in response 
to insulin is associated with the rapid translocation of GLUT4 transporters to the 
cell surface from an intracellular compartment(s) (reviewed in James et ai, 1994). 
Although the intracellular sequestration of this transporter is fundamental to the 
insulin response, the nature of the intracellular compartment(s) and the exact 
mechanism of translocation remain poorly defined. In the basal state, morphological 
studies have localised > 95% of GLUT4 to tubulovesicular elements adjacent to early 
and late endosomes, at the trans-GoXgi network (TGN) or in the cytoplasm often 
close to the plasma membrane (Slot et ai, 1991b; Slot et ai, 1991a). In response to 
insulin, GLUT4 levels are decreased by 40-50% at each of these locations suggesting 
that each of these compartments participate in insulin-stimulated GLUT4 trafficking 
{^Xoietal, 1991b; Slot etal,  1991a).
GLUT4 continuously recycles between the plasma membrane and the intracellular 
compartment(s) in the absence and presence of insulin (Yang et at., 1993; Jhun et ai, 
1992). Internalisation of GLUT4 via clathrin-coated pits (Slot et al., 1991b) and 
partial co-localisation with endosomal proteins including the TfR and the CI-M6PR 
(Tanner et al., 1989), suggests that this recycling is by way of the endosomal 
system. However, the kinetics of GLUT4 trafficking in the absence and presence of 
insulin suggests that more than one intracellular compartment is responsible for 
GLUT4 sequestration (refer to Section 1.9) (Holman et al., 1994b). On the basis of 
these data, and mathematical analysis, a three compartment model has been proposd 
for the subcellular trafficking of GLUT4 (Holman et a i,  1994b). In the model 
GLUT4 is associated with two intracellular compartments; one is the recycling 
endosomal system, and the second is a more specialised compartment where GLUT4 
is sequestrated in the basal state. It is this latter compartment which is thought to 
represent the insulin-responsive storage compartment from which GLUT4 is 
recruited to the plasma membrane upon insulin stimulation. Following recruitment to
111
the plasma membrane GLUT4 is internalised via the recycling endosomal system, 
and subsequently sorted back into the specialised storage compartment (refer to 
Figure 1.9) (Holman et aL, 1994b).
Biochemical evidence for the sequestration of GLUT4 in an intracellular 
compartment segregated from the recycling endosomal system has recently been 
provided by means of a technique referred to as compartment ablation analysis 
(Livingstone et a i ,  1996). Ablation may be achieved by the introduction of 
horseradish peroxidase (HRP) or HRP-conjugates into the appropriate 
compartment(s) (West et al, 1994). On incubation with 3,3' -diaminobenzidine 
(DAB) and H2O2 , proteins within the compartment carrying the HRP probe are 
eross-linked and rendered 'insoluble' (i.e. ablated) (West et ai, 1994). To determine 
the relationship between the intracellular sequestration of GLUT4 and the recycling 
endosomal system, this technique was exploited by using a transfeiTin-HRP (Tf- 
HRP) conjugate (Livingstone et al., 1996). By saturating the recycling pathway of 
the TfR with Tf-HRP in 3T3-L1 adipocytes, proteins present in the recycling 
endosomal system including the TfR, GLUTl and the CI-M6PR were quantitatively 
ablated in the presence of DAB and H2O2 (Livingstone et al,  1996). In contrast, 
only 40% of intracellular GLUT4 was ablated under the same conditons, suggesting 
that a larger proportion (-60%) of intracellular GLUT4 resides in a 'non-ablatable' 
storage compartment withdrawn from the endosomal system (Livingstone et al,
1996). Further ablation studies have shown GLUT4 to co-localise with the v- 
SNARE VAMP2 in this non-ablatable compartment (Martin et al,  1996). In 
striking agreement with the ablation data, a recent immunocytochemical study on rat 
adipocytes has localised GLUT4 with VAMP2 in a post-endocytic compartment, 
distinct from the TfR in the constitutively recycling endosomes (Malide et al,  
1997a).
In the present study, I wished to further characterise the non-ablatable GLUT4 
compartment and investigate the relationship of this compartment with the
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endosomal and secretory pathways. In order to do this, I studied the co-localisation 
of GLUT4 with marker proteins that define distinct intracellular compartments (y- 
adaptin, the CD-M6PR and Rab4) and proteins known to be involved in exocytosis 
(SCAMPs [secretoiy carrier-associated membrane proteins], syntaxin 4 and cysteine 
string proteins [CSPs]) in 3T3-L1 adipocytes before and after endosomal ablation. 
The results obtained provide further evidence for the existence of two distinct 
intracellular GLUT4 pools in 3T3-L1 adipocytes. I have shown that after endosomal 
ablation a smaller pool (-38%) of GLUT4 is localised to the endosomal system along 
with markers for cell surface to endosome recycling such as the TfR and SCAMPs, 
consistent with the constitutive recycling of GLUT4 between the plasma membrane 
and the early endosomes via the recycling endosomal system. The co-localisation of 
syntaxin 4 with GLUT4 within the larger non-ablatable intracellular pool suggests 
that this t-SNARE may be involved in GLUT4 intracellular trafficking. Moreover, 
the presence of TGN markers within this pool implies that GLUT4, along with the 
CD-M6PR, recycles through the TGN in AP-1 positive vesicles en route to the 
endosomal system.
3.3 Materials and Methods
3,3.1 Ablation of the Intracellular (LDM) Membranes
Ablation of the recycling endosomal system was carried out as described by 
Livingstone et al (Livingstone et al, 1996).
3T3-L1 adipocytes were cultured on 10cm plates and incubated in serum-free 
DMEM at 37°C for 3 h prior to use. For the last hour of the incubation, Tf-HRP 
conjugate (20|Lig/ml final concentration) was added to all plates. On transferring the 
plates onto ice, the cells were washed gently three times over a 10 min period with 
ice-cold isotonic citrate buffer (150mM NaCl, 20mM Tri-sodium citrate, pH 5.0) and 
once with ice-cold PBS (see Section 2.2.1). 9.5ml of PBS and 0.5ml of 3,3'-
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diaminobenzidine (DAB) (2mg/ml stock prepared freshly in PBS, vortexed 
thoroughly and filtered through a 0.22 pm-pore-size-filter) were added to each plate. 
H 2O 2 (0.02%) was then added to experimental plates only. The plates were 
wrapped in aluminium foil and incubated in the dark at 4°C for 1 h. On discarding 
the buffer, the plates were washed with ice-cold PBS. The cells were then scraped 
upon adding 1ml of ice-cold HES buffer (see Section 2.2.3) and added to a Dounce 
homogeniser. Proteinase inhibitors (Ipg/ml pepstatin A, 0.2mM DFP and 20pM 
E64) were added and the cells were homogenised with 20 handstrokes. Homogenates 
were transferred to pre-chilled Oakridge centrifuge tubes and centrifuged at 19,000 x g 
for 20 min at 4°C. The resulting supernatant was added to 5ml Ultra-Clear tubes and 
centrifuged at 100,000 x g for 60 min at 4°C. The resulting pellet, designated as the 
low density microsomes (LDM) was resuspended in HES buffer, snap frozen in 
liquid nitrogen and stored at -80°C prior to analysis.
3.3.2 Sucrose Density Gradient Analysis
The intracellular (LDM) membranes (± ablation) prepared as described above were 
resuspended in 200pl HE buffer (20mM N-2-hydroxyethylpiperazine-N'-2- 
ethanesulphonic acid (HEPES), pH 7.4 and ImM EDTA) containing proteinase 
inhibitors (Ipg/ml pepstatin A, 0.2mM DFP and 20pM E64). A discontinuous 
sucrose gradient was prepared by adding 200jil aliquots of sucrose solutions in HE 
buffer of decreasing sucrose concentration (50%, 45%, 42.5%, 40%, 37.5%, 35%, 
32.5%, 30% and 25%w / v sucrose) to a pre-chilled Beckman tube. The resuspended 
LDM sample was then loaded onto the gradient and centrifuged at 100,000 x g at 4°C 
for 24 h. A series of 125pl fractions was collected by tube puncture into Eppendorf 
tubes. 30|Lii of 0.15% w / v deoxycholate and 200pl of 72% Trichloroacetic acid were 
added to each tube which were then vortexed briefly and incubated on ice for 10 min. 
Following centrifugation of each fraction at 10,000 x g in a microfuge for 10 min, the 
supernatant was aspirated off and the precipitated protein was resuspended in 40pl
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IX SDS-PAGE sample buffer (see Section 2.6) and lOpl IM Tris before each 
fraction was snap frozen in liquid nitrogen and stored at -80°C.
3.3.3 Whole-Cell Immunofluorescence Microscopy
Whole-cell immunofluorescence microscopy was carried out as described in Section 
2.12,2. For GLUT4 staining alone whole cells were labelled with an affinity purified 
rabbit polyclonal anti-GLUT4 primary antibody (refer to Section 2.4) and the 
corresponding secondary antibody (FITC-conjugated goat anti-rabbit IgG). In the 
case of double-labelling experiments, Triton-permeabilised 3T3-L1 adipocytes were 
incubated with a mouse monoclonal anti-GLUT4 antibody (refer to Section 2.4) and 
the corresponding secondary antibody (tetramethylrhodamineisothiocyanate 
[TRITC]-conjugated goat anti-mouse IgG) in conjunction with either a rabbit anti-y- 
adaptin antibody (see Section 3.3.5) or a rabbit anti-CD-M6PR antibody (see Section
3.3.5) and the corresponding secondary antibody (FITC-conjugated goat anti-rabbit 
IgG).
3.3.4 Antibodies
The anti-GLUT4 antibody used for immunoblotting was a rabbit polyclonal against a 
peptide comprising the C-terminal 14 amino acid residues of the human isoform of 
GLUT4 (see Section 2.4). For vesicle immunoadsorption and double-labelled 
immunofluorescence a monoclonal GLUT4 antibody (1F8) was used (see Section 
2.4). An anti-transferrin receptor monoclonal antibody was purchased from UBI 
(Lake Placid, New York, USA). Anti-y-adaptin antibody was the generous gift of Dr 
M.S. Robinson (Addenbrooks Hospital, University of Cambridge, UK), and the anti- 
CD-M6PR antibody was from Dr A. Hille-Rhefeld (Utrecht, Netherlands). Anti- 
Rab4 antibodies were provided by Dr Y. LeMarchand-Brustel (INSERM, Nice, 
France) and Dr P. van der Sliujs (Utrecht, Netherlands). Anti-SCAMP antibodies
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were from Dr D. Castle (University of Virginia, USA) and antiserum against CSPs 
was generously provided by Dr R. Burgoyne (University of Liverpool, UK).
3.4 Results
3.4,1 Subcellular Distribution of Proteins in Basal and Insulin-Stimulated 
3T3-L1 Adipocytes
Initially I examined the subcellular distribution of several proteins including; y- 
adaptin, SCAMPs, the CD-M6PR, CSPs, syntaxin 4 and Rab4 in basal and insulin- 
stimulated 3T3-L1 adipocytes. Subcellular fractionation was carried out using both 
basal and insulin-stimulated adipocytes as described in Section 2.10. Figure 3.1 
shows Western blots of plasma membrane (PM), low-density microsome (LDM) 
and high-density microsome (HDM) fractions analysed for the distribution of 
GLUT4 and these proteins.
The cellular distribution of the CD-M6PR was similar to that of GLUT4 with an 
increase at the PM in response to insulin and a concomitant decrease in the LDM 
fraction. The majority of y-adaptin, a marker for the AP-1 complex which is a 
component of clathrin-coated vesicles associated with the TGN (Robinson, 1990) 
was found in the LDM fraction, consistent with this fraction being enriched in the 
Golgi complex. There was no redistribution of this protein upon insulin treatment. 
As integral membrane proteins of secretory and transport vesicles (Sudhof, 1995), 
SCAMPs are important components involved in trafficking to and from the cell 
surface. As expected, SCAMPs were localised predominantly in the LDM fraction 
enriched in GLUT4, with no significant change in distribution in response to insulin, 
consistent with a previous study in adipocytes (Laurie et ai, 1993). In agreement 
with a previous study, syntaxin 4 was highly enriched in the PM fraction with a 
smaller intracellular pool in the LDM fraction in 3T3-L1 adipocytes (Tellam et al,
1997). It must be noted that in order to examine this intracellular pool twice as much
1 1 6
protein sample had to be loaded to the lanes representing the LDM fractions of 
syntaxin 4. In response to insulin there was a decrease in syntaxin 4 levels in the 
LDM fraction, consistent with the aformentioned study. However an increase at the 
PM is not apparent as the amount of this protein lost from the LDM fraction is very 
small compared to the high levels already present at the PM.
I also studied the distribution of the small GTP-binding protein, Rab4. Several 
studies have previously suggested a role for Rab4 in GLUT4 trafficking with the 
LDM fraction containing the majority of both Rab4 and GLUT4 in the basal state 
with movement to the cytosol and plasma membrane respectively, upon insulin 
stimulation (Ricort eta l,  1994; Cormont eta i,  1993; Shibata et ai, 1996; Cormont et 
a l,  1991). Consistent with these studies I found Rab4 to be localised to the LDM 
fraction in basal adipocytes. However, in response to insulin the immunoblot shows 
little if any change in cellular distribution (see below). CSPs were also found to be 
expressed in 3T3-L1 adipocytes. Intriguingly these proteins, previously identified as 
membrane proteins localised to secretory vesicles in neuroendocrine and endocrine 
cells (Chamberlain et ai, 1996a; Chamberlain et al, 1996b), were confined to the 
plasma membrane both in basal and insulin-stimulated adipocytes.
3.4.2 Ablation of Proteins Localised to the Intracellular (LDM ) Membranes
Ablation of the recycling endosomal system has led to the identification of a distinct 
GLUT4 compartment segregated from the TfR in which the majority (-60%) of 
intracellular GLUT4 resides in the basal state, and which is thought to represent a 
unique intracellular GLUT4 compartment (referred to as the non-ablatable 
compartment) (Livingstone e ta i ,  1996). This approach exploits the recycling of the 
TfR through the endosomal system by loading the receptor with a protein conjugate 
of transferrin and horseradish peroxidase (Tf-HRP). Previous studies have shown 
that this procedure selectively ablates markers for the recycling endosomal system 
(TfR, Rab5, cellubrevin, GLUTl and the CI-M6PR), with little or no effect on
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markers for the TGN or lysosomes (Livingstone et al., 1996). Here, I have 
employed this procedure to determine the co-localisation of the proteins previously 
localised to the LDM fraction (CD-M6PR, y-adaptin, syntaxin 4, and SCAMPs) to 
this non-ablatable compartment.
Duplicate plates of 3T3-L1 adipocytes were incubated with Tf-HRP for either Ih at 
4°C or Ih at 37°C, the latter set of conditions being sufficient to allow full 
equilibration of the TfR pool with Tf-HRP in 3T3-L1 adipocytes (Livingstone et al.,
1996). At 4°C, trafficking will effectively be stopped and therefore the Tf-HRP 
conjugate will not be recycled through the endosomal system, thus rendering the 
ablation procedure ineffective. This is clearly shown by the immunoblots (Figure
3.2) as there is no change in the amount of protein in the two lanes labelled ± H2O2 
at 4°C. Following ablation (DAB ± peroxide), LDM fractions were prepared as 
described in Materials and Methods and the extent of ablation was determined by 
quantitative immunoblot analysis. Figure 3.2 shows immunoblots for the TfR, 
GLUT4, the CD-M6PR, y-adaptin and syntaxin 4. Following the loading of Tf-HRP 
at 37°C, the TfR exhibits a significant degree of ablation (79 ± 8%, mean ± s.e.m, n = 
3, p<0.01), but in contrast, only a relatively modest degree of GLUT4 ablation is 
observed (38 ± 6%, mean ± s.e.m, n = 3). No significant ablation was observed in the 
case of y-adaptin or the intracellular pool of syntaxin 4, suggesting that both of these 
proteins reside in an intracellular compartment distinct from the recycling endosomal 
system. The CD-M6PR also shows partial ablation (-35%), exhibiting a pattern 
similar to that for GLUT4. These data indicate that smaller intracellular pools of 
both of these proteins reside in the recycling endosomal system.
As the DAB-dependent protein complex forms in the lumen of endosomal vesicles 
containing the TfR, in order for a protein to become ablated, it must have a lumenal 
domain. As y-adaptin is a coat protein it does not contain a lumenal domain and 
therefore will not be susceptible to ablation. Hence, the lack of ablation when 
immunoblotting the intracellular (LDM) membranes should not be taken as evidence
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for this protein not residing in TfR positive membranes (Figure 3.2). However, 
membrane compartments which contain the DAB-dependent protein complex exhibit 
increased density following ablation. The association of proteins with vesicles which 
have undergone ablation is reflected by a change in the distribution of such proteins 
on density gradients, an approach which has previously been employed for analysis 
of Rab5 in adipocytes (Livingstone et ai, 1996). I therefore further examined the 
effect of ablation on y-adaptin and also Rab4 using sucrose density gradient 
centrifugation.
Intracellular (LDM) membranes were prepared and further subfractionated on 
discontinuous sucrose density gradients as described (see Section 3.3.2). Fractions 
were collected from the gradients and analysed for the distribution of y-adaptin, Rab4 
and GLUT4. There was little if any change in the distribution of y-adaptin on 
sucrose gradients upon ablation, suggesting that there was little formation of the 
DAB-dependent protein complex in the lumen of y-adaptin vesicles, consistent with 
a low rate of TfR recycling through the TGN (Figure 3.3). In contrast, the 
distribution of Rab4 is markedly changed upon ablation. In control cells, Rab4 is 
detected in fractions also shown to contain GLUT4 (Figures 3.4 and 3.5). However, 
following ablation, there is a complete loss of signal for Rab4. This result may be 
reflective of a weak association of Rab4 with the endosomes which is disrupted by 
ablation. However, the lack of Rab4 association with dense membranes as was 
observed for Rab5 (Livingstone et al, 1996) preludes a definitive conclusion in this 
regard. As previous studies have reported the dissociation of Rab4 from the 
intracellular (LDM) membranes into the cytosolic fraction in response to insulin 
(Cormont et al, 1993) I immunoblotted a sucrose density gradient prepared from the 
LDM fraction of insulin-stimulated adipocytes for Rab4. As shown in Figure 3.4, 
insulin stimulation results in a significant loss of Rab4 immunoreactivity, consistent 
with the dissociation of the Rab protein from the membrane fraction. This loss of 
immunoreactivity due to the dissociation of Rab4 from the intracellular membranes in 
response to insulin is notably similar to that observed following ablation, suggesting
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that the ablation procedure may have resulted in the dissociation of Rab4 from the 
intracellular membranes. However, it must be noted that the same procedure was 
without effect on the association of Rab5 with the intracellular membranes 
(Livingstone a/., 1996).
As SCAMPs have previously been shown to co-localise with GLUT4 in rat 
adipocytes (Laurie et al., 1993) I wished to compare the effect of ablation on the 
distribution of these two proteins determined by sucrose density gradient analysis 
(Figure 3.5). In control cells, GLUT4 and SCAMPs exhibit a similar distribution. 
After ablation, there is a loss of GLUT4 signal, consistent with a smaller pool of 
GLUT4 recycling through the endosomal system. In contrast, the distribution of 
SCAMPs is markedly changed in the presence of peroxide. As shown in Figure 3.5, 
essentially all of the SCAMPs undergo a density shift and are found in fraction 1 
corresponding to the pellet at the bottom of the tube. This suggests that in 
adipoctyes, SCAMPs are associated with vesicles of the recycling endosomal system 
which become more dense as a result of ablation. These results suggest that the co­
localisation previously observed between GLUT4 and SCAMPs is within the 
recycling endosomal system as opposed to the non-ablatable GLUT4 pool, distinct 
from this compartment (Laurie et al., 1993).
3.4.3 Co-Localisation of y-adaptin, the CD-M6PR and Syntaxin 4 with GLUT4- 
Containing Vesicles
To further define the non-ablatable GLUT4 compartment I examined the co­
localisation of GLUT4 with y-adaptin, CD-M6PR and syntaxin 4 by 
immunoadsoiption of GLUT4-containing vesicles. Vesicles were isolated from the 
LDM fraction of adipocytes before and after ablation using a monoclonal antibody 
(IF8) or a polyclonal antibody for GLUT4. As a control, I performed 
immunoadsorption with non-specific IgG. Figure 3.6 shows the detection of the 
CD-M6PR and syntaxin 4 in the vesicles enriched in either GLUT4 or non-specific
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IgG and in the depleted LDM fraction in each case. Figure 3.7 shows the detection 
of y-adaptin in GLUT4-containing vesicles. Syntaxin 4, y-adaptin and the CD- 
M6PR were all found to co-localise to some extent with GLUT4 both before and 
after ablation. The extent of syntaxin 4 and y-adaptin localisation to GLUT4 vesicles 
was not significantly altered upon ablation, suggesting that the majority of these 
proteins detected in GLUT4 vesicles reside in the non-ablatable GLUT4 
compartment. The loss of syntaxin 4 immunoreactivity in the depleted LDM 
fractions, further suggests that the vast majority of the intracellular pool of syntaxin 
4 is associated with the GLUT4 non-ablatable compartment. In the case of the CD- 
M6PR, although also localised to GLUT4 vesicles following ablation, a fairly large 
proportion of this protein remains in the LDM fraction following the complete 
depletetion of GLUT4.
3.4.4 Intracellular Distribution of GLUT4, y-adaptin and the CD-M6PR in 
3T3-L1 Adipocytes
The co-localisation of GLUT4 with TGN markers including the y-adaptin subunit of 
the TGN-specific adaptor complex AP-1 and the CD-M6PR which recycles between 
the TGN and endosomal compartments, suggests that GLUT4 may traffic through 
this compartment. In order to analyse the co-localisation and intracellular 
distribution of these three proteins in greater detail, immunofluorescence microscopy 
and immuno-electron microscopy were used.
Double-labelled immunofluorescence showed partial overlap of GLUT4 with the 
CD-M6PR (Figure 3.8A) and y-adaptin in the perinuclear area (Figure 3.8B). In the 
case of y-adaptin this is consistent with a recent immunocytochemical study in 
which GLUT4 is observed to partially overlap with y-adaptin positive structures in 
rat adipocytes (Malide et ai, 1997a).
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In collaboration with S. Martin (University of Queensland, Australia), the extent of 
co-localisation between GLUT4 and the CD-M6 PR or y-adaptin was analysed using 
immuno-EM studies on intracellular vesicles of basal 3T3-L1 adipocytes. Vesicles 
were isolated from 3T3-L1 adipocytes and double-labelled using colloidal gold-tagged 
antibodies of different particle sizes and the extent of overlap between the proteins 
was determined. In agreement with a previous study in rat adipocytes (Martin et a l,
1997), a significant degree of overlap between GLUT4 and the CD-M6 PR (-70%) 
was observed (Table 3.1). A high percentage (-90%) of the y-adaptin labelled 
vesicles also eo-labelled forGLUT4 in these cells (Figure 3.9, Table 3.1). Although 
the y-adaptin labelling deteeted by immuno-EM in the isolated vesicles was very 
low, the high percentage of co-labelling with GLUT4 in these vesicles eonfinns the 
immunoadsorption data, where GLUT4 vesicles were found to immunoprecipitate 
y-adaptin present in the intracellular (LDM) membranes (Figure 3.7).
The intracellular distribution of GLUT4, the CD-M6PR and y-adaptin was analysed 
in detail using immuno-EM studies on cryosections of basal 3T3-L1 adipocytes by 
T. Meerloo (University of Queensland, Australia). All three proteins were found to 
be concentrated in tubulovesicular-elements in the perinuclear region of the cells, 
associated with the TGN. However, there was also some additional labelling in the 
periphery of the cells. Double-labelled sections showed GLUT4 to co-localise with 
both the CD-M6 PR and y-adaptin in the TGN region of the basal 3T3-L1 
adipocytes (data not shown).
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Table 3.1
Analysis of Vesicle Labelling and Co-Localisation of GLUT4 with y-adaptin 
and the CD-M6 PR
A. y-adaptin Total vesicles labelled (%) % co-localisation
GLUT4 y-adaptin GLUT4 vesicles 
containing y- 
adaptin
y-adaptin vesicles 
containing 
GLUT4
3T3-L1
adipocytes
15.2 ±2.8 ' 4.9 ± 1.7 18.0 ±3.5 90.6 ±7.0
B.CD-M6PR Total vesicles labelled (%) % co-localisation
GLUT4 CD-M6 PR GLUT4 vesicles 
containing CD- 
M6 PR
CD-M6 PR
vesicles
containing
GLUT4
3T3-L1
adipocytes
17.8 ±4.9 21.5 ± 6 .8 73.3 ±3.8 70.0 ±2.3
In collaboration with S. Martin (University of Queensland, Australia) intraeellular 
vesicles were isolated from 3T3-L1 adipocytes and double-labelled with antibodies 
specific for GLUT4 and y-adaptin or the CD-M6 PR tagged with different sized 
particles of colloidal gold. The degree of co-localisation between GLUT4 and y- 
adaptin or the CD-M6 PR was determined as a function of the total population of 
either GLUT4 vesicles or y-adaptin/CD-M6 PR vesicles, that contained the other 
marker (mean ± s.e.m).
123
Figure 3.1
Subcellular Distribution of GLUT4, y-adaptin, SCAMPs, the CD-M6PR, 
Syntaxin 4, CSP and Rab4 in 3T3-L1 adipocytes and the Effect of Insulin
Shown is the distribution of GLUT4 (~45kDa), y-adaptin (~90kDa), SCAMPs 
(~37&39kDa), CD-M6 PR (~46kDa), Syntaxin 4 (~32kDa), CSP (dimer of-70kDa) 
and Rab4 (~24kDa) in subcellular fractions isolated from basal (non-stimulated) and 
insulin-stimulated 3T3-L1 adipocytes (insulin exposure for 15 min at 1 p,M). 
Subcellular membrane fractions (PM, LDM and HDM) were prepared and subjected 
to SDS-PAGE, electrophoretically transferred to nitrocellulose membranes, and 
immunoblotted with the antibodies indicated. The immunoblots were developed 
using ECL. It should be noted that equal volumes of protein were added to each lane 
except in the case of the syntaxin 4 immunoblot where twice as much protein sample 
was loaded to the lanes representing the LDM fractions in order to examine the 
intracellular pool of this protein. Each immunoblot is representative of at least two 
other experiments.
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Figure 3.2
The Effect of Endosomal Ablation on the Intracellular Levels of GLÜT4, TfR, 
Y-adaptin and CD-M6PR in 3T3-L1 Adipocytes
Duplicate plates of 3T3-L1 adipocytes were loaded with Tf-HRP at either 4°C or 
37°C (as indicated) and incubated with DAB ± H2O2 as described in Materials and 
Methods. Intracellular (LDM) membrane fractions were isolated from these cells, and 
immunoblotted with the antibodies indicated. The effect of ablation at 37°C was 
determined by comparison of the signals in the - and + lanes. The 4°C experiment is 
included as a control to show that at this temperature there is no internalisation of 
the conjugate and hence no ablation. In each experiment, 25% of the LDM fraction 
from a single 10cm plate were loaded in each lane. Immunoblots were developed by 
ECL and quantified using densitometry. Quantitation of three individual 
immunoblots indicated that -79% of the TfR signal was lost in the presence of 
peroxide whereas only -38% and -35% of the GLUT4 and the CD-M6 PR signal 
were lost in the presence of peroxide, respectively.
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Figure 3.3
Sucrose Density Gradient Analysis of y-adaptin Distribution in the
Intracellular (LDM) Membranes of 3T3-L1 Adipocytes Before and After
Ablation
3T3-L1 adipocytes were loaded with Tf-HRP at 37°C and incubated with DAB ± 
H2O2 as descibed in Materials and Methods. Intracellular (LDM) membranes were 
prepared and subfractionated on discontinuous sucrose gradients as described. 
Samples were collected and subjected to SDS-PAGE and immunoblot analysis using 
antibodies to y-adaptin. The density of sucrose solutions increases from right to left 
(as indicated). There was no significant change in the density of membranes 
containing y-adaptin following ablation. The experiment was repeated with similar 
results.
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Figure 3.4
Sucrose Density Gradient Analysis of Rab4 Distribution in the Intracellular
(LDM) Membranes of Basal and Insulin-Stimulated 3T3-L1 Adipocytes Before
and After Ablation
3T3-L1 adipocytes were loaded with Tf-HRP and treated with (+) or without (-) 
insulin (IpM) for the last 15 rain of the incubation at 37°C. The cells were then 
incubated with DAB ± H2O2 as descibed in Materials and Methods. Intracellular 
(LDM) membranes were prepared and subfractionated on discontinuous sucrose 
gradients as described. Samples were collected and subject to SDS-PAGE and 
immunoblot analysis using antibodies to Rab4. The density of sucrose solutions 
increases from right to left (as indicated). In the presence of peroxide (+ H2O2) the 
Rab4 signal is lost in a manner similar to that observed in insulin-stimulated cells 
both before and after ablation. Each immunoblot is representative of at least two 
other experiments.
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Figure 3.5
Sucrose Density Gradient Analysis of GLUT4 and SCAMPs Distribution in
the Intracellular (LDM) Membranes of 3T3-L1 Adipocytes Before and After
Ablation
3T3-L1 adipocytes were loaded with Tf-HRP at 37°C and incubated with DAB ± 
H2O2 as descibed in Materials and Methods. Intracellular (LDM) membranes were 
prepared and subfractionated on discontinuous sucrose gradients as described. 
Samples were collected and subject to SDS-PAGE and immunoblot analysis using 
antibodies to GLUT4 and SCAMPs as indicated. In the experiment shown, fraction 
1 is the material which pelleted at the bottom of the gradient (far left); samples 2 -1 2  
were isolated from the gradient such that sample 2 eontains the highest density of 
sucrose and sample 12 the lowest (far right). In the presence of peroxide, a partial 
loss of GLUT4 signal was observed whereas essentially all of the SCAMPs signal 
was recovered in sample 1.
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Figure 3.6
Co-Localisation of the CD-M6PR and Syntaxin 4 with GLUT4-Containing 
Vesicles
3T3-L1 adipocytes were loaded with Tf-HRP at 37°C and incubated with DAB ± 
H2O2 as descibed. Intracellular (LDM) membranes were isolated and incubated with 
anti-GLUT4 antibody or non-specific IgG (control) pre-coupled to Staph, a. cells as 
described in Section 2.11. Immunoadsorbed vesicles (GLUT4 and IgG) and depleted 
LDM fractions (GLUT4 and IgG) were subjected to SDS-PAGE and immunoblot 
analysis with antibodies, as indicated.
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Figure 3.7
Co-Localisation of y-adaptin with GLUT4-Containing Vesicles
3T3-L1 adipocytes were loaded with Tf-HRP at 37°C and incubated with DAB ± 
H2 0 2 'as descibed. Intracellular (LDM) membranes were isolated and incubated with 
anti-GLUT4 antibody pre-coupled to Staph, a. cells as described. Immunoadsorbed 
GLUT4 vesicles were subjected to SDS-PAGE and immunoblot analysis with y- 
adaptin and GLUT4 antibodies.
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Figure 3.8
Double-Labelled Immunofluorescence Analysis of Basal 3T3-LI Adipocytes
Triton-permeabilised 3T3-L1 adipocytes were incubated with a mouse monoclonal 
anti-GLUT4 antibody and the corresponding secondary antibody (TRITC- 
conjugated goat anti-mouse IgG, stained red in A and B) in conjunction with either a 
rabbit anti-y-adaptin antibody or a rabbit anti-CD-M6 PR antibody and the 
corresponding secondary antibody (FITC-conjugated goat anti-rabbit IgG, stained 
green in A and B, respectively). All three proteins were predominantly present in 
the perinuclear region of the cells, although there was also some peripheral punctate 
labelling observed. The yellow colour indicates co-staining between proteins.
138
B
Figure 3.9
Immuno-EM of y-adaptin and GLUT4 in Isolated Vesicles
In collaboration with S. Martin (University of Queensland, Australia), intracellular 
vesicles were prepared from basal (non-stimulated) 3T3-L1 adipocytes. Vesicles 
were absorbed to formvar carbon-copper coated grids and double-labelled using 
antibodies specific for y-adaptin detected using lOnm protein A-gold, followed by 
antibodies for GLUT4 detected using 5nm protein A-gold. Similar results were 
obtained when the antibodies were applied in reverse order. Labelling of individual 
vesicles was quantified, the results of which are shown in Table 3.1.
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3.5 Discussion
Endosomal ablation and immuno-electron microscopy analysis have recently 
suggested that there is a GLUT4-containing compartment distinct from the recycling 
endosomal system (Livingstone et a i, 1996; Martin et a i, 1996), In 3T3-L1 
adipocytes, under conditions in which all the recycling TfR-containing endosomes are 
destroyed (ablated), a large proportion of GLUT4 (-60%) is recovered in a post- 
endocytic compartment (referred to as the non-ablatable compartment) (Livingstone 
et a i, 1996). Moreover, GLUT4 was found to co-localise with VAMP2 in this 
post-endocytic compartment in both 3T3-L1 adipocytes (Martin et a i, 1996) and 
rat adipocytes (Malide et a l, 1997a), consistent with the notion that this may be a 
specialised secretory compartment from which the translocation of GLUT4 to the 
plasma membrane is regulated by insulin. Here, I have used endosomal ablation to 
determine the protein composition of the non-ablatable GLUT4 compartment with 
the aim of further defining the relationship of this compartment to other, well 
chararcterised, intracellular membrane structures.
In the present study, I wished to investigate the co-localisation of GLUT4 relative to 
marker proteins that define distinct intracellular compartments (y-adaptin, the CD- 
M6 PR and Rab4) and proteins known to be involved in exocytosis (SCAMPs, 
syntaxin 4 and CSPs) in 3T3-L1 adipocytes. To do this, I initially determined the 
subcellular distribution of these proteins in the absence and presence of insulin. On 
determining which proteins were localised to the intracellular membranes enriched in 
GLUT4, I examined the effect of endosomal ablation on the intracellular levels of 
these proteins and finally, determined their co-localisation with GLUT4 using vesicle 
immunoadsorption and / or immuno-electron microscopy analysis.
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3.5.1 SCAMPs, Syntaxin 4 and CSPs: Markers for Exocytosis
The sequestration of GLUT4 from the recycling endosomal system into a specialised 
storage compartment in the absence of insulin is similar in many ways to the re­
formation of synaptic vesicles in neuronal cells. Furthermore, the co-localisation of 
GLUT4 with synaptobrevin homologues (VAMP2 and cellubrevin / v-SNAREs) 
(Martin et a i, 1996; Volchuk et a i, 1995) and SCAMPs (Laurie et a i, 1993), 
suggests that GLUT4-containing vesicles are indeed analagous to small synaptic 
vesicles found in neuroendocrine cells. However, recent ablation studies have shown 
that the two v-SNAREs, although both found to co-localise with GLUT4 vesicles, 
are actually localised to distinct compartments (refer to Section 1.13) (Martin et al, 
1996), suggesting that they define separate classes of secretory vesicles. Indeed, the 
co-localisation of VAMP2 in the non-ablatable GLUT4 compartment suggests a 
possible role for this protein in the regulation of insulin-dependent GLUT4 
trafficking, whereas the quantitative ablation of cellubrevin suggests that this v- 
SNARE may mediate the trafficking of the transporter through the endosomal 
system (Martin et a l, 1996).
In this study I have examined whether SCAMPs and syntaxin 4, secretoiy proteins 
previously identified in adipocytes, co-localise with GLUT4 in the non-ablatable 
compartment. The recent observation that CSPs are associated with secretory 
granules in endocrine cells as well as synaptic vesicles (Chamberlain et a l, 1996b), 
suggesting a role for these proteins in regulated exocytosis, also prompted me to to 
determine whether these proteins were present in adipocytes, and if they co-localised 
with GLUT4 vesicles.
SCAMPs are ubiquitously expressed proteins localised to membranes of both 
secretory and endocytic vesicles involved in transport both to and from the cell 
surface (Laurie et a l, 1993). They have previously been identified in adipocytes and 
have been shown to co-localise with GLUT4. In agreement with a previous study on
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rat adipocytes (Laurie et a i, 1993), I observed the majority of SCAMPs to be 
localised to the intracellular (LDM) fraction enriched in GLUT4. However, in 
contrast to GLUT4, there was no significant decrease in the intracellular levels of 
SCAMPs in response to insulin (Figure 3.1). Prolonged exposure of the 
immunoblots did, however, reveal a small increase in SCAMP levels in the plasma 
membrane fraction in response to insulin. This increase is not apparent in the 
immunoblot shown in Figure 3.1, but is observed at higher protein loads, consistent 
with a previous study in adipocytes (Laurie et a l, 1993).
Syntaxin 4, a t-SNARE predominantly targeted to the plasma membrane of 3T3-L1 
adipocytes, is thought to interact with VAMP2, facilitating the docking and fusion of 
GLUT4 vesicles in response to insulin (Olson et a l, 1997; Tellam et a l, 1997). 
However, a smaller but significant intracellular pool of syntaxin 4 was also observed 
in the intracellular (LDM) membrane fraction (Tellam et al., 1997), suggesting a 
possible role for the t-SNARE in intracellular trafficking as well as in docking and 
fusion at the cell surface. As syntaxin 4 has been found to bind both VAMP2 and 
cellubrevin in vitro (Tellam et a l, 1997), I wished to determine whether this protein 
co-localised with GLUT4 in the GLUT4/VAMP2-positive post-endocytic 
compartment. In agreement with the aforementioned study in 3T3-L1 adipocytes, 
syntaxin 4 was predominantly localised to the plasma membrane, but a small fraction 
was also detected in the intracellular (LDM) membrane fraction. Similarily to 
GLUT4, in response to insulin there was a decrease in syntaxin 4 in this fraction. 
However, the low level of expression preluded quantitative analysis of the extent of 
this effect (Figure 3.1).
CSPs were found to be membrane-associated in 3T3-L1 adipocytes. However, in 
contrast to previous studies in endocrine cells where CSPs were found to be 
associated with secretory granules (Chamberlain et a l, 1996b), in 3T3-L1 adipocytes 
these proteins were localised to the plasma membrane, and were not detectable in the 
intracellular LDM fraction (Figure 3.1). There was no change in the distribution of
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these proteins in response to insulin. These data suggest that CSPs are not 
associated with GLUT4 vesicles sequestrated within the cell in the absence of 
insulin.
As both SCAMPs and syntaxin 4 were observed in the intracellular (LDM) 
membrane fraction enriched in GLUT4,1 examined the effect of endosome ablation 
on the intracellular levels of these proteins. As shown in Figure 3.2, I did not 
observe any ablation of syntaxin 4 in these cells, indicating that the intracellular 
complement of this protein does not reside in the recycling endosomal system. To 
determine whether this intracellular pool of syntaxin 4 co-localised with GLUT4 in 
the non-ablatable compartment, I examined the extent of co-localisation of syntaxin 4 
and GLUT4 by vesicle immunoadsorption (Figure 3.6). Syntaxin 4 was found to co- 
localise to the same extent with GLUT4 vesicles both before and after ablation, 
suggesting that the majority, if not all, of the syntaxin 4 detected in GLUT4 vesicles 
resides in the non-ablatable compartment. Furthermore, the absence of syntaxin 4 in 
the depleted LDM membranes, suggests that almost the entire intracellular 
complement of this protein is associated with the GLUT4 non-ablatable 
compartment. Thus, it seems plausible that syntaxin 4 may also play a role in the 
intracellular trafficking of GLUT4, as well as regulating the docking of GLUT4 
vesicles with the cell surface, as has been recently proposed (Olson et a l, 1997; 
Tellam era/., 1997).
In marked contrast, the ablation procedure effectively removed the vast majority of 
the immunodetectable SCAMPs from the intracellular membrane pool, indicated by a 
shift of SCAMP immunoreactivity to the most dense fraction of the sucrose gradient 
(Figure 3.5). The quantitative ablation of these proteins indicates that the SCAMPs 
are localised within the recycling endosomal system in these cells, and that the co­
localisation previously observed between GLUT4 and SCAMPs in rat adipocytes 
(Laurie et a l, 1993) was most likely within this endosomal compartment. The 
identification of a distinct compartment highly enriched in GLUT4 but not SCAMPs
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may also explain the segregation of the two proteins in response to insulin as only 
GLUT4 was found to redistribute appreciably to the plasma membrane in a previous 
study on rat adipocytes (Laurie et a i, 1993). In response to insulin, GLUT4 may 
translocate to the plasma membrane from the non-ablatable compartment devoid of 
SCAMPs and also from the recycling endosomal system as constitutive recycling is 
upregulated in response to insulin (Tanner et a l, 1987; Tanner et a i, 1989). 
However, as SCAMPs are localised to the recycling endosomal system the 
upregulation of constitutive recycling alone will account for the smaller increase of 
these proteins at the plasma membrane in response to insulin. Taken together, these 
data further support the existence of an intracellular GLUT4 compartment which is 
distinct from the recycling endosomal system.
3.5.2 Rab4
The small GTP-binding protein Rab4, has previously been characterised as a 
compartmental marker for the endosomal system, where it mediates the recycling of 
early endosomes (Van Der Sluijs et al., 1992; Bottger et a l, 1996). Recent studies 
have implicated Rab4 as a component of the GLUT4 trafficking machinery, involved 
in both insulin-stimulated GLUT4 translocation and the biogenesis of the storage 
compartment (Cormont et a l, 1996; Shibata et a l, 1996; Mora et a l, 1997). The 
association of Rab4 with GLUT4 vesicles is consistent with both these proteins 
being present in the recycling endosomal system. However, as Rab4 is thought to be 
involved in insulin-stimulated GLUT4 translocation I wished to determine whether a 
sub-population of Rab4 may associate with GLUT4 in the non-ablatable 
compartment in 3T3-L1 adipocytes. Analysis of the subcellular distribution of these 
proteins showed Rab4 to be localised to the intracellular (LDM) membranes enriched 
in GLUT4 (Figure 3.1), consistent with previous observations (Cormont et a l, 
1993). However, in the aforementioned study, insulin induced a redistribution of 
both GLUT4 and Rab4 from this fraction to the plasma membrane and cytosolic 
fractions, respectively (Cormont et a l, 1993). I was unable to detect the
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redistribution of Rab4 from the LDM fraction in this study. The fact that Rab4 was 
not detected in the cytosolic fraction (data not shown) may be explained by the 
degradation of this protein (despite the presence of proteinase inhibitors) following 
the complete subcellular fractionation of 3T3-L1 adipocytes. Indeed, a rapid and 
simple preparation of only total membranes and cytosol was required in rat 
adipocytes in order to observe the redistribution of Rab4 to the cytosolic 
compartment in response to insulin (Cormont et al., 1993).
As Rab4 is not a transmembrane protein and therefore does not exhibit a lumenal 
domain within the vesicles to which they are associated, endosome ablation was 
analysed by sucrose density gradient analysis (Figure 3,4). Under these conditions, 
GLUT4 exhibited a partial loss of signal, consistent with the partial ablation of this 
protein (Figure 3.5). In contrast, the ablation procedure effectively removed all of 
the immunodetectable Rab4 from the intracellular membrane pool, suggesting that the 
entire cellular complement of this protein resides with the TfR within the recycling 
endosomal system. However, the complete lack of immunoreactivity in the 
immunoblot implies that Rab4 may no longer be associated with the LDM fraction 
possibly as a result of the ablation procedure, as observed for the dissociation of 
Rab4 from this fraction in response to insdlin, as shown in Figure 3.4. However, as 
the ablation procedure did not appear to effect the association of Rab5 with 
intracellular membranes (Livingstone et a l, 1996), it is surprising that the same 
procedure would have an adverse effect on the association Rab4 with membranes. 
Unfortunately, as I was unable to detect Rab4 in the cytosolic fraction both after 
ablation or insulin treatment, we cannot confirm whether this is indeed the case (see 
above). On interpretation of these data at face value, the implication that the co­
localisation of Rab4 and GLUT4 within 3T3-L1 adipocytes occurs within the 
recycling endosomal system is consistent with the notion that Rab4 participates in 
the trafficking of GLUT4 from the recycling endosomal system to the specialised 
storage compartment (Cormont et oL, 1996). However, a role for this small GTP- 
binding protein in insulin-stimulated GLUT4 translocation whilst localised to the
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recycling system is not as clear. Although, if an alternative model of insulin- 
stimulated GLUT4 translocation to the cell surface is considered, where in response 
to insulin GLUT4 from the storage compartment fuses with the endosomal system 
instead of directly with the plasma membrane (Robinson et a i, 1992a), it is possible 
to envisage a possible role for Rab4 in this process. However, from these studies it 
is apparent that an alternative approach is required in order to further our 
understanding of the exact role of Rab4 in terms of GLUT4 intracellular trafficking.
3.5.3 y-adaptin and the CD-M6 PR: Markers for the TGN
As the TGN mediates the sorting of proteins destined for a wide variety of 
intracellular destinations including the endosomal system and the regulated secretory 
pathway, I wished to determine whether GLUT4 traffics through this compartment. 
Sorting of membrane proteins at the TGN involves the recruitment of cytosolic 
adaptors including AP-I and AP-3 onto the membrane (refer to Section 1.4.3). The 
localisation of GLUT4 with clathrin-coated pits at the plasma membrane (Slot et a l, 
1991b), suggests that the internalisation and / or intracellular targeting of the 
transporter may be mediated via interaction of the adaptor complex AP-2, associated 
with these pits. Similarily, sorting of GLUT4 at the TGN may be mediated by the 
clathrin-associated AP-1 complex. As y-adaptin is a component of the AP-1 
complex, we examined the extent of co-localisation between this protein and GLUT4 
in 3T3-L1 adipocytes. Analysis of the subcellular distribution of y-adaptin showed 
the majority of this protein to be localised to the intracellular (LDM) membranes 
(Figure 3.1), consistent with this fraction being enriched in the TGN. In contrast to 
GLUT4, y-adaptin did not exhibit any significant redistribution in response to 
insulin. However, insulin-stimulated clathrin-coated budding from the TGN cannot 
be ruled out as many nascent secretory granules in the TGN are clathrin-coated, but 
shed their coat prior to exocytosis (Austin et a i, 1996).
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Endosome ablation did not result in a significant loss of y-adaptin immunoreactivity 
under conditions where quantitative ablation of the TfR from intracellular (LDM) 
membranes was observed (Figure 3.2). Similarily, no significant increase in the 
density of the intracellular membranes with which y-adaptin is associated was 
observed following ablation (Figure 3.3). These data provide further evidence for the 
relatively low levels of y-adaptin present in the recycling endosomal system. 
Analysis of GLUT4 vesicles immunoadsorbed both before and after ablation showed 
a significant level of co-localisation between these two proteins (Figures 3.7), 
suggesting that the majority'of the y-adaptin detected in the GLUT4 vesicles resides 
in the non-ablatable GLUT4 compartment. Furthermore, the co-localisation of 
GLUT4 with a component of AP-1 coated vesicles, suggests that GLUT4 is present 
within the TGN region of 3T3-L1 adipocytes.
Newly synthesised lysosomal enzymes are transported from the TGN to the 
prelysosome by a mannose 6 -phosphate dependent pathway (Klumperman et a l, 
1993). Most mammalian cells contain two distinct M6 PRs: the cation-independent 
M6 PR (CLM6 PR, also known as the insulin-like growth factor II receptor ) of ~ 
300kD and the cation-dependent M6 PR (CD-M6 PR), a homodimer of 46kD, both of 
which traffic from the TGN in AP-1 coated vesicles en route to the endosomes 
(Klumperman et a i, 1993). Although both the CI-M6 PR and the CD-M6PR co- 
localise, a difference in distribution has been observed, probably due to functional 
differences between the two receptors (Klumperman et a i, 1993). The CI-M6 PR is 
predominantly localised to early endosomes and to prelysosomal compartments 
(Klumperman et a i, 1993), consistent with the delivery of exogenous lysosomal 
enzymes to lysosomes via the endocytic pathway. In contrast, the requirement for 
the CD-M6 PR to deliver ligands to both the lysosomes and the extracellular 
environment has localised this receptor predominantly to the TGN and 
tubulovesicular elements associated with the early endosomes (Klumperman et a i, 
1993).
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Previous studies have observed complete ablation of the CI-M6 PR under conditions 
which resulted in only a ~ 40% ablation of GLUT4 (Livingstone et a l, 1996), 
suggesting that the pre-lysosomal compartments are unlikely to be the site of 
GLUT4 sequestration. In this study, we have examined the extent of co-localisation 
of the CD-M6PR with GLUT4 in 3T3-L1 adipocytes. The subcellular distribution 
of the CD-M6 PR was found to be similar to that of GLUT4, as both proteins were 
localised to the intracellular (LDM) membranes and redistributed to the plasma 
membrane in response to insulin (Figure 3.1). However, the extent of this 
translocation to the plasma membrane was notably smaller in the case of the CD- 
M6 PR. Under conditions in which ~ 38% of GLUT4 was ablated, a small 
proportion (~ 35%) of the CD-M6 PR was also lost from the intracellular (LDM) 
membranes (Figure 3.2), suggesting that smaller pools of both of these proteins reside 
with the TfR in the recycling endosomal system. Vesicle immunoadsorption analysis 
showed that there was some degree of overlap between the two proteins after 
ablation, indicating that the CD-M6PR does co-Iocalise to some extent with GLUT4 
in the non-ablatable GLUT4 compartment (Figure 3.6). However, a significant 
proportion of the CD-M6PR remained in the depleted LDM fraction under 
conditions where the GLUT4 immunoreactivity was completely removed. 
Collectively, these data suggest that the CD-M6 PR is localised in part to both the 
recycling endosomal system and the non-ablatable GLUT4 pool, but that these two 
fractions do not constitute the total cellular complement of this protein, Futhermore, 
the localisation of the CD-M6 PR in the GLUT4 non-ablatable pool provides further 
evidence for the localisation of GLUT4 in the TGN region of 3T3-L1 adipocytes.
To determine whether the co-localisation observed between GLUT4 and y-adaptin or 
the CD-M6 PR was indeed within the TGN, I further examined the co-localisation 
and intracellular distribution of the three proteins by immunofluorescence 
microscopy and immuno-electron microscopy in collaboration with S. Martin and T. 
Meerloo (University of Queensland, Australia). Immuno-electron microscopy 
analysis of double-labelled intracellular vesicles of basal 3T3-L1 adipocytes revealed
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a significant overlap between GLUT4 and the CD-M6 PR (-70%), consistent with 
the co-localisation of these two proteins both within the recycing endosomal system 
and the GLUT4 non-ablatable compartment (Table 3.1). A high percentage (-90%) 
of the Y-adaptin labelled vesicles were also found to co-label for GLUT4, confirming 
the co-localisation of these two proteins in 3T3-L1 adipocytes (Table 3.1, Figure 
3.9). Upon analysis of 3T3-L1 adipocyte cryosections by immuno-electron 
microscopy, all three of the proteins were found to be localised in tubulovesicular 
elements associated with the TGN. Furthermore, double-labelling of these sections 
revealed that both the CD-M6PR and y-adaptin co-localised with GLUT4 within 
this region, consistent with the partial overlap of GLUT4 with the CD-M6 PR 
(Figure 3.8 A) and y-adaptin (Figure 3.8B) in the perinuclear region of 3T3-L1 
adipocytes observed by double-labelled immunofluorescence.
Together these data confirm that the co-localisation of GLUT4 with the CD-M6 PR 
and y-adaptin within the GLUT4 non-ablatable compartment is within the region of 
the TGN in 3T3-L1 adipocytes. The localisation of GLUT4 to AP-1 positive 
vesicles is consistent with the partial overlap of GLUT4 with y-adaptin in 
perinuclear structures in rat adipocytes (Malide et a l, 1997a). However, as these 
vesicles are also enriched in CD-M6 PR which does not appear to translocate to the 
cell surface in response to insulin to the same extent as GLUT4, it is unlikely that 
these vesicles bud directly from the TGN forming the insulin-responsive storage 
compartment. Indeed, co-localisation with the CD-M6 PR suggests that the vesicles 
fuse with the endosomal system. Thus, we propose that GLUT4 traffics through 
the TGN in AP-1 positive vesicles, and suggest that along with the CD-M6PR, 
GLUT4 recycles back to the endosomal system where GLUT4 may be sorted into 
the specialised storage compartment.
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3.6 Summary
By comparing the distribution and susceptibility to endosome ablation of GLUT4 
and several other marker proteins, I have shown that a small pool of GLUT4 resides 
within the recycling endosomal system, consistent with the partial ablation of this 
transporter compared to the quantitative ablation of the TfR and SCAMPs, known 
markers for cell surface to endosome recycling. Within the larger non-ablatable pool, 
GLUT4 was found to co-localise with syntaxin 4, the CD-M6 PR and y-adaptin. 
These data confirm that the well-characterised recycling endosomal system plays a 
fundamental role in the constituive recycling of GLUT4. The co-localisation of 
GLUT4 with the CD-M6 PR and y-adaptin is consistent with the non-ablatable 
GLUT4 compartment deriving, at least in part, from the TGN. Moreover, this adds 
further support to the notion that GLUT4 traffics through the TGN as part of its 
recycling itinerary. The observation that a small proportion of syntaxin 4 co- 
localises with GLUT4 in an intracellular compartment suggests that this t-SNARE 
may be involved in intracellular protein sorting, but this point will require further 
characterisation. In short, these data add further support to the notion that a 
significant proportion of the intracellular GLUT4 resides in a specialised post- 
endocytic storage compartment. Regardless of the identity of the pools identified by 
endosome ablation, this appproach offers a powerful tool with which to resolve the 
intracellular segregation of GLUT4. In the following chapter I will consider how 
GLUT4 traffics from the GLUT4/VAMP2-positive non-ablatable compartment to 
the cell surface in response to insulin.
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Chapter 4
Compartment Ablation Analysis 
of Insulin-and GTPvS-Stimulated 
GLUT4 Translocation 
from Multiple Intracellular Compartments
153
4.1 Aims
1. To examine the effect of endosomal ablation on protein trafficking through
the recycling endosomal system.
2. To examine the effect of endosomal ablation on insulin- and GTPyS-
stimulated GLUT4 and GLUTl translocation.
3. To examine the effect of wortmannin on insulin-stimulated GLUT4
translocation following ablation of the endosomal system.
4. To examine the effect of endosomal ablation on constitutive secretion in 3T3-
L1 adipocytes.
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4.2 Introduction
Insulin stimulates the uptake of glucose in adipose cells by inducing the 
redistribution of GLUT4 from an intracellular site to the plasma membrane. Recent 
studies have shown that GLUT4 resides within at least two intracellular 
compartments, one of which is endosomal, marked by the presence of endosomal 
recycling proteins such as the TfR and SCAMPs (refer to Section 3.5.1), and the 
other a post-endocytic storage compartment (Livingstone et a i, 1996; Martin et al., 
1996; Malide et a i, 1997a).' However, the exact mechanism of insulin-stimulated 
translocation from these intracellular compartments to the cell surface remains poorly 
understood.
Two models have been used to describe possible mechanisms for the insulin- 
stimulated translocation of GLUT4 to the cell surface (reviewed in Rea et ai, 1997). 
In the first model, the insulin-responsive storage compartment is thought to be 
sequestered within a topologically continuous subdomain of the endosomal system. 
Upon trafficking through the recycling system, interaction with various retention 
factors withdraws GLUT4 into this endosomal subdomain. Insulin stimulation is 
predicted to disrupt the interaction between GLUT4 and the retention factors, 
allowing the transporter to re-enter the constitutive recycling pathway and gain 
access to the cell surface. In this model, no specialised trafficking machinery is 
required for GLUT4 translocation as this function would presumably be fulfilled by 
the constitutive machinery utilised by the endosomal system.
The second model suggests that GLUT4 is sorted and removed from the endosomal 
system into a specialised secretory compartment, from which GLUT4 may 
translocate to the cell surface in response to insulin, independently of the recycling 
system. An important feature of this model is that a possible site of insulin action is 
the machinery that mediates the targeting and the docking/fusion of the GLUT4- 
containing vesicles with the plasma membrane.
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The mechanism of insulin-stimulated GLUT4 translocation described by the second 
model is similar in many ways to the regulated exocytosis of synaptic secretory 
vesicles (SSVs) in neurons (refer to Section 1.13). In this regard, two independent 
studies have recently shown that VAMP2, a v-SNARE that targets SSVs to the pre- 
synaptic plasma membrane (refer to Section 1.5), co-localises with GLUT4 in the 
post-endocytic storage compartment (Martin et a i, 1996; Malide et a l, 1997a). In 
addition, syntaxin 4 and SNAP-23, homologues of neuronal VAMP2-binding 
proteins (t-SNAREs), have recently been identified in adipocyte plasma membranes 
(refer to Section 1.13) (Tellam et a l, 1997; Araki et a l, 1997). Furthermore, 
inhibition of the insulin-stimulated translocation of GLUT4 by VAMP2 peptides 
(Macaulay et a l, 1997) as well as syntaxin 4 fusion proteins (Olson et a l, 1997) in 
permeabilised or microinjected adipocytes, suggests that both of these proteins play 
an essential role in insulin-stimulated GLUT4 trafficking. Together these findings 
strongly support the regulated exocytosis model of GLUT4 trafficking, and further 
suggest that GLUT4 may be stored in intracellular vesicles that resemble SSVs.
Insulin-sensitive cells also express two other v-SNAREs, VAMPl and cellubrevin, 
the latter of which is abundantly expressed in adipocytes (Volchuk et a l, 1995) 
(refer to Section 1.13). Similarily to VAMP2, cellubrevin translocates to the cell 
surface in response to insulin (Volchuk et a l, 1995) and binds to syntaxin 4 with 
reasonable affinity (Tellam et a l,  1997). However, in contrast to VAMP2, 
cellubrevin resides predominantly within the endosomal system (Martin et a l, 1996) 
(refer to Section 1.13). The differential distribution of these two v-SNAREs and 
their ability to interact with the t-SNARE syntaxin 4, further suggests that 
endosomes and GLUT4 vesicles derived from the post-endocytic compartment can 
independently dock and fuse with the cell surface.
In addition to insulin, various other stimuli can induce GLUT4 translocation to the 
cell surface. For example, the introduction of non-hydrolysable GTP analogs such as 
GTPyS markedly stimulates GLUT4 translocation in permeabilised 3T3-L1
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adipocytes (Baldini et a i, 1991; Robinson et a l, 1992c; Clarke et a l, 1994). 
However, as the trafficking machinery involved in GTPyS-stimulated trafficking is 
still to be elucidated it is unclear whether GTPyS stimulates GLUT4 translocation 
through common and/or distinct trafficking pathways to that of insulin.
In the present study, I have used endosomal ablation to examine the translocation of 
GLUT4 from the endosomal and non-ablatable post-endocytic compartments to the 
cell surface in response to insulin and GTPyS. I have shown that ablation of the 
recycling endosomal systerri using Tf-HRP significantly inhibits GTPyS-stimulated 
GLUT4 and GLUTl translocation. In contrast, insulin still elicits the translocation 
of GLUT4 to the cell surface after the ablation of the recycling pathway. However, 
insulin-stimulated GLUTl translocation was blocked under the same conditions. I 
further show that insulin-stimulated GLUT4 translocation from the post-endocytic 
compartment is inhibited by wortmannin, suggesting a role for PI 3-kinase in 
trafficking from this post-endocytic compartment. On the basis of these and other 
data, I propose that GTPyS and insulin stimulate the exocytosis of GLUT4 from 
two distinct compartments, one being endosomal containing GLUTl and the other 
being a separate post-endocytic GLUT4 compartment.
4.3 Materials and Methods
4.3.1 Transferrin Receptor Externalisation Assay
The rate of externalisation of the TfR was measured as described by Tanner and 
Lienhard (Tanner e/a/., 1987).
Duplicate wells of 3T3-L1 adipocytes cultured on a 6 -well plate were incubated in 
serum-free DMEM containing 1 mg/ml BSA for 2 h at 37°C. During the last hour of 
the incubation, 3nM ['^^I] transferrin was added directly to the media, together with 
Tf-HRP at a final concentration of 20pg/ml. After the cells were transferred onto ice,
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cell surface attached transferrin and Tf-HRP was removed by acid washing
with ice-cold isotonic citrate buffer (l50mM NaCl, 20mM Tri-sodium citrate, pH 
5.0) over a period of 10 min with three changes of buffer and then the monolayer was 
washed once with ice-cold PBS (see Section 2.2.1). 1.9ml of PBS and lOOjil of 3,3'- 
diaminobenzidine (DAB) (2mg/ml stock prepared freshly in PBS, vortexed 
thoroughly and filtered through a 0 .2 2  pm-pore-size-filter) were added to each well, 
and H2O2 (0.02%) was added to one of each pair of wells. After a 60 min incubation 
at 4°C in the dark, the reaction was stopped by washing in PBS containing I mg/ml 
BSA. The cells were washed once with KRP buffer (see Section 2.2.2) at 37°C 
containing 1 mg/ml BSA, and then incubated in 1ml of KRP buffer containing 
unlabelled transferrin (IfxM) ± insulin (IpM) at 37°C for the times shown. After 
this incubation, cells were rapidly washed three times with ice-cold PBS, and 1ml of 
IM NaOH was added to each well. Cells were triturated, and the radioactivity 
associated with the cells was determined by y counting. As a measure of non­
specific binding, duplicate sets of plates were incubated with transferrin in the 
presence of lOpM unlabelled transferrin and treated exactly as described above. The 
radioactivity associated with cells under these conditions was regarded as non­
specific association, and this value was subtracted from measurements of cell- 
associated counts from all other conditions.
4.3.2 Cell-Surface Transferrin Receptor Internalisation Assay
An adaptation of the above method was employed to determine whether 
internalisation of the TfR is observed following the ablation of the endosomal 
system. As before, duplicate wells of 3T3-L1 adipocytes cultured on a 6 -well plate 
were incubated in serum-free DMEM containing 1 mg/ml BSA for 2 h at 37°C. For 
the last hour of this incubation the cells were loaded with Tf-HRP only and ablation 
was carried out as described above. The cells were washed once with KRP buffer at 
37°C, and then incubated in 1ml of 3nM transferrin in KRP containing 1 mg/ml 
BSA at 37°C for the times shown. At the desired time, the cells were transferred
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onto ice and subsequently washed three times with ice-cold isotonic citrate buffer 
(see above) and then the monolayer was washed once with ice-cold PBS. Following 
the addition of 1ml of IM NaOH cell-associated radioactivity was measured as 
described above. Again, non-specific binding was measured by setting up duplicate 
sets of plates to which excess (lOp-M) unlabelled transferrin was added in addition to 
the radio-labelled transferrin.
4.3.3 Cell-Surface Transferrin Receptor Externalisation Assay
A further adaptation of the assay was employed to determine whether constitutive 
recycling of the TfR is observed following endosome ablation. Duplicate wells of 
3T3-L1 adipocytes cultured on a 6 -well plate were incubated in serum-free DMEM 
containing 1 mg/ml BSA for 2 h at 37°C. For the last hour of this incubation the cells 
were loaded with Tf-HRP only and ablation was carried out as described above. The 
cells were then washed once with KRP buffer at 37°C, and incubated in 1ml of 3nM 
transferrin in KRP buffer containing 1 mg/ml BSA at 37°C for 20 min. This 
time was previously shown to allow internalisation of transferrin (see Figure 
4.8). Following washes with ice-cold citrate buffer and PBS as described above, the 
cells were washed once with KRP buffer containing 1 mg/ml BSA and then the cells 
were incubated in 1ml of KRP containing unlabelled transferrin (IpM) at 37°C for 
the times shown. After this incubation, cells were rapidly washed three times with 
ice-cold PBS, 1ml of IM NaOH was added to each plate and cell-associated 
radioactivity was measured as described above. Non-specific binding was measured 
as before.
4.3.4 Plasma Membrane Lawn Assay
During a 2 h incubation in serum-free DMEM, 3T3-L1 adipocytes cultured on 
collagen-coated coverslips were incubated with Tf-HRP conjugate (20p.g/ml final 
concentration) for 60 min at 37°C. Endosomal ablation was carried out as described
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in Section 2.9.2. Following the 1 h incubation at 4°C in the dark, the reaction was 
stopped by washing the monolayer with ice-cold PBS (see Section 2.2.1). The cells 
were washed with KRP buffer (see Section 2.2.2) at 37°C and then incubated in 1ml 
of KRP buffer containing I mg/ml BSA ± insulin (IpM) for the times shown. At the 
desired time, the cells were rapidly washed with ice-cold buffer A (see Section 
2.12.1) and plasma membrane lawns were prepared as described in Section 2.12.1.
Coverslips were viewed using a 40X objective lens on a Zeiss Axiovert microscope 
operated in a Laser Scanning'Confocal mode. Samples were illuminated at 488nm and 
the signal at 5 lOnm collected. For each condition, five to ten representative fields 
were collected using a constant set of parameters (contrast, brightness, laser intensity 
and pin-hole size) from triplicate coverslips at each experimental condition, and the 
data analysed for fluorescent intensity using MetaMorph software (Universal 
Imaging). Data was quantified and presented as mean ± s.e.m.
4,3.5 Permeabilisation of 3T3-L1 Adipocytes
a-toxin permeabilisation of 3T3-L1 adipocytes was carried out as described by 
Herbst et al (Herbst et a i, 1995). a-toxin is a 34kDa protein that inserts into the 
plasma membrane and then oligomerizes to form a 3nm diameter aqueous pore that 
allows the passage of molecules of ~ 5kDa or less (Fussle et a l, 1981). 3T3-L1 
adipocytes were cultured on collagen-coated coverslips and incubated in serum-free 
DMEM for 2h prior to use. During the last hour of the incubation, Tf-HRP was 
added to the media at a final concentration of 20pg/ml. Following endosomal ablation 
as described in Section 2.9.2, the cells were washed three times in IC buffer (lOmM 
NaCl, 20mM HEPES, 50mM KCl, 2mM K2HPO4, 90mM potassium glutamate, 
ImM MgCU, 4mM EGTA, 2 mM CaCU, pH7.2) at 37°C and then incubated in 
0.5ml ICR buffer (IC buffer plus 4mM MgATP, 3mM sodium pyruvate, lOOpg/ml 
bovine serum albumin, pH 7.4) containing a-toxin at 250 haemolytic units/ml 
(Calbiochem material, approximately 8pg/ml) for 5 min to permeabilise the plasma
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membrane. The medium containing a-toxin was removed and the cells were 
incubated in 0.5ml of ICR buffer containing GTPyS (200jaM), insulin (IjiM) or 
buffer alone for 15 min at 37°C. The reaction was terminated by washing the cells 
rapidly in ice-cold buffer A (see Section 2.12.1) and plasma membrane lawns were 
prepared as described in Section 2.12.1. Coverslips were viewed and the data 
analysed and quantified as described above.
4.3.6 Adipsin Release:
Endosome Ablation
3T3-L1 adipocytes were cultured on 10cm plates and incubated in serum-free
DMEM for 2 h at 37°C prior to use. For the last 60 min of the incubation Tf-HRP
(20|Lig/ml final concentration) was added, and experimental plates were ablated by the 
addition of H2O2 as described in Section 2.9.2. Following incubation at 4°C for 60 
min in the dark, the cells were washed extensively with PBS (see Section 2.2.1), 
washed a further two times with KRP buffer (see Section 2.2.2) at 37°C and adipsin 
release was measured as described in Section 2.14.
Wortmannin Treatment
3T3-L1 adipocytes were cultured on 10cm plates and incubated in serum-free
DMEM for 2 h prior to use. For the last 30 min of the incubation, wortmannin
(lOOnM) was added to experimental plates only. After the incubation, cells were 
washed twice with KRP buffer at 37°C and adipsin release was measured as 
described in Section 2.14.
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4.3.7 Antibodies
The anti-GLUT4 antibody used for plasma membrane lawn assays was a rabbit 
polyclonal against a peptide comprising the C-terminal 14 amino acid residues of the 
human isoform of GLUT4 (see Section 2.4).
4.3.8 Statistical Analysis
Statistical analysis was performed using Statview 4.0 on a Mac Power PC.
4.4 Results
4.4.1 Effect of Endosomal Ablation on Transferrin Receptor Trafficking in 
3T3-L1 Adipocytes
In the previous study,le used endosomal ablation analysis to resolve at least two 
intracellular pools of GLUT4 in 3T3-L1 adipocytes (refer to Section 3.2). Briefly, 
this technique relies on the ability of Tf-HRP to bind to TfRs on the cell surface and 
to traffic throughout the reycling endosomal pathway. The HRP enzyme activity 
can then be used to cross-link the proteins resident within the recycling system in the 
presence of 3,3'-diaminobenzidine and H2O2 . By initiating the enzymatic activity of 
HRP within the living cell, it is possible to achieve compartment-specific ablation of 
proteins that co-localise with the conjugate within the recycling endosomal system.
As a first step to determine the effect of endosomal ablation on protein trafficking, I 
examined the recycling of TfRs as a marker of the constitutive recycling pathway. 
Cells were loaded with radiolabelled transfen in and Tf-HRP for 60 min at 37°C to fill 
the endosomal recycling pathway, after which endosomes were ablated as described 
in Section 4.3.1. Following ablation (DAB ± H2O2), cells were rapidly washed at 
37°C, and the amount of cell-associated radiolabelled transferrin was followed over
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time as a measure of transferrin recycling both in the absence and presence of insulin. 
As shown in Figure 4.1, there was a rapid loss of radiolabelled transferrin from cells 
that had been incubated with Tf-HRP and DAB in the absence of H2O2 , indicating 
that the recycling pathway was still intact under these conditions. However, 
following the ablation of the endosomal system by the addition of H2O2, there was 
no reduction in cell-associated radiolabelled transferrin, indicating that the endosomal 
recycling pathway had been effectively disrupted (Figure 4.1).
4.4.2 Effect of Endosomal Ablation on Insulin-Stimulated GLUT4 and GLUTl 
Translocation
I next wished to determine whether insulin was still capable of stimulating GLUT4 
translocation to the cell surface in adipoeytes following ablation of the endosomal 
system. In these experiments, duplicate sets of cells cultured on coverslips were 
exposed to Tf-HRP and DAB, but H2O2 was added to only one of each pair. 
Following ablation (DAB ± H2O2), cells were rapidly washed and incubated with or 
without insulin (IpM) at 37°C for the times indicated. Cell surface levels of GLUT4 
were determined by immunofluorescence of plasma membrane lawns as described in 
Section 4.3.4. The results of a typical experiment are presented in Figure 4.2A. In 
the absence of insulin, cell surface levels of GLUT4 were very low both in ablated 
and non-ablated cells. Insulin-stimulated the time-dependent movement of GLUT4 
to the plasma membrane even after ablation of the recycling system. However, the 
extent of translocation to the plasma membrane was reduced by - 2 0 % in ablated 
cells, possibly due to the loss of endosomal GLUT4 (Figure 4.2B). It should also be 
noted that the time course of this translocation was slower than that observed in non­
ablated cells.
Insulin also stimulates the translocation of other recycling proteins to the cell surface 
in adipocytes including GLUTl. However, in contrast to GLUT4, endosomal 
ablation analysis has previously shown GLUTl to reside predominantly in the
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recycling endosomal system (Livingstone et ai, 1996). Therefore, to provide further 
evidence that insulin stimulates the exocytosis of two distinct intracellular 
compartments I examined the effect of endosomal ablation on the insulin-stimulated 
recruitment of GLUTl to the plasma membrane. If endosomal ablation disrupts 
trafficking through the recycling endosomal system, then in contrast to what we have 
observed for GLUT4 (Figure 4.2), insulin-stimulated recruitment of GLUTl to the 
plasma membrane should be effectively inhibited. As shown in Figure 4.3, even after 
20  min of incubation with insulin, there was no change in the cell surface levels of 
GLUTl, whereas there was à marked increase in cell surface levels of GLUT4 under 
the same conditions.
4.4.3 Effect of Endosomal Ablation on GTPyS-Stimulated GLUT4 and GLUTl 
Translocation
It has previously been shown that non-hydrolysable GTP analogs such as GTPyS 
markedly stimulate the translocation of GLUT4 to the cell surface in 3T3-L1 
adipocytes (Baldini et a i, 1991; Robinson et a i, 1992c). However, it has been 
suggested that the mode of action of GTPyS may differ from that observed with 
insulin (Shibata et a l, 1996). With this in mind, I therefore set out to determine 
whether GTPyS could also stimulate GLUT4 translocation after ablation of the 
endosomal system. I examined, by immunofluorescence of PM lawns, the effect of 
GTPyS on GLUT4 translocation in a-toxin permeabilised 3T3-L1 adipocytes 
following endosomal ablation, and compared these effects to those induced by 
insulin. Parallel experiments were performed in which cells had been ablated prior to 
permeabilisation and then treated with GTPyS or insulin as described in Section 
4.3.5. As shown in Figure 4.4, the fold increase in GLUT4 cell surface levels induced 
by GTPyS was -50% of that induced by insulin. Upon ablation of the endosomal 
system, insulin was still capable of inducing GLUT4 translocation. In contrast, 
GTPyS stimulated GLUT4 translocation was completely inhibited, suggesting that
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GTPyS stimulates the translocation of GLUT4 primarily from the endosomal 
compartment.
I also examined the ability of GTPyS to stimulate the translocation of an endosomal 
protein, GLUT 1. The observation that GTPyS-stimulated GLUTl translocation 
was also blocked following endosomal ablation indicates that GTPyS-stimulates 
trafficking through the recycling endosomal system (Figure 4.5), consistent with the 
above data.
4.4.4 Effect of Wortmannin on Insulin- and GTPyS-Stimulated GLUT4 
Translocation
It is well documented that PI 3-kinase activity is necessary to stimulate glucose 
transport activity and GLUT4 translocation to the cell surface (refer to Section 1.14). 
However, it has not been clearly established whether the effects of wortmannin, a 
potent inhibitor of PI 3-kinase activity, are specific for GLUT4 trafficking or apply 
to protein trafficking through the recycling system in general (refer to Section 1.6 ). 
In an effort to address this issue, I examined the role of PI 3-kinase in insulin- 
stimulated GLUT4 trans location after ablation of the endosomal system. 3T3-L1 
adipocytes (± ablation) were treated with the selective PI 3-kinase inhibitor 
wortmannin (lOOnM) for 15 min prior to insulin stimulation. Insulin stimulated a 
large increase in the trans location of GLUT4 to the cell surface, which was 
completely inhibited by wortmannin in both non-ablated and ablated cells (Figure 
4.6). These data indicate that the translocation of GLUT4 from the non-ablatable 
compartment to the cell surface is PI 3-kinase dependent.
As PI 3-kinase activity is thought to be involved in trafficking through the endosomal 
system I also examined the effect of wortmannin on GTPyS stimulated GLUT4 
translocation. Under the same conditions where insulin-stimulated GLUT4 
translocation was completely inhibited (Figure 4.7), pretreatment with wortmannin
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was without effect on GTPyS-stimulated GLUT4 translocation, suggesting that the 
site of action of GTPyS lies downstream of PI 3-kinase.
4.4.5 Effect of Endosomal Ablation on Cell-Surface Transferrin Receptors
Although insulin is still capable of eliciting a significant increase in cell surface levels 
of GLUT4, there is however, a notable delay in the insulin-stimulated arrival of 
GLUT4 under these conditions (Figure 4.2). If we hypothesize that GLUT4 
translocates from the non-ablatable compartment directly to the cell surface 
independently of the recycling system, the delay observed may be explained if 
insulin stimulates GLUT4 movement from the endosomal system to the plasma 
membrane more rapidly than the exocytosis of GLUT4 vesicles from the post- 
endocytic compartment (refer to Section 4.2). Therefore, in ablated cells the 
significant reduction of insulin-stimulated GLUT4 translocation at early times may 
be accounted for by loss of endosomal GLUT4. However, it is also possible that 
GLUT4 derived from the non-ablatable compartment may join the endosomal 
pathway prior to its arrival to the cell surface and this pathway is blocked 
immediately after ablation but not at later times when endosomes have had the 
chance to reform.
In order to address this issue, I set out to determine whether we could observe the de 
novo formation of endosomes following endosomal ablation. I therefore performed 
an experiment to determine whether TfRs present at the cell surface, which are not 
destroyed by the ablation procedure, are internalised following ablation of the 
endosomal system. After ablation (± H2O2), cells were warmed to 37°C and the 
internalisation of radiolabelled transferrin was followed as a function of time. As 
shown in Figure 4.8, radiolabelled transferrin was internalised in ablated cells with 
indistinguishable kinetics from that observed in non-ablated cells.
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To ensure that the TfR was internalised into a functional endosomal system, I carried 
out a further experiment to determine whether the radiolabelled transferrin could be 
re-externalised, thus indicating the re-formation of a recycling system. In this 
experiment, following the internalisation of radiolabelled transferrin, cell-surface 
bound transferrin was removed by acid washing. On re-warming the cells to 37°C, 
the externalisation of radiolabelled transferrin was measured as a function of time 
(Figure 4.9). There was no significant difference between the rate of externalisation 
of radiolabelled transferrin from non-ablated cells compared to ablated cells. Taken 
together these data show that following ablation of the endosomal system, cell 
surface TfRs are capable of recycling, indicating that a functional endosomal system 
has reformed.
4.4.6 Effect of Endosomal Ablation and Wortmannin on Constitutive Secretion 
in 3T3-L1 Adipocytes
As well as inducing the translocation GLUT4, insulin also stimulates the secretion of 
adipsin, a serine protease, from adipocytes in culture (Kitagawa et a l, 1989). To 
determine whether these two processes share a common pathway, I examined the 
effect of endosomal ablation on the constitutive (basal) and insulin-stimulated release 
of adipsin. Following ablation as described in Section 2.9.2, cells were warmed to 
37°C and adipsin release was assayed as a function of time. Figure 4.10 represents 
the results obtained at 5 and 10 min after exposure to insulin. In agreement with 
previous studies, insulin caused a modest stimulation of adipsin secretion (Kitagawa 
et a l, 1989). In both basal and insulin-stimulated cells, adipsin secretion was 
significantly attenuated by ablation of the endosomal system, suggesting that the vast 
majority of this soluble protein traffics through the endosomal system en route to the 
cell surface.
Consistent with the notion that PI 3-kinase plays a role in trafficking through the 
endosomal system, prior treatment of 3T3-L1 adipocytes with wortmannin
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inhibited the secretion of adipsin in both basal and insulin-stimulated 3T3-L1 
adipocytes (Figure 4.11), providing further evidence for the trafficking of this soluble 
protein through the endosomal system.
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Figure 4.1
Effect of Endosomal Ablation on Transferrin Receptor Exocytosis
3T3-LI adipocytes were incubated with 3nM [*25i] transferrin together with Tf- 
HRP at 20pg/ml. Subsequently, cell surface attached Tf/Tf-HRP was removed, and 
DAB with (ablated) or without (control) H2O2 was added. Cells were incubated at 
4°C in the dark for 60 min to complete the ablation reaction. Thereafter, the cells 
were rapidly washed and incubated at 37°C and cell-associated radioactivity was 
measured at the times shown allowing the rate of radioactive transferrin release to be 
determined. Data from a representative experiment are shown. Each point is the 
mean of three determinations at each time point (± s.e.m).
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Figure 4.2
Effect of Endosomal Ablation on Insulin-Stimulated GLUT4 Translocation
Duplicate coverslips of 3T3-L1 adipocytes were loaded with Tf-HRP and incubated 
with DAB with (ablated) or without (control) H2O2 as described in Materials and 
Methods. After completion of the DAB cytochemistry, the cells were rapidly 
washed and incubated with or without insulin (l]iM) for the times shown. At the 
end of this incubation, plasma membrane lawns were prepared and labelled with an 
antibody specific for GLUT4. A, a representative experiment. B, quantitation of 
three similar experiments (mean ± s.e.m).
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Figure 4.3
Effect of Endosomal Ablation on Insulin-Stimulated GLUTl Translocation
Duplicate coverslips of 3T3-L1 adipocytes were loaded with Tf-HRP and incubated 
with DAB with (ablated) or without (control) H2O2 as described in Materials and 
Methods. After completion of the DAB cytochemistry, the cells were rapidly 
washed and incubated with or without insulin (IjiM) for the times shown. At the 
end of this incubation, plasma membrane lawns were prepared and labelled with 
antibodies specific for either GLUTl or GLUT4. Shown is a representative 
experiment, repeated three times with similar results.
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Figure 4,4
Effect of Endosomal Ablation on GTPyS-Stimulated GLUT4 Translocation
Triplicate coverslips of 3T3-L1 adipocytes were loaded with Tf-HRP and incubated 
with DAB ± H2O2 as described in Materials and Methods. After completion of the 
DAB cytochemistry, the cells were rapidly washed and permeabilised with a-toxin 
at 37°C. The cells were then treated for 15 min with buffer alone or buffer containing 
insulin (ipM) or GTPyS (200(iM), Plasma membrane lawns were prepared and the 
extent of GLUT4 translocation relative to the basal value was determined using 
scanning laser confocal immunofluorescence microscopy. Shown are data of a 
representative experiment (n = 2). Data are presented as the mean fold increase 
relative to basal (unstimulated cells) ± s.e.m. (*p<0.05, compared to cells without 
H2O2, ** p<0.05 compared to cells treated with insulin).
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Figure 4.5
Effect of Endosomal Ablation on GTPyS-Stimulated GLUTl Translocation
Triplicate coverslips of 3T3-LI adipocytes were loaded with Tf-HRP and incubated 
with DAB ± H2O2 as described in Materials and Methods. After completion of the 
DAB cytochemistry, the cells were rapidly washed and permeabilised with a-toxin 
at 37°C. The cells were then treated for 15 min with buffer alone or buffer containing 
insulin (IftM) or GTPyS (200juM). Plasma membrane lawns were prepared and the 
extent of GLUTl translocation relative to the basal value was determined using 
scanning laser confocal immunofluorescence microscopy. Shown are data of a 
representative experiment (n = 2). Data are presented as the mean fold increase 
relative to basal (non-stimulated) cells ± s.e.m.
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Figure 4.6
Effect of Wortmannin on Insulin-Stimulated GLUT4 Translocation
Triplicate coverslips of 3T3-L1 adipocytes were loaded with Tf-HRP and incubated 
with DAB ± H2O2 as described in Materials and Methods. After completion of the 
DAB cytochemistry, the cells were rapidly washed and treated with or without 
wortmannin (lOOnM) at 37°C. After 15 min, the cells were incubated with or 
without insulin (IftM) for a further 15 min. Thereafter, GLUT4 levels at the plasma 
membrane were determined using the plasma membrane lawn assay. Shown is the 
quantitation of three experiments of this type. Data are presented as the mean fold 
increase relative to basal (non-stimulated) cells ± s.e.m.
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Figure 4.7
Effect of Wortmannin on GTPyS-Stimulateci GLUT4 Translocation
Triplicate coverslips of 3T3-L1 adipocytes were loaded with Tf-HRP and incubated 
with DAB ± H2O2 as described in Materials and Methods. After completion of the 
DAB cytochemistry, the cells were rapidly washed and permeabilised with a-toxin 
at 37°C. The cells were then treated for 15 min with buffer alone or buffer containing 
wortmannin (lOOnM) before treatment with insulin (lp,M) or GTPyS (200p,M) for a 
further 15 min. Thereafter, GLUT4 levels at the plasma membrane were determined 
using the plasma membrane lawn assay. Shown are data of a representative 
experiment (n = 2). Data are presented as the mean fold increase relative to basal 
(non-stimulated) cells ± s.e.m.
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Figure 4.8
Effect of Endosomal Ablation on the Internalisation of Cell-Surface
Transferrin Receptors
3T3-L1 adipocytes were loaded with Tf-HRP and incubated with DAB ± H2O2 as 
described in Materials and Methods. After completion of the DAB cytochemistry, 
the cells were rapidly washed and incubated with 3nM transferrin at 37°C for 
the times shown. After the desired time, cell surface attached transferrin was 
removed and cell-associated radioactivity was measured in cells that were incubated 
with (ablated) or without (control) H2O2 . Data from a representative experiment are 
shown (n = 2). Each point is the mean of three determinations at each time point (± 
s.e.m.).
184
Figure 4.8
1
Il2
60 n
5 0 -
40 -
3 0 -
2 0 -
1 0 -
Control
Ablated
10 15
Time (min)
20
“ I
25
Figure 4.9
Effect of Endosomal Ablation on the Recycling of Cell-Surface Transferrin 
Receptors
3T3-L1 adipocytes were loaded with Tf-HRP and incubated with DAB ± H2O2 as 
described in Materials and Methods. After completion of the DAB cytochemistry, 
the cells were rapidly washed and incubated with 3nM [125%] transferrin at 37°C for 
20 min. After the removal of cell surface attached transferrin, the cells were 
incubated at 37°C and cell-associated radioactivity was measured at the times shown 
allowing the rate of radioactive transferrin release to be determined in cells that were 
incubated with (ablated) or without (control) H2O2 . Data from a representative 
experiment are shown (n = 2) . Each point is the mean of three determinations at 
each time point (± s.e.m.).
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Figure 4.10
Effect of Endosomal Ablation on Adipsin Secretion from 3T3-L1 Adipocytes
3T3-L1 adipocytes were loaded with Tf-HRP and incubated with DAB ± H2O2 as 
described. Cells were then rapidly washed and incubated in buffer with or without 
insulin at 37°C. Adipsin secretion was assayed as described in Materials and 
Methods. A, a representative immunoblot of adipsin secretion at 5 and 10 min after 
exposure to insulin. B, quantitation of adipsin secretion. Adipsin secretion is 
expressed in arbitrary units as described in Section 2.14.
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Figure 4.11
Effect of Wortmannin on Adipsin Secretion from 3T3-L1 Adipocytes
3T3-L1 adipocytes cultured on 10cm plates were pre-treated with wortmannin at the 
indicated concentrations for 15 min at 37°C. Thereafter, the cells were treated with 
insulin (IftM) for a further 15 min. Adipsin secretion was assayed and quantified as 
described. Shown is a representative experiment of at least three similar experiments, 
with wortmannin inhibition being expressed as a % of adipsin secretion measured in 
the absence of wortmannin. Note that both basal and insulin-stimulated adipsin 
secretion were wortmannin sensitive, with indistinguishable IC50S. Hence for clarity, 
only the data for insulin-stimulated adipsin secretion is presented.
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4.5 Discussion
The segregation of GLUT4 within two intracellular compartments, one enriched in 
cellubrevin and the other VAMP2, is consistent with a model in which insulin 
stimulates the exocytosis of GLUT4 from a storage compartment to the plasma 
membrane in a manner anal ago us to the exocytosis of SSVs (Rea et al., 1997). To 
examine such a model in 3T3-L1 adipocytes, I used endosomal ablation to determine 
whether insulin-stimulated GLUT4 translocation remains intact following the 
disruption of the recycling endosomal system. In collaboration with D.E. James and 
colleagues (University of Queensland, Australia) this model was further tested by 
examining the effect of recombinant glutathione S-Transferase (GST) fusion proteins 
encompassing the entire cytoplasmic tails of VAMP 1, VAMP2 and cellubrevin and 
N-terminal VAMP2 peptides on insulin-stimulated GLUT4 translocation in 
streptolysin O (SLO) permeabilised 3T3-L1 adipocytes. The results for this study 
are not shown and shall be referred to in this discussion for comparative purposes 
only.
On determining that the ablation procedure effectively disrupted recycling of the TfR 
through the endosomal system (Figure 4.1), I set out to examine whether insulin was 
still capable of stimulating GLUT4 translocation to the cell surface under the same 
conditions. As shown in Figure 4.2, insulin still elicits a significant increase in 
GLUT4 cell-surface levels following disruption of the endosomal system, suggesting 
that the post-endocytic VAMP2-positive pool of GLUT4 translocates directly to 
the plasma membrane, independently of the recycling pathway. In addition, 
endosomal ablation effectively inhibited the translocation of the endosomal protein, 
GLUTl to the cell surface (Figure 4.3). In agreement with these findings, D.E. 
James' group have shown that the introduction of N-terminal VAMP2 peptides into 
SLO-permeabilised 3T3-L1 adipocytes inhibited the insulin-dependent movement of 
GLUT4 by -35% but had no significant effect on insulin-stimulated GLUTl 
translocation (Martin et a i, 1998). In addition, this collaborative study also showed
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that the introduction of a GST-cellubrevin fusion protein under the same conditions 
inhibited GLUTl but not GLUT4 insulin-stimulated translocation (L. Martin and 
D.E. James, personnel communication). Collectively, these data not only provide 
further evidence for the segregation of GLUTl and GLUT4 within distinct 
compartments, but also support the notion that the individual compartments 
independently translocate to the cell surface in response to insulin. On the basis of 
these and previous data, we suggest that one of these compartments is a post- 
endocytic storage compartment for GLUT4 and the other is the constitutive 
recycling endosomal system. The localisation of cellubrevin to the endosomal 
system (Martin et al., 1996) suggests that this v-SNARE regulates the docking and 
fusion of the recycling endosomes with the cell surface, while VAMP2 may be 
involved predominantly in the regulation of GLUT4 exocytosis from the post- 
endocytic compartment. It is important to note that a significant proportion of 
GLUT4 (-35%) resides within the endosomal system (refer to Section 1.10), which 
may explain the lower levels of GLUT4 observed at the cell surface following 
endosomal ablation (Figures 4.2 and 4.4) and the inability of the N-terminal VAMP2 
peptide to completely block GLUT4 trans location (see above).
Although the above data provide strong evidence for the direct translocation of 
GLUT4 from the post-endocytic compartment to the cell surface independently of 
the recycling pathway, I noted that there was a significant delay in the insulin- 
stimulated arrival of GLUT4 at the cell surface following ablation of the endosomal 
system (Figure 4.2). This delay may simply be explained by insulin stimulating 
protein trafficking through the endosomal system more rapidly than the exocytosis 
of GLUT4 from the post-endocytic compartment. Therefore, in ablated cells the 
significant reduction of GLUT4 at early times may be accounted for by the loss of 
endosomal GLUT4. However, on considering an alternative model of insulin- 
stimulated GLUT4 translocation to the cell surface, where in response to insulin 
GLUT4 derived from the storage compartment merges with the endosomal system 
instead of directly with the plasma membrane (refer to Section 4.2), it is possible that
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the delay observed may be a result of the time taken for the re-formation of 
endosomes, following disruption of the recycling system. To try to distinguish 
between these two possibilities, I examined the effect of endosomal ablation on the 
recycling of TfRs localised to the plasma membrane which are not destroyed by the 
ablation procedure. As shown in Figures 4.8 and 4.9, the internalisation and 
subsequent externalisation of radiolabelled transferrin, clearly shows that cell-surface 
TfRs are capable of recycling following the ablation of the endosomal system. 
Therefore, on the basis of endosomal ablation analysis alone I cannot discount the 
possibility that GLUT4 from the post-endocytic compartment may traffic through 
the endosomal system en route to the cell surface. Consistent with this possibility is 
the observation that a small proportion of syntaxin 4 co-localises with GLUT4 in the 
non-ablatable storage compartment in adipocytes (refer to Section 3.5.1), suggesting a 
role for this VAMP2-binding protein at an intracellular location. However, as the 
majority of syntaxin 4 is localised to the plasma membrane in adipocytes, it is most 
likely that the syntaxin 4 peptides and antibodies previously shown to inhibit 
insulin-stimulated GLUT4 translocation (refer to Section 1.13) do so by inhibition of 
vesicle docking and fusion with the plasma membrane.
It is well documented that the non-hydrolysable GTP analogue, GTPyS markedly 
stimulates the translocation of GLUT4 to the cell surface (Clarke et a l, 1994; Herbst 
et a l, 1995; Robinson et a l, 1992c). However, it has been suggested that the mode 
of action of this stimulus may differ from that observed with insulin (Shibata et al,
1996). I therefore reasoned that examining the GTPyS stimulation of GLUT4 
translocation following endosomal ablation might provide further insight by 
identifying common and / or distinct pathways for GLUT4 trafficking. Consistent 
with previous studies (Herbst et a l, 1995), 1 showed both insulin and GTPyS to 
stimulate GLUT4 translocation in a-toxin permeablised 3T3-L1 adipocytes (Figure
4.4). In contrast to insulin, GTPyS-stimulated GLUT4 and GLUTl translocation 
were effectively blocked following ablation of the endosomal system, suggesting that 
GTPyS selectively targets the recycling endosomal pool as opposed to the post-
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endocytic storage compartment. Further support for this idea was provided by the 
observation that the N-terminal VAMP2 peptide previously shown to inhibit 
insulin-stimulated GLUT4 translocation (see above), had no significant effect on 
GTPyS-stimulated GLUT4 translocation (Martin et ai, 1998).
Previous studies have reported contradictory findings regarding the extent of GTPyS- 
stimulated GLUT4 translocation in 3T3-L1 adipocytes. A study by Clarke et al 
found the extent of GTPyS-stimulated GLUT4 translocation to be significantly less 
than that observed for insulin (Clarke et a i, 1994), whereas several other groups 
reported both GTPyS and insulin to stimulate GLUT4 translocation to the same 
extent (Herbst et a i, 1995; Robinson et a l, 1992c). Although the basis of this 
difference is not apparent, our endosomal ablation and VAMP2 peptide studies 
show GTPyS-stimulated GLUT4 translocation to be -50% of that induced by 
insulin. A plausible explanation for this data is that GTPyS stimulates the 
exocytosis of only one of the GLUT4 pools in 3T3-L1 adipocytes, in this case the 
endosomal compartment.
Several biochemical studies have shown that wortmannin, a potent inhibitor of PI 3- 
kinase, blocks the translocation of GLUT4 to the plasma membrane in 3T3-L1 
adipocytes by inhibiting the exocytic movement of GLUT4-containing vesicles 
(Clarke et a i, 1994; Yang et a l, 1996) (refer to Section 1.14). However, it has also 
been reported that wortmannin blocks the insulin-stimulated exocytosis of the CI- 
M6 PR and the TfR in 3T3-L1 adipocytes (Shepherd et a i, 1995a; Shepherd et a l, 
1995b), suggesting a more general role of PI 3-kinase activity for insulin stimulation 
of the steps along the recycling pathway. My data clearly demonstrate that insulin- 
stimulated GLUT4 translocation is completely blocked upon prior treatment of 3T3- 
L1 adipocytes with wortmannin both in ablated and non-ablated cells (Figure 4.6), 
suggesting that the translocation of GLUT4 from the post-endocytic compartment is 
PI 3-kinase dependent. In support of this interpretation, a recent confocal 
microscopy study has shown that upon pre-treatment of intact rat adipose cells with
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wortmannin, the pattern of GLUT4 intracellular staining following insulin treatment 
is indistinguishable to that observed in basal cells not treated with wortmannin 
(Malide et al.  ^ 1997b). The inability of GLUT4 to redistribute within the cell as well 
as to translocate to the cell surface under these conditions further suggests that 
GLUT4 translocation is blocked or markedly delayed at a very early step in the 
forward movement of the vesicles out of the post-endocytic compartment to the 
plasma membrane. In addition, these data argue against the possibility that the 
inhibitory effect of wortmannin observed after endosomal ablation may indeed be a 
general effect on the recycling pathway following the re-formation of the endosomal 
system (see above). It is also important to note that in contrast to the some-what 
modest inhibiton of insulin-stimulated GLUT4 translocation by the VAMP2 peptide 
(-35%), wortmannin completely blocks insulin-stimulated GLUT4 translocation, 
suggesting that PI 3-kinase plays a role in at least two distinct steps in GLUT4 
translocation and recycling. In this regard, my observation that GTPyS-stimulated 
GLUT4 translocation is wortmannin-insensitive (Figure 4.7) suggests that GTPyS 
acts at a step(s) distal to PI 3-kinase, possibly by a direct interaction with vesicle 
trafficking machinery.
It is well documented that insulin induces a 2 to 4 -fold increase in cell surface levels 
of several endosomal proteins including the TfR, the CI-M6 PR and GLUT! (Tanner 
et a i, 1987; Tanner et a i, 1989), indicating that insulin stimulates general recycling 
through the endosomal system. However, the constitutive secretion of the serine 
protease adipsin, has also been reported to be stimulated by insulin in 3T3-L1 
adipocytes (Kitagawa et al., 1989). Hence, I wished to determine whether this 
protein may exhibit a similar mode of translocation to that of GLUT4 in response to 
insulin. In contrast to GLUT4, both basal (constitutive) and insulin-induced adipsin 
release were effectively inhibited following endosomal ablation (Figure 4.10), 
suggesting that the increase in secretion observed in response to insulin was most 
likely a result of the general stimulation of the recycling endosomal system. 
Furthermore, these data also argue against direct trafficking from intracellular
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membranes to the plasma membrane, suggesting that protein transport utilises the 
endosomal system en route to the cell surface in 3T3-LI adipocytes.
In summary, the use of endosomal ablation analysis has enabled me to uncouple 
insulin- and GTPyS-stimulated GLUT4 translocation in 3T3-L1 adipocytes. I have 
shown that insulin is still capable of stimulating GLUT4 translocation following 
endosomal ablation under conditions where GTPyS-stimulated GLUT4 translocation 
was effectively inhibited. In addition, both insulin- and GTPyS-stimulated GLUTl 
translocation were blocked following ablation of the recycling endosomal system. In 
accordance with these results, a collaborative study by D.E. James and co-workers 
showed a requirement for VAMP2 in insulin-stimulated but not GTPyS-stimulated 
trans location (Martin et a i, 1998), The most plausible explanation for these data is 
that insulin stimulates the exocytosis of two distinct intracellular compartments. We 
suggest that one of these is the VAMP2-positive post-endocytic storage 
compartment containing GLUT4 and the other is the constitutive recycling 
endosomal system containing GLUTl which may also be stimulated by GTPyS.
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Chapter 5
Analysis of the Role of ARF Proteins and 
Phospholipase D 
in
Insulin-Stimulated GLUT4 Translocation
199
5.1 Aims
1. To examine the effect of insulin on the subcellular distribution of ARF 
proteins in 3T3-L1 adipocytes.
2. To investigate the role of ARF proteins in insulin-stimulated GLUT4 
translocation and 2 -deoxy-D-glucose transport.
3. To examine the expression of PLD isoforms in 3T3-L1 adipocytes.
4. To investigate the role of PLD in insulin-stimulated GLUT4 translocation 
and 2-deoxy-D-glucose transport.
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5.2 Introduction
ADP-ribosylation factors (ARFs) are ubiqitous small GTPases that play an 
important role in membrane trafficking and secretory processes in eukaryotic cells 
(Boman et a i, 1995). The ARF family consists of 15 structurally related gene 
products that include 6 ARF proteins and 11 ARF-like (ARL) proteins. The ARF 
proteins are divided into 3 classes on the basis of size and amino acid identity. ARFs 
1 to 3 form class I, ARF 4 and 5 form class II and ARF6 forms class III. All the 
ARFs contain a glycine at position 2 that is a site for N-terminal myristoylation 
(reviewed in Donaldson et ai, 1994;Moss et a l, 1995).
Although ARFs are implicated in several intracellular trafficking events including 
endosome fusion (Lenhard et a i, 1992) and endocytosis (D' Souza-Schorey et a l, 
1995), the most extensively studied process is the secretory pathway, mediated at 
least in part, by ARFl (for examples see Chen et a i, 1996; Ktistakis et a i, 1996). 
Like other members of the Ras superfamily, ARFl interconverts between an inactive 
GDP-bound form and an active GTP-bound form as it cycles between the cytosol 
and the Golgi membranes. Upon binding to the Golgi it promotes binding of the 
adaptor protein-1 (AP-1), a component of the clathrin coat (Traub et a i, 1993; 
Seaman et a i, 1996b) and coatomer, the protomer of the COPl coat (Donaldson et 
a i, 1992) to the membrane allowing the budding of secretory vesicles (Chen et a i, 
1996; Ktistakis et a i, 1996).
ARFl is also a possible site of action for phosphoinositides in membrane trafficking. 
Both the guanine nucleotide exchange factor (GEF) (Chardin et a i, 1996) and the 
GTPase activating protein (ARF-GAP) (Randazzo et ai, 1994) which are thought to 
regulate the guanine nucleotide exchange status of ARFl, are dependent upon 
phosphatidylinositol 4,5-bisphosphate (PIP2). Furthermore, ARFl is also an 
effective activator of phospholipase D (PLD) (Cockcroft et al., 1994; Brown et a i, 
1993). PLD hydrolyses phosphatidylcholine to choline and phosphatidic acid (PA),
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which along with PIP2 has been proposed to be involved in regulated secretion 
(Stutchfield et a i, 1993; Fensome et ai, 1996).
As insulin-stimulated GLUT4 translocation may be mechanistically similar to 
regulated secretion (discussed in Chapter 1), I wished to investigate the role of both 
ARFs and PLD in this event in 3T3-L1 adipocytes. In the present study, I examined 
the role of ARF proteins 1/3, 5 and 6 and PLD in insulin-stimulated GLUT4 
translocation and glucose transport. Previous studies have shown that myristoylated 
N-terminal ARF peptides inhibit ARF function (Kahn et a i, 1992; Galas et a i,
1997). Introduction of myristoylated peptides corresponding to the N-terminus of 
ARF6 into a-toxin permeabilised 3T3-L1 adipocytes, markedly inhibited insulin- 
stimulated GLUT4 trans location and 2-deoxy-D-glucose transport, whereas ARF 5 
and ARFl peptides were without effect. In addition, I demonstrate that 3T3-L1 
adipocytes express two isoforms of phospholipase D, PLDl and PLD2. However, 
prior treatment of 3T3-L1 adipocytes with butan-l-ol, had no affect on insulin- 
stimulated glucose transport and GLUT4 translocation, suggesting that PLD does not 
function as a downstream effector of ARF in this event. Taken together with the 
above data, I propose that ARF6 plays a crucial role in insulin-stimulated GLUT4 
translocation, consistent with a general role for this small GTP-binding protein in 
regulated exocytosis in endocrine cells (Galas et ai, 1997).
5.3 Materials and Methods
5.3.1 Permeabilisation of 3T3-L1 Adipocytes
a-toxin permeabilisation of 3T3-L1 adipocytes was carried out as previously 
described (see Section 4.3.5). 3T3-L1 adipocytes were cultured on collagen-coated 
coverslips and incubated in serum-free DMEM for 2h prior to use. The cells were 
then washed three times in IC buffer (lOmM NaCl, 20mM HEPES, 50mM KCl, 
2mM K2HPO4 , 90mM potassium glutamate, ImM MgCh, 4mM EGTA, 2mM
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CaCl2, pH7.2) at 37°C and then incubated in 0.5ml ÏCR buffer (IC buffer plus 4mM 
MgATP, 3mM sodium pyruvate, lOOpg/ml bovine serum albumin, pH 7.4) 
containing a-toxin at 250 haemolytic units/ml (Calbiochem material, approximately 
8pg/ml) for 5 min to penneabilise the plasma membrane. The medium containing a- 
toxin was removed and the cells were incubated in 0.5ml of ICR buffer containing 
peptides at the required concentration for 10 min, followed by the addition of insulin 
(IjiM) or vehicle for a further 15 min at 3TC. Insulin stimulation was terminated by 
washing the cells rapidly in ice-cold buffer A (see Section 2.12.1) and plasma 
membrane lawns were prepared as described in Section 2 .12 . 1. Coverslips were 
viewed and the data analysed as described in Section 4.3.5.
5.3.2 2-Deoxy-D-GIucose Transport Assays:
Effect of Myristoylated Peptides
In order to measure the uptake of glucose following the treatment of 3T3-L1 
adipocytes with myristoylated peptides, cells cultured on 6 -well plates were 
permeabilised with a-toxin and treated with peptides and insulin as described above. 
At the end of the 15 min insulin stimulation, glucose transport was measured by the 
uptake of 2-deoxyglucose, according to a method previously described for 3T3-L1 
adipocytes permeabilised with a-toxin (Herbst et a i, 1995). A small volume of 
(25|il) of radiolabeled 2-deoxy-D-glucose and sucrose was added to the 0.5ml of 
buffer in each well, such that the final concentration was 50jiM 2-deoxy-D-glucose 
(0.5pCi of pH] 2-deoxy-D-glucose) and 50|liM sucrose (0.06pCi of [^^C] sucrose), 
and incubated for 5 min at 37°C. Transport was terminated by 'flipping' the plates 
rapidly to remove the incubation buffer and then 'dipping' them sequentially into 3 
volumes of ice-cold PBS (see Section 2.2.1). The plates were left to air diy and 1ml 
of 1% Triton X-100 in H2O was added to each well. Following incubation for 60 
min at room temperature, [^H] 2-deoxy-D-glucose and [^^C] sucrose uptake was 
determined by liquid scintillation dual-labelled counting. The amount of sucrose
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remaining with the cells provided a measure of non-specific trapping and uptake from 
the medium, and the raw values for 2-deoxy-D-glucose uptake were corrected by 
subtraction of the corresponding amount of this compound. Each experiment 
consisted of transport assays on triplicate wells of cells in the basal state and cells 
treated with insulin alone or peptide and insulin.
Effect of Butan-l-ol
3T3-L1 adipocytes cultured on 6 -well plates were incubated in serum-free DMEM 
for 2 h prior to use. For the last 30 min of the incubation, butan-l-ol (30mM) or 
butan-2-ol (30mM) were added to experimental plates only. After the incubation, 
cells were washed twice with KRP buffer (see Section 2.2.2) at 37°C and 2-deoxy-D- 
glucose transport was measured as described in Section 2.13.
5.3.3 Double-Labelled Immunofluorescence Microscopy
Double-labelled immunoflurescence microscopy was carried out as described in 
Section 2.12.2. In this case, triton-permeabilised 3T3-L1 adipocytes were incubated 
with a mouse monoclonal anti-GLUT4 antibody and the corresponding secondary 
antibody (TRITC-conjugated goat anti-mouse IgG) in conjunction with a rabbit anti- 
ARF5 antibody (see Section 5.3.5) and the corresponding secondary antibody 
(FITC-conjugated goat anti-rabbit IgG).
5.3.4 Adipsin Release: 
Effect of Butan-l-ol
3T3-L1 adipocytes were cultured on 10cm plates and incubated in serum-free 
DMEM for 2 h prior to use. For the last 30 min of the incubation, butan-l-ol 
(30mM) or butan-2-ol (30mM) were added to experimental plates only. After the
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incubation, cells were washed twice with KRP buffer (see above) at 37°C and adipsin 
release was measured as described in Section 2.14.
5.3.5 Peptide Synthesis
Peptides corresponding to the residues 2 through 16 of murine ARF5 were 
synthesised by Thistle Research (Glasgow, UK) and were > 99% pure as determined 
using HPLC, A myristoyl group was included at the position corresponding to Gly-
2 . Myristoylated ARF6 and ARFl peptides were supplied by Dr M-F. Bader 
(INSERM, Strasborg, France).
5.3.6 Antibodies
The anti-GLUT4 antibody used for immunoblotting and vesicle immunoadsorption 
was a rabbit polyclonal against a peptide comprising the C-terminal 14 amino acid 
residues of the human iso form of GLUT4 (see Section 2.4). For double-labelled 
immunofluorescence a monoclonal GLUT4 antibody (1F8) was used (see Section
2.4). Anti-ARF5 antibodies were from Professor J. Moss (NIH, Bethesda, 
Maryland, USA) and Professor R.A. Kahn (NIH, Bethesda, Maryland, USA). Anti- 
ARF 1/3 antibody was a generous gift from M.J.O Wakelam (University of 
Birmingham, UK) and anti-ARF 6 antibodies were supplied by Dr M-F. Bader 
(INSERM, Strasborg, France) and Dr J. Donaldson (NIH, Bethesda, Maryland, 
USA). Anti-adipsin antibody was generously provided by Professor B. Spiegelman 
(Dana Farber Cancer Institute, Boston, USA). Anti-PLDl and PLD2 were from 
Quality Controlled Biochemicals Inc (Hopkinton, MA, USA).
5.3.7 Statistical Analysis
Statistical analysis was performed using Statview 4.0 on a Mac Power PC.
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5.4 Results
5.4.1 Distribution of ARF Proteins and the Effect of Insulin and Wortmannin 
in 3T3-L1 Adipocytes
Initially, I wished to examine the effect of insulin on the subcellular distribution of 
ARF isoforms in 3T3-L1 adipocytes. Adipocytes treated with or without insulin for 
15 min were fractionated into plasma membrane (PM), low density microsomal 
(LDM), high density microsomal (HDM) and soluble protein (SP, corresponding to 
cytosolic proteins) fractions as previously described in Section 2.10. Equal amounts 
of protein (40p,g) from each fraction were resolved by SDS-PAGE, transferred to 
nitrocellulose membranes and immunoblotted with antibodies to ARF 1/3 (an 
antibody known to cross react with both ARFl and 3 was used), ARF5, ARF6 and 
GLUT4. 3T3-L1 adipocytes were found to express ARFs 1/3, 5 and 6 . In basal 
(non-stimulated) adipocytes ARF 1/3 was localised mainly in the SP fraction with 
smaller amounts in the LDM and HDM fractions, while ARF6 was present to some 
extent in most fractions although clearly enriched in the PM, consistent with 
previous studies for this cell type (Yang et ai, 1998) (Figure 5.1).
ARF’5, found to be localised to the LDM and SP protein fractions in basal cells, was 
the only isoform observed to exhibit altered subcellular distribution in response to 
insulin (Figure 5.2). When adipocytes were stimulated with insulin (IpM), an 
increase in both ARF5 and GLUT4 levels was observed at the PM. In the case of 
GLUT4 there was a concommitant decrease in the LDM fraction, as has been well 
documented. In contrast, the redistribution of ARF5 to the PM was from both the 
the SP fraction and the LDM fraction.
It is well documented that PI 3-kinase is involved in insulin-induced glucose uptake 
(reviewed in Shepherd et al., 1996a). Indeed, GLUT4 translocation is blocked by PI 
3-kinase inhibitors such as wortmannin and LY294002 (Cheatham et a l, 1994;
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Clarke et ai, 1994; Yang et ai, 1996). To investigate a possible involvement of PI 3- 
kinase in insulin-induced ARF5 translocation, adipocytes were treated with insulin 
(IpM) for 15 min in the presence or absence of wortmannin (lOOnM). As expected, 
wortmannin blocked the insulin-induced departure of GLUT4 from the LDM 
fraction (Figure 5.2). In contrast, the inhibitor enhanced ARF5 levels present within 
the plasma membrane, almost completely depleting the SP and LDM fractions. 
These results suggest that the cycling of ARF5 between the cytosol and the plasma 
membrane is PI 3-kinase dependent.
The observation that ARF6  was predominantly localised to the plasma membrane in 
3T3-L1 adipocytes, together with the recent data that this small GTP-binding 
protein has been involved in regulated exocytosis (Galas et a l, 1997), tempted me to 
examine the effect of wortmannin on the subcellular distribution of this protein in 
adipocytes. Consistent with the initial fractionation study, ARF6 was clearly 
enriched in the plasma membranes (Figure 5.2). No change in distribution was 
observed on exposure to insulin with or without prior treatment with wortmannin.
5.4.2 Co-Localisation of ARF5 and GLUT4 within 3T3-L1 Adipocytes
The translocation of ARF5 to the PM in response to insulin and the localisation of 
this isoform in the LDM fraction in which GLUT4 is enriched, prompted me to 
determine whether ARF5 co-localised with GLUT4 in 3T3-L1 adipocytes. Further 
analysis of their subcellular distribution was examined by immunoadsorption of 
GLUT4 vesicles and immunofluorescence microscopy.
Vesicles were immunadsorbed from the LDM fraction of basal 3T3-L1 adipocytes 
using either the affinity-purified GLUT4 antibody or a non-specific IgG as described 
in Section 2.11. Both the vesicles and the depleted LDM were analysed for the 
presence of ARF5 and GLUT4. Under my experimental conditions, most of the 
GLUT4 protein was immunoadsorbed, as indicated by the depletion of GLUT4 from
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the LDM fraction, where anti-GLUT4 was used but not non-specific IgG (Figure 
5.3). The lack of detection of GLUT4 in the GLUT4 vesicles suggests that upon 
removal of the vesicles from the Staph, a. cells, the GLUT4 remained firmly attached 
to the cells, thus preventing any detection of the protein in this fraction. ARF5 was 
not detected in either the GLUT4 vesicles or the vesicles obtained using the non­
specific IgG. The lack of immunoprécipitation of ARF5 with GLUT4 was 
confirmed by the analysis of the GLUT4-depleted LDM, which did not show any 
significant reduction in the amount of ARF5 compared to that in the non-depleted 
LDM (Figure 5.3).
The co-localisation of ARF5 and GLUT4 in insulin-stimulated adipocytes was 
analysed using double-labelled immunofluorescence. Figure 5.4 shows 
parafonnaldehyde fixed, Triton-permeabilised basal and insulin treated cells labelled 
with a GLUT4 monoclonal antibody (IF8) and an anti-ARF 5 antibody. Under basal 
conditions, GLUT4 immunofluorescence is almost entirely intracellular and is found 
in the perinuclear region with some evidence of fine punctate spots distributed at the 
cell surface. In contrast, ARF5 immunofluorescence is both cytoplasmic and 
perinuclear in disribution in basal cells. Only partial co-localisaton between GLUT4 
and ARF5 is observed in the perinuclear region. After a 15 min treatment with 
insulin (IpM), redistribution of both GLUT4 and ARF5 to the plasma membrane is 
observed, consistent with the subcellular fraction data. Translocation of GLUT4 and 
ARF5 to the plasma membrane results in an increase in co-localisation, although the 
extent of overlap is still limited. This is probably a result of the constant cycling of 
ARF5 between the plasma membrane and the cytosol, thus at any one time ARF5 
will still be observed in the cytoplasm in insulin-stimulated cells. Together, these 
results confirm the subcellular fractionation data as GLUT4 and ARF5 are localised 
to distinct compartments in the basal state from which they translocate to the plasma 
membrane in response to insulin.
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5.4.3 Role of ARFs in Insulin-Stimulated GLUT4 Translocation
To investigate whether ARF5 or ARF6 play an essential role in insulin-stimulated 
GLUT4 translocation we introduced peptides designed to inhibit ARF function into 
a-toxin permeabilsed 3T3-L1 adipocytes and examined the effect on insulin action. 
As previous studies have shown that only peptides with a myristoyl group at Gly-2 
inhibit ARF function (see Table 5.1) (Kahn et a l, 1992; Galas et a l, 1997), I 
examined, by immunofluorescence of PM lawns, the effects of both myristoylated 
ARF5(2-17) and ARF6 (2-i3) peptides on cell surface levels of GLUT4 in response to 
insulin. In the absence of peptides, insulin (lp,M) increased cell surface levels of 
GLUT4 by 6.3-fold in permeabilised cells (Figure 5.5a). In cells incubated with 
myristoylated ARF5(2-i7) (lOOjiM), insulin increased surface levels of GLUT4 by 
6 .8 -fold, similar to that observed in the absence of peptides. However, in the 
presence of myrisoylated ARF6 (2- i 3) (lOOpM) insulin-stimulated GLUT4 
translocation was reduced by over 60%, indicating that insulin action was specifically 
inhibited by the myristoylated ARF6 (2-i3) peptide (Figure 5.5). I also examined the 
effect of a myristoylated ARFl peptide(2_i7) (Figure 5.5). However, this peptide 
had no significant effect on insulin-stimulated cell surface levels of GLUT4, 
indicating that the strong inhibition of insulin-stimulated GLUT4 translocation 
observed in the presence of myristoylated ARF6 (2-i3) was not due to some non­
specific effect.
Under similar conditions, I also examined the effect of the myristoylated ARF 
peptides on insulin-stimulated glucose transport. The effects of insulin and 
myristoylated ARFl, 5 and 6 peptides on the uptake of 2-deoxy-D-glucose by a- 
toxin permeabilised adipocytes are shown in Figure 5.6. In the absence of peptides, 
insulin (IpM) stimulated glucose transport by 8.3-fold. Similarily, in cells incubated 
with myristolated ARF5 (2- i7) (lOOpM) and myristolated ARFl(2_i7) peptides 
(lOOpM), insulin stimulated glucose transport by 7.3 to 8 .8 -fold. However, in 
accordance with the plasma membrane lawn data, incubation with myristoylated
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ARF6(2-13) (lOOpM) reduced insulin-stimulated glucose transport by ~ 60%. Taken 
together, these results provide evidence that ARF6 plays an essential role in insulin- 
induced GLUT4 translocation.
5.4.4 Subcellular Distribution of PLDs and the Effect of Insulin in 3T3-L1 
Adipocytes
As previous reports have shown that ARF is an effective activator of PLD 
(Cockcroft et a i, 1994; Brown et a i, 1993), it is possible that ARF6 may act 
catalytically via this enzyme at the docking and / or fusion stage of GLUT4 vesicles 
with the plasma membrane. It is also possible that ARF isoforms yet to be identified 
in 3T3-L1 adipocytes, may be involved in the budding of GLUT4 vesicles from the 
intracellular storage compartment, similar to the role of ARFl in the formation of 
secretory vesicles at the Golgi (Chen et al., 1996; Chen et a i, 1997b). Again, PLD 
may act as a downstream effector of ARF in this process.
As a first step in determining whether PLD may be involved in the insulin-regulated 
exocytosis of GLUT4,1 examined the expression and localisation of PLD isoforms in 
3T3-L1 adipocytes using antibodies specific for PLDl, PLD2 and GLUT4. As 
shown in Figure 5.7, both PLDl and 2 were expressed and localised to the LDM 
fraction in adipocytes, with no change in their redistribution in response to insulin. 
This is in marked contrast to GLUT4, which, in the same cells, exhibited a large 
movement from the LDM fraction to the PM fraction.
5.4.5 Role of Phospholipase D in Insulin-Stimulated Trafficking in 3T3-L1 
Adipocytes
Next, I wished to examine the role of PLD in insulin-stimulated GLUT4 
translocation. To inhibit PLD activity I utilised the primary alcohol butan-l-ol, and 
compared the effect of this alcohol to that of butan-2-ol which does not inhibit PLD
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activity (Cook et a l, 1991). Treatment with butan-l-ol (30 or 60mM) for 30 min 
before adipocytes were stimulated with insulin (IpM) for 15 min, had no effect on 
GLUT4 translocation to the cell surface as assessed using the plasma membrane lawn 
assay (Figure 5.8). Under similar conditions, I also investigated the effect of butan-1- 
ol (30 or 60mM) on insulin-stimulated glucose transport. In accordance with the 
immunofluorescence data, butan-l-ol was without effect on 2-deoxy-D-glucose 
uptake in basal and insulin stimulated cells (Figure 5.9).
To ensure that the treatment of adipocytes with butan-l-ol was indeed targeting PLD 
activity in these cells, I decided to examine the effect of the inhibitor on the insulin- 
stimulated secretion of the serine proteinase adipsin. In agreement with previous 
studies, insulin increased adipsin secretion from 3T3-L1 adipocytes by ~ 2-fold 
(Figure 5.10) (Kitagawa et a i, 1989). Treatment of adipocytes with butan-l-ol (30 
mM) for 30 min prior to insulin stimulation inhibited both basal (constitutive) and 
insulin-stimulated adipsin secretion (Figure 5.11). Butan-2-oI was without effect, 
consistent with the inability of this secondary alcohol to inhibit PLD activity (Cook 
et al., 1991).
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Table 5.1
Sequence Alignment of ARF Proteins at the Amino Terminus
ARFlaaARF2aaARF3aaARF4aaARFSaaARF6aa
MGNIFANLFKGLFGKK MGNVFEKLFKSLFGKK MGNIFGNLLKSLIGKK MGLTISSLFSRLFGKK MGLTVSALFSRIFGKK MGKVLSK IFGNK
Shown is a sequence alignment of the murine isoforms of the ARF family (Hosaka et 
al, 1991). The myristoylated ARF6 peptide used in Figures 5.5 and 5.6 is 
underlined. The same peptide was also found to inhibit secretion from chromaffin 
cells (Galas et ai, 1997).
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Figure 5.1
Subcellular Distribution of GLUT4, ARFl/3 and ARF6 in 3T3-L1 Adipocytes
and the Effect of Insulin
Shown is the distribution of GLUT4, ARF 1/3 and ARF6 In subcellular fractions 
isolated from basal (unstimulated) and insulin-stimulated 3T3-L1 adipocytes (insulin 
exposure for 15 min at 1 pM). Subcellular membrane fractions (PM, LDM HDM 
and SOL) were prepared, subjected to SDS-PAGE, electrophoretically transferred to 
nitrocellulose membranes, and immuhoblotted for GLUT4, ARFs 1/3 and 6. In each 
immunoblot, 40pg of protein was loaded per lane. Note that GLUT4 exhibits 
translocation from the intracellular (LDM) membrane fraction to the plasma 
membrane, but neither ARF 1/3 nor ARF6 exhibited altered distribution in response 
to insulin treatment. This set of immunoblots was from the same preparation of 
cellular fractions, and is representative of at least two other experiments.
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Figure 5.2
Subcellular Distribution of GLUT4, ARF5 and ARF6 in 3T3-L1 Adipocytes and 
the Effect of Insulin and Wortmannin
Shown is a representative immunoblot of subcellular fractions (PM, LDM, SP) of 
3T3-L1 adipocytes from basal (non-stimulated), insulin-stimulated (Ip-M) for 15 
min, or cells pre-treated with lOOnM wortmannin before insulin treatment. Note the 
insulin-stimulated re-distribution of GLUT4 from the LDM fraction to the PM, 
which is inhibited by prior exposure of the cells to lOOnM wortmannin. In contrast, 
insulin-stimulated ARF5 movement to the PM arises from both the SP and LDM 
fractions, and is markedly potentiated by prior exposure of the cells to wortmannin. 
Similar data were obtained using two different anti-ARF5 antisera. No change in 
ARF6 distribution was observed in response to insulin or wortmannin treatment.
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Figure 5.3
Immunoadsorption of GLUT4-Containing Vesicles
Intracellular (LDM) membranes were isolated from basal 3T3-L1 adipocytes and 
incubated with anti-GLUT4 antibody or non-specific IgG (control) pre-coupled to 
Staph, a. cells as described in Section 2,11. Immunoadsorbed vesicles (GLUT4 and 
IgG) and depleted LDM fractions (GLUT4 and IgG) were subjected to SDS-PAGE 
and immunoblot analysis with anti-GLUT4 and anti-ARF5 antibodies as indicated.
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Figure 5.4
Double-labelled Immunofluorescence Analysis of GLUT4 and ARF5 in Basal 
and Insulin-Stimulated 3T3-L1 Adipocytes
Triton-permeabilised (BASAL) basal (non-insulin-stimulated) and (INSULIN) 
insulin-stimulated 3T3-L1 adipocytes were incubated with a mouse monoclonal anti- 
GLUT4 antibody and the corresponding secondary antibody (TRITC-conjugated 
goat anti-mouse IgG, stained red) in conjunction with a rabbit anti-ARF5 antibody 
and the corresponding secondary antibody (FITC-conjugated goat anti-rabbit IgG, 
stained green). The yellow colour indicates co-staining of the proteins at the plasma 
membrane in the insulin-stimulated cells.
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Figure 5,5
Effect of Myristoylated ARF Peptides on Insulin-Stimulated GLUT4
Translocation in Permeabilised 3T3-L1 Adipocytes
Triplicate coverslips of a-toxin permeabilised 3T3-L1 adipocytes were incubated at 
37°C in buffer alone or in buffer containing myristoylated ARF peptides (lOOpM) as 
indicated. After 10 min, the cells were treated with or without insulin (l|xM) for a 
further 15 min. Plasma membrane lawns were prepared and the extent of GLUT4 
translocation relative to the basal value was determined using scanning laser confocal 
immunofluorescence microscopy. Shown are data of a representative experiment (n 
= 3). Data are presented as the mean fold increase relative to basal (non-stimulated) 
cells ± s.e.m.
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Figure 5.6
Effect of Myrisoylated ARF Peptides on Insulin-Stimulated 2-Deoxy-D- 
Glucose Transport in Permeabilised 3T3-L1 Adipocytes
Triplicate wells of a-toxin permeabilised 3T3-L1 adipocytes were incubated at 37°C 
in buffer alone or in buffer containing myristoylated ARF I (lOOjaM), ARF5 
(lOOpM) and ARF6 ( 100 and lOpM) peptides as indicated. After 10 min, the cells 
were treated with or without insulin (lp.M) for a further 15 min. Glucose transport 
was measured by the assay of 2-deo^y-D-glucose uptake for 5 min as described in 
Materials and Methods. Shown are data from a representative experiment (n = 3). 
Data are represented as the mean fold increase relative to basal (non-stimulated ) cells 
± s.e.m
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Figure 5.7
Subcellular Distribution of GLUT4, PLDl and PLD2 in 3T3-L1 Adipocytes and 
the Effect of Insulin
Shown is the distribution of GLUT4, PLDl and PLD2 in subcellular fractions 
isolated from basal (non-stimulated) and insulin-stimulated 3T3-L1 adipocytes 
(insulin exposure for 15 min at l|iM). Subcellular membrane fractions (PM, LDM 
RDM and SOL) were prepared, subjected to SDS-PAGE, electrophoretically 
transferred to nitrocellulose membranes, and immunoblotted for GLUT4, PLDl and 
PLD2. In each immunoblot, 40p.g of protein was loaded per lane. Note that GLUT4 
exhibits translocation from the intracellular (LDM) membrane fraction to the plasma 
membrane, but neither PLD1 or PLD2 exhibited altered distribution in response to 
insulin treatment. This set of immunoblots was from the same preparation of cellular 
fractions used for the immunodetection of ARF proteins in 3T3-L1 adipocytes 
(Figure 5.1).
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Figure 5.8
Effect of Butan-l-oi on Insulin-Stimulated GLUT4 Translocation in 3T3-L1
Adipocytes
Triplicate coverslips of 3T3-LI adipocytes were incubated in buffer containing 
butan-l-ol (30mM) or butan-2-ol (30mM, as a control) for 30 min at 37°C, before 
being treated with or without insulin (lp,M) for a further 15 min. GLUT4 
translocation was assessed using the plasma membrane lawn assay. Butan-l-ol and 
butan-2-ol were without effect on GLUT4 translocation, even at concentrations of 
up to 60mM. Quantification of three experiments of this type revealed no significant 
differences in fluorescence intensity in the butan-l-ol, butan-2-ol and non-treated 
coverslips in either basal (non-stimulated) or insulin-stimulated state. Data are 
presented as the mean fold increase relative to basal cells ± s.e.m.
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Figure 5.8
Figure 5.9
Effect of Butan-l-ol on Insulin-Stimulated 2-Deoxy-D-Glucose Transport in 
3T3-L1 Adipocytes
3T3-L1 adipocytes were incubated in buffer containing butan-l-ol (30mM) or butan- 
2-ol (30mM, as a control) for 30 min at 37°C, before being treated with or without 
insulin (IpM) for a further 15 min. Glucose transport was measured by the assay of 
2-deoxy-D-glucose uptake as described in Section 2.13. At concentrations up to 
60mM, butan-l-ol had no effect oh either basal or insulin-stimulated glucose 
transport. Shown is a representatative experiment of three similar experiments. Data 
are presented as the mean 2-deoxy-D-glucose transport rate ± s.e.m.
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Figure 5.10
Effect of Butan-l-ol on Adipsin Secretion in 3T3-L1 Adipocytes
A. Time course of adipsin secretion from 3T3-L1 adipocytes. Cells were treated 
with or without insulin (IpM) for the indicated times. The relative amount of 
adipsin in the medium was determined by immunoblotting. Adipsin secretion is 
expressed in arbitrary units as described in Section 2.14. This experiment was 
repeated with similar results.
B. Time course of adipsin secretion from cells pre-treated with butan-l-ol ( an 
inhibitor of PLD activity) and butan-2-ol (as a control) as described. Cells were 
treated with or without insulin for the indicated times. Shown is a representative 
experiment of at least two similar experiments.
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5.5 Discussion
ARF proteins have been implicated in the regulation of vesicular transport through 
the secretory pathway (reviewed in Moss et ai,  1995). Recent studies have shown 
that ARFs may play a role in both the formation of secretory vesicles (Chen et al, 
1996) and the initiation or facilitation of vesicle fusion at the plasma membrane 
(Galas etal., 1997) in endocrine cells. As insulin-stimulated GLUT4 translocation to 
the cell surface in adipocytes exhibits many similarities to regulated secretion in 
neuroendocrine and endocrine cells, I wished to investigate whether ARF proteins 
may also be an important component of the GLUT4 trafficking machinery.
As a first step towards identifying ARF proteins involved in insulin-stimulated 
GLUT4 translocation we examined the effect of insulin on the subcellular distribution 
of ARFs 1/3, 5 and 6 in 3T3-L1 adipocytes. An antibody reported to cross-react 
mainly with ARFl and 3 identified a protein present within the intracellular (LDM) 
membrane fraction and the cytosolic fraction (Figure 5.1), consistent with previously 
published data (Hosaka et aL, 1991). In agreement with a previous study on 3T3-L1 
adipocytes (Yang et a i,  1998), ARF6 was predominantly localised within the 
plasma membrane, with some immunoreactivity present in the cytosolic and 
intracellular membrane fractions. Flowever, under our experimental conditions, 
neither of these isoforms exibited an altered distribution in response to insulin. In 
contrast, both GLUT4 and ARF5 levels increased within the plasma membrane in 
response to insulin. In the case of GLUT4, this was concomitant with a decrease in 
the intracellular (LDM) fraction, as has been well documented. However, ARF5, 
localised to the intracellular (LDM) fraction and the soluble protein (cytosolic) 
fraction in the basal state, redistributed to the plasma membrane from both of these 
fractions in response to insulin (Figure 5.2). Consistent with these findings, double­
labelled immunofluorescence showed little overlap between GLUT4 and ARF5 in 
basal cells, with an increase in co-localisation at the plasma membrane in response to 
insulin (Figure 5.4). The extent of co-localisation at the plasma membrane is
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possibly limited due to the cycling of ARF5 between the cytosol and plasma 
membrane.
As PI 3-kinase is known to play an important role in insulin-stimulated GLUT4 
translocation (reviewed in Shepherd et a i,  1996a), I also examined the effect of 
wortmannin on ARF5 translocation. As expected, wortmannin effectively inhibited 
insulin-stimulated GLUT4 translocation to the plasma membrane. In marked 
contrast, in the same cells, ARF5 translocation to the plasma membrane was 
markedly enhanced, suggesting that the cycling of ARF5 between the cytosol and the 
plasma membrane is dependent upon PI 3-kinase.
Conversion of A R F g d p  to A R F q tp  is promoted in vivo by a guanine nucleotide 
exchange factor (GEF). Several of these proteins have recently been identified, all of 
which contain a central sec7 domain responsible for nucleotide exchange and a 
pleckstrin homology (PH) domain which interacts with inositol phospholipids 
(Chardin et a l,  1996; Klarlund et a i,  1997). Recent evidence suggests that the 
interaction between the PH domain and the inositol phospholipid mediates GEF 
association at the membrane, thus increasing GEF and ARF localisation resulting in 
enhanced catalytic activity (Paris et al, 1997). Interestingly, a protein previously 
identified in 3T3-L1 adipocytes, GRP I, has recently been reported to catalyse 
guanine nucleotide exchange for ARFs 1 and 5 in vitro (Klarlund et al,  1998). 
Furthermore, binding of the PI 3-kinase product, phophatidylinositol 3,4,5- 
trisphosphate (PIP3), markedly enhances the exchange activity (Klarlund et al, 
1998), suggesting a model in which the selective recruitment of GRPl to PIP3 in 
membranes activates ARFs 1 and 5.
Based on these recent studies and the observation that inhibition of PI 3-kinase 
activity in insulin-stimulated 3T3-LI adipocytes leads to an increase in ARF5 levels 
at the plasma membrane, I hypothesise that ARF5 cycles between the cytosol and 
the plasma membrane, mediated in part via guanine nucleotide exchange. In response
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to insulin, PI 3-kinase activation results in the synthesis of PIP3 , which in turn 
recruits a guanine nucleotide exchange factor such as GRP 1 or its homologs to the 
plasma membrane where it localises with A R F 5 g d p  resulting in its activation and the 
subsequent hydrolysis of GTP. Inhibition of PI 3-kinase by wortmannin would 
block PIP3 production thus preventing the recruitment of the GEF to the plasma 
membrane, resulting in the accumulation of the weakly bound A R F 5 g d p  at the 
plasma membrane as guanine nucleotide exchange and hydrolysis of ARF5 is 
impaired. However, although this hypothesis provides an attractive working model 
for insulin-stimulated PI 3-kinase-dependent trafficking in 3T3-LI adipocytes, 
further studies are required to determine whether GRPl catalyses nucleotide 
exchange of ARF5 at the plasma membrane in vivo. Interestingly, a most recent 
study has reported that upon expression of ARNO (ARF nucleotide-binding-site 
opener) in 3T3-L1 adipocytes, insulin stimulates the translocation of the GEF to the 
plasma membrane in a PI 3-kinase dependent manner (Kanamarlapudi et al, 1998), 
suggesting that our model may indeed be a reasonable hypothesis.
Previous studies have shown that myristoylated N-terminal ARF peptides inhibit 
ARF function (Kahn et al, 1992; Galas et al, 1997). To investigate whether ARF5 
plays a specific role in GLUT4 insulin-stimulated trafficking in 3T3-LI adipocytes, I 
used myristoylated peptides corresponding in sequence to the N-terminal residues of 
ARF5. In addition, the predominant localisation of ARF6 to the plasma membrane 
in adipocytes, together with the recent data that this small GTP-binding protein has 
been implicated in the regulated exocytosis of chrommaffin granules in endocrine cells 
(Galas et a l,  1997), prompted us to examine the effect of myristoylated ARF6 
peptides on insulin-stimulated GLUT4 translocation. As illustrated in Figures 5,5 
and 5.6, the myristoylated ARF6 (2- i3) peptide strongly inhibited both insulin- 
stimulated GLUT4 translocation and glucose transport in 3T3-L1 adipocytes, 
consistent with a role for this small GTPase in regulated exocytosis. In contrast, the 
myristoylated ARF5 (2- i7) peptide had no effect on insulin-stimulated GLUT4 
translocation or glucose transport. Although the role of ARF5 is unclear, it is
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possible that this small GTP-binding protein may be involved in general trafficking 
processes within these cells.
It is important to note, however, that the myristoylated ARF6 (2-i3) peptide did not'I
completely block insulin-stimulated GLUT4 translocation. On considering the 
localisation of GLUT4 to two distinct intracellular compartments within adipocytes 
(refer to Section 3.2), a plausible explanation for these data is that ARF6 is involved 
in the exocytosis of GLUT4 from the insulin-responsive storage compartment in 
response to insulin but does not regulate the docking and fusion of recycling 
endosomes with the cell surface. Thus, stimulation of the recycling endosomal 
system in response to insulin (Tanner et ai,  1987; Tanner et a i,  1989) would result 
in an increase in GLUT4 levels at the plasma membrane even when GLUT4 
translocation from the storage compartment is blocked. To determine whether ARF6 
is involved predominantly in the regulation of the insulin-responsive storage 
compartment, further studies may be carried out to investigate whether this ARF 
protein regulates the insulin-dependent trafficking of proteins previously shown to 
be localised to the recycling endosomal system such as the transferrin receptor (TfR) 
and GLUTl (Livingstone etal., 1996).
I cannot rule out the possibility, however, that complete inhibition is not observed 
due to experimental limitations. In this regard, myristoylated peptides are difficult to 
solubilise thus reducing the efficiency of the internalisation of the peptide, resulting 
in a possible reduction of the inhibitoiy effect. Again, further studies are required to 
determine the efficiency of internalisation of the peptide in order to resolve this 
issue. However, due to the time constraints of this work I was unable to pursue 
either of the aforementioned studies.
Taken together, these data implicate ARF6 as a key component of the insulin- 
responsive GLUT4 trafficking machinery. Although this present study does not 
enable me to define a precise role for ARF6 in GLUT4 trafficking, the predominant
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localisation of ARF6 at the plasma membrane suggests that the small GTP-binding 
protein may function in the latter stages of trafficking, possibly at the stage of 
docking / fusion of GLUT4 vesicles at the cell surface. Similar to the cycling of 
ARFl between the cytosol and Golgi membranes (see above), ARF6 may function 
by cycling between the cytosol or indeed another membrane compartment and the 
plasma membrane as it interconverts between an inactive GDP-bound form and an 
active GTP-bound form in response to insulin. In this regard, a recent study has 
shown that ARF6 cycles between the plasma membrane and a novel internal 
membrane compartment in'HeLa cells (Radhakrishna et a l,  1997). It should be 
noted however, that the subcellular fractionation immunoblots (Figures 5.2 and 5.3) 
did not reveal any significant change in ARF6 subcellular distribution in response to 
insulin. One plausible explanation for this finding is that the membrane 
compartments between which ARF6 cycles in response to insulin, may be isolated in 
the same fraction by the fractionation procedure employed in this study. 
Interestingly, the ARF6-associated membrane compartment in HeLa cells is distinct 
from the early endosomal compartment containing TfRs (Radhakrishna et al, 1997). 
Accordingly, it would not be detected as an 'early endosome' in the intracellular 
membrane fraction, but may be isolated with the plasma membrane under the 
experimental conditions used in this study. However, further studies are required in 
order to determine whether such an ARF6-associated internal membrane 
compartment exists in 3T3-L1 adipocytes.
There is an accumulating body of evidence which proposes a role for PLD as a 
downstream effector of ARF in regulated secretion (see for example Stutchfield et al, 
1993; Ktistakis et a l,  1996; Chen et al, 1997b). With this in mind, I wished to 
identify which PLD isoforms are expressed in 3T3-L1 adipocytes, and determine 
whether PLD activity plays a role in insulin-stimulated GLUT4 translocation. Using 
antibodies for PLDl and PLD2, I showed that both these isoforms are expressed in 
3T3-L1 adipocytes, and are both localised to the intracellular (LDM) membrane 
fraction (Figure 5.7). In the case of PLDl, this observation is consistent with the
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localisation of PLDl activity to intracellular membranes thought to be involved in 
ARF-regulated vesicular budding and secretion (Chen et ai,  1997b; Ktistakis et al, 
1996; Fensome et al, 1996). However, although PLD2 has been localised to the 
plasma membrane in overexpression studies (Colley et al, 1997), there is little data 
on the location of endogenous PLD2 as relatively few cell types or tissues have been 
examined in this regard. Indeed, to my knowledge this is the first terminally 
differentiated, growth arrested cellular context in which PLDl and PLD2 distribution 
has been examined. As neither of the isoforms exhibited an insulin-dependent 
redistribution to the plasma membrane it seems improbable that ARF6 may regulate 
PLD activity at the cell surface in response to insulin. In collaboration with M.J.O 
Wakelam (University of Birmingham), we have been unable to effectively assay PLD 
activity in 3T3-LI adipocytes, probably due to the high level of lipid in these cells 
interfering with the lipid miceller structures required for PLD assays in broken cells. 
However, it is tempting to speculate that these PLD isoforms may act as 
downstream effectors of ARF isoforms localised to the intracellular membranes in 
these cells.
To determine whether PLD may be involved in insulin-stimulated GLUT4 
translocation we used the primary alcohol, butan-l-ol, to divert the production of 
phosphatidic acid to phosphatidylbutan-l-ol, previously shown to inhibit PLD 
activity (Cook et al, 1991). Here I have shown that even at concentrations known 
to inhibit PLD activity (Cook et al., 1991), butan-I-ol has no affect on insulin- 
stimulated GLUT4 translocation and 2-deoxy-D-glucose transport (Figures 5.8 and 
5.9). However, under the same conditions, both the constitutive and insulin- 
stimulated secretion of adipsin from adipocytes is inhibited by butan-l-ol but not 
butan-2-ol, a secondary alcohol unable to inhibit the PLD catalysed reaction (Figure 
5.11). These data indicate that butan-l-ol is effectively targeting PLD activity within 
the adipocytes. However, this activity appears to play a role in adipsin secretion 
but does not appear to be involved in the ability of insulin to recruit GLUT4 to the 
cell surface.
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The data presented in the previous study (refer to Section 4.4.6) suggests that 
adipsin secretion utilises the recycling endosomal system. The most likely 
mechanism of secretion would involve the fusion of TGN-derived secretory vesicles 
with the endosomal network en route to the plasma membrane, consistent with a 
PLD-mediated step. However, although I have also shown GLUT4 to traffic through 
the TGN in AP-1 positive vesicles (refer to section 5.3.3), the data imply that the 
insulin-responsive GLUT4 storage compartment does not bud directly from the 
TGN and therefore inhibition of PLD activity at the TGN will have no effect on 
insulin-stimulated GLUT4 translocation. Furthermore, recent evidence suggests that 
the recruitment of AP-1 adaptors onto the TGN does not involve PLD activity even 
though AP-1 recruitment is ARF-mediated (West et al, 1997). Thus, inhibition of 
PLD activity localised to the TGN would effectively block adipsin secretion but not 
insulin-stimulated GLUT4 translocation.
In summary therefore, I have shown that the introduction of myristoylated ARF6 
peptides inhibits both insulin-stimulated GLUT4 translocation and glucose transport 
in 3T3-L1 adipocytes. On the basis of these and other data, I propose that ARF6 
plays a crucial role in the regulated exocytosis of GLUT4 in response to insulin. In 
the view of the current proposed functions for ARF proteins in vesicular traffic, it is 
tempting to speculate that ARF6 facilitates fusogenic events at the plasma membrane 
in response to insulin.
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Chapter 6
Construction of an ssHRP Chimera
for
Compartment Ablation Analysis
in
3T3-L1 Adipocytes
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6.1 Aims
1. To construct a chimeric cDNA comprising the human growth hormone signal 
sequence (sshGH) fused in frame at the N-terminus of horseradish 
peroxidase (HRP).
2. To subclone the ssHRP chimera into a suitable vector for high-level 
expression in mammalian cells.
3. To establish stable 3T3-L1 adipocyte cell lines expressing the ssHRP 
protein.
4. To use the expression of this protein in conjunction with DAB- 
cytochemistry to carry out compartment ablation analysis in 3T3-L1 
adipocytes.
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6.2 Introduction
In a previous study (refer to Chapter 4) I used a transferrin-horseradish peroxidase 
(Tf-HRP) conjugate in combination with DAB-cytochemistry to selectively target 
trafficking through the recycling endosomal system. In addition to defining the 
constitutive recycling pathway, HRP probes may also be used to target other 
trafficking pathways. By coupling targeting signals from other proteins to HRP, 
intracellular pathways which cannot be readily accessed from the cell surface can be 
examined. In this regard, a secretory form of peroxidase comprising the signal 
sequence of the human growth hormone and HRP (ssHRP) has previously been used 
as a probe for the exocytic pathway (Connolly et a l, 1994). Upon expression of the 
chimeric protein in mammalian cells, HRP was shown to be active from the earliest 
part of the secretory pathway and was efficiently secreted from the cells via the 
trans cisternae of the Golgi complex, thus acting as an excellent tracer for the exocytic 
pathway (Connolly et a l, 1994).
I have previously shown GLUT4 to extensively co-localise with y-adaptin and the 
CD-M6PR within the TGN region of 3T3-L1 adipocytes (refer to Chapter 3), 
suggesting that this membrane sorting compartment plays an important role in 
GLUT4 trafficking. To further investigate the role of the TGN in this regard, I set 
out to construct an ssHRP chimeric protein with the intention of targeting this 
protein to the exocytic pathway in 3T3-LI adipocytes. Blocking the secretion of 
ssHRP from the TGN by incubating the cells at 20°C (Connolly et a l, 1994) would 
enable me to disrupt trafficking through this compartment using HRP-mediated 
ablation analysis (refer to Section 3.2), thus allowingmes to investigate the role of the 
TGN in GLUT4 trafficking.
In the present study, I show that ssHRP may be targeted to the exocytic pathway 
and efficiently secreted from 3T3-L1 adipocytes. Furthermore, I demonstrate that 
the secretion of the HRP from the cells may be stimulated by insulin. However,
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preliminary ablation studies of the TGN did not show a change in the level of 
TGN38 in the intracellular (LDM) membranes, suggesting that the technique adopted 
needs to be optimised before it may be employed to study the role of the TGN in 
GLUT4 trafficking.
6.3 Materials and Methods
6.3.1 Construction of pOP13.ssHRP.aP2
DNA manipulations were carried out by standard procedures as described in 
Materials and Methods (refer to Chapter 2).
I obtained the HRP cDNA as an engineered gene from Armoracia msticana cloned 
between the Hind III and Eco R1 sites in the polylinker of pUC19. To enable entry 
into the secretory pathway, the signal sequence from human growth hormone (Hall et 
a l, 1990) was added. The signal sequence was removed from the poly linker site of 
pMTL22p (Chambers et a l, 1988) where it had been inserted as a Bam WVHindlll 
fragment to produce pEKSP. To construct the ssHRP chimera, the sshGH fragment 
was excised from pEKSP with Bam }\\-Hind III and inserted into the multiple 
cloning site of pGEM-7Zf(+)® (Promega) linearised with Bam Ul-Hind III. The 
DNA encoding HRP was excised by Min dill-EcoKl from pUC19, and ligated 
downstream of the sshGH into the Hind l\l-Eco RI sites of pGEM-7Zf(+)®. As 
shown in Figure 6.2, the ssHRP construct was subsequently excised by Bam HI from 
pGEM“7Zf(+) and subcloned into the polylinker site of the shuttle vector pNotNot 
(a pGEMlIz and pBluescript polylinker fusion kindly provided by Professor K. 
Siddle, University of Cambridge) (Figure 6.2) cut with Bam HI from which the 
chimera could be subcloned into a suitable mammalian expression vector.
pOP13CAT.aP2 was chosen as a suitable expression vector for transfection into 
3T3-L1 adipocytes as the aP2 element has been shown to function as an adipocyte
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specific promoter (Graves et al., 1992). ssHRP cDNA was excised from pNotNot 
by Not I and inserted into pOP13CAT.aP2 following the removal of the CAT 
reporter gene using Not I (Figure 6.2). The plasmid DNA was digested to ensure that 
the cDNA was inserted in the correct orientation (Figure 6.3).
6.3.2 Calcium Phosphate Transfection of 3T3-L1 Fibroblasts and Selection of 
Stable Transfectants
The method of transfection used was calcium phosphate precipitation, a procedure 
which is especially suitable for fibroblastic cell lines. The transfection mixture 
outlined below was sufficient to transfect one 10cm plate of cells which were seeded 
to be approximately (but no more than) 50% confluent at the time of transfection.
3-4 h prior to transfection the media was changed and the cells were incubated at 
37°C in a humidified atmosphere of 10 % CO2 . 3 h after the media change, the 
transfection mixture was prepared by adding 36jil of 2M CaCl2 and 10 or 20pg of 
DNA made up to 300pl with sterile water, to a 10ml polypropylene tube. 300pl of 
HEPEs Buffered Saline (HBS) was added to a separate tube and the CaCl2-DNA 
mixture was added dropwise (over 2 min) using a pasteur pipette to the HBS, while 
bubbling air through the HBS with another pipette. This resulted in the formation of 
a fine precipitate which was incubated at room temperature for 30 min before being 
added dropwise to the cells. The cells were then incubated at 37°C in a humidified 
atmosphere of 10% CO2 for a further 48 h.
Subsequent selection was then carried out by replacing the media with fresh 
DMEM/10% (v/v) newborn calf serum, 1% (v/v) penicillin and streptomycin 
containing G418 (500pg/ml) as the selection antibiotic. Selection was maintained for 
2-3 weeks with frequent media changes changes to eliminate dead cells and was 
continued until discrete colonies could be visualised. Individual colonies were then
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trypsinised using cloning rings and transferred to 6cm plates for subsequent 
propagation.
6.3.3 HRP Assay
To measure the release of HRP activity into the media, transfected or wild type 3T3~ 
LI adipocytes cultured on 6-well plates were incubated for 2 h at 20°C in external 
solution ([ES] 140mM NaCl, 5mM KCl, 2mM CaCl2, ImM MgCU, lOmM glucose, 
lOmM HEPES, pH7.4) to block secretion. After the incubation, the buffer was 
removed and ES at 37°C was added. Cells were incubated at 37°C and lOOfxl 
fractions of ES were collected every 30 min for 2 h. To measure cell-associated HRP 
activity, cells cultured on 10cm plates were incubated in serum-free DMEM for 2h at 
20°C and then rinsed three times in PBS (refer to Section 2.2.1) containing 0.5% 
BSA. Cells were suspended in 500|al of 50mM Tris/Cl (pH 2.5) and lysed by three 
cycles of freezing and thawing in liquid nitrogen before being centrifuged in a 
microfuge for 5 min at 10,000 x g to produce a high speed supernatant.
The assay to measure HRP activity was carried out as described by Connolly et al 
(Connolly et a i, 1994). Reactions were carried out in a 96-well microtitre plate. 
Equal volumes of reagent (250pl of a saturable solution of o-phenylene diamine in 
methanol, 10ml of lOOmM sodium citrate / 1% Triton X-100 [pH 5.5)] and 7p.l 30% 
H2O2) and sample (ES fractions or supernatant from the above procedures) were 
added to the microtitre plate and incubated at 37°C in the dark. After 60 min, the 
reaction was stopped by the addition of 0.5 volumes of 2M HCl. HRP activity 
released into the media was quantitated by measuring the absorbance at 450nm and is 
expressed in arbitrary units. Buffer alone (as a negative control) and Tf-HRP loaded 
cells (as a positive control) were assayed in parallel.
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6.3.4 Ablation of the Intracellular (LDM) Membranes using ssHRP
Cells cultured on 10cm plates were incubated in serum-free DMEM for 2 h at 20°C 
to block protein trafficking through the TON (Matlin et a i, 1983). The cells were 
transferred onto ice and treated with DAB ± H2O2 (Section 3.3.1), incubated at 4°C 
in the dark for 60 min, washed and the intracellular membranes were prepared as 
described in Section 3.3.1.
6.3.5 Antibodies
The anti-GLUT4 antibody used for immunoblotting the intracellular (LDM) 
membranes was a rabbit polyclonal against a peptide comprising the C-tenninal 14 
amino acid residues of the human isoform of GLUT4 (see Section 2.4). Anti-TGN38 
was a generous gift from Dr G. Banting (University of Bristol, UK).
6.4 Results
6.4.1 Restriction Digestion Analysis of pOP13.ssHRP.aP2
The chimeric cDNA of ssHRP was excised from the pNotNot vector as a Not I 
fragment of ~lkb in length. The fragment was subsequently purified and ligated into 
pOP13.aP2 following the digestion of pOP13CAT.aP2 with Not I to remove the 
CAT reporter gene (Figure 6.2). Following the transformation of competent E. coli 
cells, individual clones were screened by digestion with Not I for the presence of the 
~ Ikb insert. On selection of positive clones, restriction with Sma I and Kpn I would 
yield a fragment ~ 1.5kb in length if in the correct orientation as shown in Figure 6.3, 
or a smaller fragment ~ O.Skb in length if in the incorrect orientation.
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6.4.2 Secretion of HRP from 3T3-L1 Adipocytes and the Effect of Insulin
To target HRP to the exocytic pathway in 3T3-L1 adipocytes, I constructed a 
chimeric cDNA comprising the signal sequence of the human growth hormone 
attached to the amino terminus of HRP (Figure 6.1). This chimeric cDNA ssHRP, 
was then eloned into a suitable mammalian expression vector to create 
pOP13.ssHRP.aP2 (Figure 6.2) and transfected into 3T3-L1 fibroblasts.
I then attempted to establish stable lines of 3T3-L1 adipocyte cells expressing 
ssHRP. This was successful, although the extent of differentiation varied between 
the cell lines. Initially, cells were screened for ssHRP expression by measuring the 
activity of cell-associated HRP activity (refer to Section 6.3.3). In preliminary 
studies I found that HRP activity was barely detectable when cells were incubated at 
37°C. I therefore reduced the incubation temperature to 20°C to block trafficking 
through the TON and induce an increase in the level of intracellular HRP. Figure 6.4 
illustrates the level of eeli-associated HRP activity of two pOP13.ssHRP.aP2 clones 
referred to as SS-2 and SS-3, compared to wild type 3T3-L1 adipocytes. The 
difference in the levels of cell-associated HRP activity exhibited by SS-2 and SS-3 is 
most likely a function of the level of expression exhibited by the individual clones. 
However, it should be noted that such a difference in cell-associated activity may 
also be a reflection of the extent of differentiation. In each passage, the SS-3 cell line 
consistently produced a uniform lawn of cells, whereas the SS-2 cell line was 
noticably more patchy upon differentiation.
To test if the ssHRP was entering the exocytic pathway, I investigated whether the 
HRP activity was efficiently secreted from the 3T3-L1 adipocytes by assaying for 
enzyme activity in the medium. As before, to increase the level of detectable HRP 
activity secreted into the medium, the cells were incubated at 20°C to allow HRP 
activity to accumulate within the cell before being released at 37°C. As shown in 
Figure 6.5A and B, HRP activity is secreted from both basal (non-stimulated) SS-2 
and SS-3 cell lines, indicating that the ssHRP chimera has been targeted to the
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constitutive secretory pathway in 3T3-L1 adipocytes. Consistent with the cell- 
association data, the SS-3 done exhibited a much higher level of secretion than the SS- 
2 clone. Upon exposure to insulin, both cell lines exhibited an increase in the 
secretion of HRP activity, consistent with the insulin-stimulated secretion of adipsin 
in 3T3-L1 adipocytes (refer to Section 5.4.5).
6.4.3 Ablation of Intracellular (LDM) Membranes using ssHRP
Having established stable cell lines of 3T3-L1 adipocytes in which HRP activity is 
present within the secretoiy pathway, I wished to use the peroxidase probe to ablate 
the TON compartment within these cells. To do this I incubated SS-2 and SS-3 
adipocytes at 20°C for 2 h in order to allow HRP activity to accumulate within the 
TON. I then exposed the cells to DAB ± H2O2 as described in Section 3.3.1. To 
determine whether the TGN was effectively ablated under these conditions, I 
immunoblotted the intracellular (LDM) membranes of the cells for the presence of a 
putative TGN marker, TGN38. As shown in Figure 6.6, there was no significant 
change in the immunoreactivity of the TGN marker following ablation of either of the 
cell lines, indicating that the experimental conditions employed did not result in 
ablation of the TGN. In addition, I also immunoblotted the samples for GLUT4. No 
significant change was observed in the immunoreactivity of this protein in the 
presence of H2O2 .
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Figure 6.1 
Structure of ssHRP
hGH HRP
M GSA FPTIPLS SGTKLH MQLT VNSNS
t
Signal Peptidase
This figure shows the elements of the ssHRP construct used in this 
study. Boxed sequences are the main components (hGH, human 
growth hormone); KL indicates the site of fusion of hGH to the N- 
terminus of HRP. The predicted site of signal peptidase cleavage is 
shown.
Figure 6.2
Construction of pOP13.ssHRP.aP2
pOP13CAT.aP2 was chosen as a suitable expression vector for transfection into 
3T3-L1 adipocytes as the aP2 element has been shown to function as an adipocyte 
specific promoter (Graves et a l, 1992). The ssHRP construct was excised by Bam 
HI from pGEM-7Zf(+)® and subcloned into the polylinker site of the shuttle vector 
pNotNot (a pGEMl Iz and pBluescript polylinker fusion) cut with Bam HI. ssHRP 
cDNA was excised from pNotNot by Not I and inserted into pOP13CAT.aP2 
following the removal of the CAT reporter gene using Not I.
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Figure 6.3
Restriction Digestion Analysis of the pOP13.ssHRP.aP2 Construct
Following the transformation of competent E. coli cells, individual clones were 
screened by digestion with Not I for the presence of the ~ Ikb insert. In order to 
determine whether the chimeric cDNA was inserted into the vector in the correct 
orientation, the positive clones were subjected to restriction digestion analysis. 
Restriction with Sma I and Kpn I would yield a fragment ~ 1.5kb in length if in the 
correct orientation or a smaller fragment ~ O.Skb in length if in the incorrect 
orientation.
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Figure 6.4
Cell-Associated HRP Activity of SS-2 and SS-3 Adipocytes
Transfected (SS-2 and SS-3) or wild type 3T3-L1 adipocytes cultured on 10cm 
plates were incubated in serum-free DMEM for 2h at 20°C and then rinsed three 
times in PBS containing 0.5% BSA. Cells were suspended in Tris/Cl, lysed and 
centrifuged to produce a high speed supernatant as described in Materials and 
Methods. HRP activity in the supernatant was assayed as described. As the cell- 
associated HRP activity was only measured for the purpose of screening the 
individual clones, this experiment was only carried out once for each cell line.
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Figure 6.5
Secretion of HRP Activity from SS-2 and SS-3 Adipocytes
Duplicate wells of SS-2 (A) and SS-3 or wild type (WT) (B) 3T3-L1 adipocytes 
were incubated in ES buffer for 2 h at 20°C. Cells were then incubated in fresh ES 
buffer with or without insulin at 37°C. Secreted HRP activity was assayed as 
described in Materials and Methods. In each case, the data shown are of a 
representative experiment (n = 2).
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Figure 6.6
Ablation of Intracellular (LDM) Membranes using ssHRP
Duplicate plates of SS-2 and SS-3 adipocytes were incubated with DAB ± H2O2 as 
described. Intracellular (LDM) membrane fractions were prepared and subjected to 
SDS-PAGE (20pg/lane), electrophoretically transferred to nitrocellulose membranes, 
and immunoblotted with the antibodies indicated. The immunoblots were developed 
using ECL. The effect of ablation was determined by comparison of the signals in 
the - and + lanes. It should be noted that due to time constriants n = 1.
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6.5 Discussion
In previous studies (refer to Chapters 3 and 4) we exploited the ability of HRP in the 
presence of DAB and H2O 2 , to render co-localised proteins insoluble in the 
endocytic pathway. This ablation technique proved to be extremely useful for 
quantitative studies of protein distribution between intracellular compartments 
within 3T3-L1 adipocytes. In this regard, we observed GLUT4 to co-localise with 
TGN specific markers, y-adaptin and the CD-M6PR, suggesting that GLUT4 traffics 
through this membrane sorting compartment.
As an attempt to investigate the role of the TGN in GLUT4 trafficking, we wished 
to further exploit this ablation technique by targeting an HRP probe to the exocytic 
pathway in 3T3-L1 adipocytes. To do this, we set about constructing a cDNA 
chimera comprising the human growth hormone signal sequence fused in frame to the 
N-terminus of HRP (Figure 6.1). By doing so, we wished to establish stable 3T3-L1 
adipocyte cell lines in which a chimeric protein, ssHRP, would be targeted to the 
exocytic system.
As a first step to determine whether the antibiotic selected cell lines expressed HRP 
activity, we initially screened the cell lines by measuring the cell-associated HRP 
activity. Due to low levels of detectable HRP activity in preliminary studies, we 
carried out a temperature block at 20°C to allow the HRP to accumulate within the 
intracellular membranes. This resulted in the identification of two cell lines, refen ed 
to as SS-2 and SS-3, both of which expressed HRP activity compared to wild type 
3T3-L1 adipocytes (Figure 6.4). The level of HRP activity observed in the SS-3 cell 
line was much higher than that of SS-2, suggesting a higher level of expression in the 
SS-3 cells. However, it should be noted that the extent of differentiation was much 
poorer in the case of the SS-2 cell line, which may also result in a lower level of HRP 
activity.
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Next, to determine whether the ssHRP was entering the exocytic pathway in 3T3-L1 
adipocytes, we measured the HRP activity secreted from the cells into the medium. 
Preliminary studies showed both basal (non-stimulated) SS-2 and SS-3 adipocytes to 
secrete HRP into the medium, consistent with the targeting of the protein to the 
constitutive secretory pathway within these cells (Figure 6.5A and B). Furthermore, 
both cell lines exhibited an increase in HRP secretion in response to insulin. This 
data is consistent with the insulin-stimulated release of adipsin, a soluble protein 
which is also constitutively secreted from 3T3-L1 adipocytes (Kitagawa et a i, 
1989). However, further studies are required to compare the time course of insulin- 
stimulated adipsin release with that for insulin-stimulated HRP release.
The expression of such a protein in several other mammalian cell lines has shown that 
the HRP is active from the beginning of the secretory pathway (Connolly et a l, 
1994). Furthermore, morphological studies on these cells have shown that it is 
possible to load the trans side of the Golgi stack with this activity by incubating the 
cells at 20°C. The accumulation of HRP activity is thought to result as at 20°C 
trafficking is blocked from the TGN, but the processes which concentrate secretory 
product still operate within compartments proximal to this block (Connolly et a l, 
1994). With this in mind, we set out to attempt to ablate the TGN of 3T3-L1 
adipocytes. Initially, we incubated SS-2 and SS-3 adipocytes at 20°C for 2 h in order 
to allow the accumulation of HRP activity within the TGN before exposing the cells 
to DAB and H2O2 . Under these conditions, proteins localised to the TGN should be 
rendered 'insoluble' and therefore quantitatively ablated upon immunoblot analysis of 
the intracellular (LDM) membranes. However, as shown in Figure 6.6, there was no 
significant difference in either cell line in the immunoreactivity of the TGN38 in the 
presence of H2O2 , suggesting that the experimental conditions employed in this 
preliminary study did not result in the ablation of the TGN.
In these initial experiments, the procedure for HRP-mediated ablation was performed 
as described for the ablation of the endosomal system (refer to Section 3.3.1).
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However, from this data it is apparent that the conditions under which ssHRP- 
mediated ablation of the TGN is carried out need to be optimised. In this regard, we 
need to determine the conditions required for the accumulation of ssHRP in the TGN 
in terms of the incubation period at 20°C. This may be achieved by determining the 
amount of ssHRP localised to TGN38 vesicles immunoadsorbed from the 
intracellular membranes of cells incubated at 20°C for varying periods of time. In 
addition, as the TGN is likely to be a much more restricted compartment than the 
endosomes loaded with Tf-HRP, it is possible that in order to target this 
compartment with DAB and H2O2 , higher concentrations of these reagents may be 
required for the disruption of the TGN function in a manner analagous to that 
performed using Tf-HRP. However, due to the time constraints of this work I was 
unable to pursue such studies.
In summary, we have established stable cell lines of 3T3-L1 adipocytes expressing an 
ssHRP chimeric protein which is targeted to the exocytic pathway within these cells. 
However, the experimental conditions required to exploit this protein for ssHRP- 
mediated ablation of the TGN have yet to be optimised.
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6.6 Future Work
Unfortunately, due to the time constraints of this work we were unable to exploit the 
compartment ablation technique to further investigate the role of the TGN in GLUT4 
trafficking. In this regard, it would be of interest to examine insulin-stimulated 
GLUT4 translocation following the disruption of the TGN. In addition, by studying 
the re-internalisation and / or intracellular distribution of GLUT4 upon insulin 
withdrawl, following the disruption of the TGN, it may be possible to determine 
whether the TGN is required for the sorting of GLUT4 into the post-endocytic 
storage compartment. However, the ability to carry out such experiments will 
depend on the optimisation of the conditions required for ssHRP-mediated ablation 
of the TGN.
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Chapter 7 
Overview
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In the post-prandial state, high levels of circulating blood glucose induce the release 
of insulin from the pancreas. In turn, insulin stimulates the disposal of glucose from 
the circulation into the peripheral tissues, fat and muscle. It is well established that 
the rapid increase in glucose uptake into these cells in response to insulin is due to 
the translocation of a pool of intracellular glucose transporters (GLUT4) to the cell 
surface. Defects in glucose uptake into these peripheral tissues have a profound 
effect on whole body glucose homeostasis, leading to insulin resistance, such as is 
observed in individuals with diabetes. A potential defect in this system is the 
impairment of GLUT4 translocation in response to insulin. Such a defect may arise 
due to defective insulin signalling to the intracellular GLUT4 pool, abnormalities in 
the GLUT4 trafficking machinery or mistargeting of GLUT4 within the cells 
intracellular compartments. Thus, it is important that we gain further insight into the 
nature of the GLUT4 intracellular compartment(s) and the mechanism of GLUT4 
translocation to the cell surface in response to insulin.
Recently, several independent studies have indicated that GLUT4 resides within at 
least two distinct intracellular compartments in adipocytes, one of which is 
endosomal, the other a non-ablatable post-endocytic compartment (Livingstone et 
al., 1996; Martin et a i, 1996; Malide et a l, 1997a). It is thought that this non- 
ablatable post-endocytic compartment represents the insulin-responsive GLUT4 
pool. However, to date the nature of this compartment remains poorly defined. 
With this in mind, I wished to elucidate the protein composition of the non-ablatable 
GLUT4 storage compartment in the expectation that this may further our 
understanding of the relationship of this compartment with other, well established, 
intracellular compartments. Using endosomal ablation analysis in combination with 
several other techniques, I have provided further evidence for the segregation of 
GLUT4 between the recycling endosomal system, enriched in cell surface to 
endosome recycling markers such as the TfR and SCAMPs, and a non-ablatable 
post-endocytic compartment. The observation that syntaxin 4 co-localised with 
GLUT4 in the latter compartment suggests that this t-SNARE may be involved in
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GLUT4 trafficking at an intracellular level. In addition, I found GLUT4 to co- 
localise with two distinct TGN markers; the y-adaptin subunit of the TGN-specific 
adaptor complex AP-1 and the CD-M6PR which recycles between the TGN and 
endosomal compartments. These data suggest that the GLUT4 trafficking pathway 
in basal 3T3-L1 adipocytes includes trafficking through the TGN in AP-1 coated 
vesicles. However, as these vesicles also contain a significant proportion of the CD- 
M6PR it is unlikely that they fuse directly with the cell surface, but rather recycle 
back as far as the TGN before GLUT4 is withdrawn from the endosomal system into 
the post-endocytic storage compartment.
The observation that several of the components of the insulin-regulatable trafficking 
machinery are indeed homologous if not indentical to the molecules used for SSV 
exocytosis in neurons, suggests that vesicles from the GLUT4 storage compartment 
have the potential to dock and fuse directly with the cell surface in response to 
insulin. In an effort to address this issue, I used endosomal ablation to examine the 
translocation of GLUT4 from the endosomal and non-ablatable post-endocytic 
compartments to the cell surface in response to insulin. Initial studies showed 
insulin to stimulate GLUT4 translocation following the disruption of trafficking 
through the endosomal system, suggesting that GLUT4 vesicles derived from the 
post-endocytic storage compartment may indeed fuse directly with the plasma 
membrane. However, further studies indicated that under the experimental 
conditions used in this study recycling through a re-formed endosomal system was 
possible. Thus, endosomal ablation analysis did not provide definitive evidence for 
the translocation of GLUT4 from the post-endocytic compartment to the plasma 
membrane independently of the endosomal system. Under the same conditions, 
however, I found GTPyS-stimulated GLUT4 translocation to be inhibited. In 
addition I observed both insulin and GTPyS-stimulated GLUTl translocation to be 
inhibited following ablation of the recycling endosmal system. Together these data 
suggest that insulin stimulates the exocytosis of GLUT4 from two distinct
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compartments, one being the post-endocytic storage compartment and the other 
being the endosomal system,which may also be stimulated by GTPyS.
Recent studies have implicated ARF proteins as key components of the regulated 
exocytotic machinery in endocrine cells (Chen et a l, 1996; Galas et a l, 1997). As 
insulin-stimulated GLUT4 translocation exhibits many similarities to regulated 
secretion in neuroendocrine and endocrine cells, I set out to investigate whether ARF 
proteins may also be an important component of the GLUT4 trafficking machinery. 
By introducing myristoylated N-terminus ARFl, 5 or 6 peptides into a-toxin 
permeabilised 3T3-L1 adipocytes, I found that the ARF6 peptide markedly inhibited 
insulin-stimulated GLUT4 translocation and glucose transport, whereas the ARF5 
and ARFl peptides were without effect. These results suggest that ARF6 plays a 
crucial role in insulin-stimulated GLUT4 translocation, consistent with a general role 
for this small GTP-binding protein in regulated exocytosis. In addition, I investigated 
the role of PLD in insulin-stimulated GLUT4 translocation, as this enzyme has 
recently been shown to act as a downstream effector of ARF in regulated secretory 
events (Stutchfield e ta l,  1993; Ktistakis etal., 1996; Chen e ta l,  1997b). However 
butan-l-ol, an effective inhibitor of PLD activity, had no effect on insulin-stimulated 
GLUT4 translocation or glucose transport, suggesting that PLD does not function as 
a downstream effector of ARF in this event.
Finally, the observation that GLUT4 traffics through the TGN (see above), 
prompted me to construct a chimeric cDNA comprising the signal sequence of the 
human growth hormone and HRP (ssHRP) with the intention of targeting the 
resultant protein to the exocytic pathway in 3T3-L1 adipocytes. By doing so,Ie 
wished to further examine the role of the TGN in GLUT4 trafficking by disrupting 
trafficking through this sorting compartment by HRP-mediated ablation. However, 
although I established several stable cell lines expressing ssHRP activity which was 
constitutively secreted from the cells, I was unable to demonstrate that such a 
technique may be employed to ablate the TGN.
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